var title_f41_59_42928="Inspection for pelvic obliquity";
var content_f41_59_42928=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F80105&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F80105&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Inspection for pelvic obliquity",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 265px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This test is used as a screening maneuver for leg length discrepancy. The patient is asked to stand. The hands are placed on top of the iliac crests and the level of the pelvis is estimated. Asymetry of the iliac crests is seen with leg length discrepancy, pelvic fracture, scoliosis, and unilateral paraspinal muscle spasm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42928=[""].join("\n");
var outline_f41_59_42928=null;
var title_f41_59_42929="LV noncompaction short axis";
var content_f41_59_42929=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59614&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Left ventricular noncompaction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Short-axis view of a two-dimensional echocardiogram at endsystole in a patient with isolated left ventricular noncompaction. The ratio of noncompacted myocardium (white line) to compacted myocardium (red line) is 2.2:1. A ratio &ge;2:1 at end-systole with thickening of the myocardial wall is considered to be diagnostic of left ventricular noncompaction. A ratio &ge;2:1 is occasionally seen in patients with dilated cardiomyopathy, but there is no thickening of the myocardial wall.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42929=[""].join("\n");
var outline_f41_59_42929=null;
var title_f41_59_42930="DEB1";
var content_f41_59_42930=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86594&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86594&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Recessive dystrophic epidermolysis bullosa (DEB)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 382px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Large nonhealing erosions and ulcers in severe generalized recessive dystrophic epidermolysis bullosa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dedee F Murrell, MD, Johann Bauer, MD, and Martin Laimer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42930=[""].join("\n");
var outline_f41_59_42930=null;
var title_f41_59_42931="Headache treatment in adults";
var content_f41_59_42931=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Headache treatment in adults (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?41/59/42931/contributors\">",
"       Authors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42931/contributors\" id=\"au1611\">",
"       Zahid H Bajwa, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42931/contributors\" id=\"au4358\">",
"       R Joshua Wootton, MDiv, PhD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?41/59/42931/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42931/contributors\" id=\"se7359\">",
"       Jerry W Swanson, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?41/59/42931/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42931/contributors\" id=\"de6967\">",
"       John F Dashe, MD, PhD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?41/59/42931?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      HEADACHE OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     In many people, headaches can be well controlled with a combination of medicines and complementary therapies. Treatment is most successful when it is tailored to your needs.",
"    </p>",
"    <p>",
"     The treatment of tension, chronic daily, medication overuse, and cluster headaches will be reviewed here (",
"     <a class=\"graphic graphic_table graphicRef76857 \" href=\"mobipreview.htm?41/59/42939\">",
"      table 1",
"     </a>",
"     ). Migraine headaches are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/57/35731?source=see_link\">",
"      \"Patient information: Migraine headaches in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The causes and diagnosis of headache are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/51/16179?source=see_link\">",
"      \"Patient information: Headache causes and diagnosis in adults (Beyond the Basics)\"",
"     </a>",
"     .) A discussion of headaches in children is also available. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/15/36086?source=see_link\">",
"      \"Patient information: Headache in children (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      HEADACHE TREATMENT TYPES",
"     </span>",
"    </p>",
"    <p>",
"     Headache treatment depends upon the frequency, severity, and symptoms of your headache.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Acute treatment refers to medicines you can take when you have a headache to relieve the pain immediately.",
"      </li>",
"      <li>",
"       Preventive treatment refers to medicines you can take on a regular (usually daily) basis to prevent headaches in the future.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      TENSION TYPE HEADACHE TREATMENT",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Acute treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Tension type headaches that occur less than 15 times per month can usually be treated with a pain reliever. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/13/37079?source=see_link\">",
"      \"Tension-type headache in adults: Acute treatment\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h3\">",
"      Pain reliever",
"     </span>",
"     &nbsp;&mdash;&nbsp;A pain reliever may be recommended first for the treatment of tension type headache. These drugs include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Aspirin",
"      </li>",
"      <li>",
"       Acetaminophen (eg, Tylenol&reg;)",
"      </li>",
"      <li>",
"       Nonsteroidal antiinflammatory drugs (NSAIDs) such as ibuprofen (eg, Motrin or Advil), indomethacin, or naproxen (eg, Naprosyn or Aleve).",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Pain relievers should not be used too often because overuse can lead to medication-overuse headaches or chronic daily headaches. If you respond to a pain reliever, you should continue taking these with each headache. However:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Do not use pain relievers more than nine days per month on average, or more than two doses per episode.",
"      </li>",
"      <li>",
"       If a pain reliever does not control your headache, talk to your healthcare provider for other suggestions.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     People with gastritis (inflammation of the stomach), ulcers, kidney disease, and bleeding conditions should not take products containing aspirin or NSAIDs.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h3\">",
"      Pain medicine combinations",
"     </span>",
"     &nbsp;&mdash;&nbsp;Mild pain relievers are also available in combination with caffeine, which enhances the drug's effect. As an example, Excedrin&reg; contains a combination of acetaminophen-aspirin-caffeine. This combination may be recommended if a pain reliever alone does not relieve the headache. However, this combination is not recommended more than nine days per month due to the potential risk of developing medication-overuse headaches.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h3\">",
"      Combination medicines containing butalbital and opioids",
"     </span>",
"     &nbsp;&mdash;&nbsp;A small percentage of people with headaches do not respond to routine treatments and may require additional, prescription medicines for pain. Combinations of an opioid (narcotic) and a pain reliever are available, but are generally not recommended since they are habit-forming and can increase the risk of medication-overuse headaches and chronic daily headaches. Even so, such medications may be considered in special situations where simple pain relievers are ineffective or contraindicated (eg, women in the third trimester of pregnancy, patients with ulcers, severe kidney failure, or liver failure). When healthcare providers encounter patients who are using opioids and barbiturates inappropriately, a \"stop or brake\" policy may be put into place. The use of these medications is then either stopped, or the frequency of use is braked by limiting them to no more than two days per week and 18 tablets per month.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Preventive treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Preventive therapy is recommended for people with headaches more than two to three times per week. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/25/1433?source=see_link\">",
"      \"Tension-type headache in adults: Preventive treatment\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h3\">",
"      Antidepressants",
"     </span>",
"     &nbsp;&mdash;&nbsp;Antidepressant medicines called tricyclics (TCAs) are often used to help prevent frequent tension headaches. Examples of TCAs include amitriptyline (used most commonly), nortriptyline, and protriptyline.",
"    </p>",
"    <p>",
"     The dose of TCAs used for people with headaches is typically much lower than that used for treating depression. It is believed that these drugs reduce pain perception when used in low doses, although it is not exactly clear how the medicines work.",
"    </p>",
"    <p>",
"     It is common to feel tired when you start taking TCAs; this is not always an undesirable side effect since it can help improve sleep if you take TCAs in the evening. TCAs are generally started in low doses and increased gradually. Their full effect may not be seen for weeks to months.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h3\">",
"      Other treatments",
"     </span>",
"     &nbsp;&mdash;&nbsp;Tricyclic antidepressants are sometimes used in combination with behavioral therapy to prevent tension-type headaches. The goal of behavioral therapy is to identify and try to avoid behaviors that can trigger a headache. (See",
"     <a class=\"local\" href=\"#H17\">",
"      'Lifestyle changes'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      CHRONIC DAILY HEADACHE TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     The management of chronic daily headache depends on the type of background headache (eg, chronic migraine or chronic tension-type headache) and the presence or absence of medication overuse. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37830?source=see_link&amp;anchor=H18#H18\">",
"      \"Overview of chronic daily headache\", section on 'Treatment'",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The treatment of chronic migraine should focus on preventive therapy while avoiding migraine triggers and limiting the use of acute headache medications to avoid medication overuse headache. Preventive treatments include medicines, behavioral therapy, or physical therapy. Management often requires the simultaneous use of these different treatments. (See",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?6/61/7128?source=see_link&amp;anchor=H7#H7\">",
"        \"Chronic migraine\", section on 'Management'",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       For chronic tension-type headache, effective treatment involves the use of daily preventive medications (eg, tricyclic antidepressants), behavioral therapies and physical therapy. Like chronic migraine, the combined use of these interventions is often best. (See",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?1/25/1433?source=see_link\">",
"        \"Tension-type headache in adults: Preventive treatment\"",
"       </a>",
"       and",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?33/59/34744?source=see_link&amp;anchor=H12#H12\">",
"        \"Tension-type headache in children\", section on 'Treatment'",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       For medication overuse headache, basic steps are patient education, withdrawal of the overused medication, bridge therapy aimed at headache relief during medication withdrawal, establishment of a headache treatment program appropriate for the underlying type of headache, and relapse prevention. (See",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?16/48/17161?source=see_link\">",
"        \"Medication overuse headache: Treatment and prognosis\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      CLUSTER HEADACHE TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Most people who suffer with cluster headaches will need both acute and preventive medicines. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/51/3898?source=see_link\">",
"      \"Cluster headache: Acute and preventive treatment\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Acute therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Acute therapy often includes one or more of the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Inhaling 100 percent oxygen through a face mask for 20 minutes. Oxygen treatment is often recommended first because it has few side effects.",
"      </li>",
"      <li>",
"       Triptans are medicines often used to treat migraines. Triptans (especially injections of sumatriptan) can stop a cluster headache, often within 20 to 30 minutes. If you are unable to give yourself an injection, options include inhaled (nasal spray) sumatriptan or zolmitriptan.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     If neither oxygen nor triptans are helpful, alternative choices include octreotide (an injection), lidocaine (liquid applied inside the nose), and ergotamine (a tablet dissolved under the tongue).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Preventive treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Preventive therapy is usually started as soon as possible and taken every day when a new cluster of headaches develops. Some people require a combination of medicines. Preventive medicines may be gradually stopped after the cluster has passed, but can be restarted if symptoms recur. The best studied medicines include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Verapamil, a calcium channel blocker, is a pill that is effective and has few side effects. The dose may be slowly increased as needed.",
"      </li>",
"      <li>",
"       The glucocorticoid drug prednisone (a pill) is an effective preventive therapy. However, long-term use of glucocorticoids is not recommended due to the risk of side effects.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      COMPLEMENTARY HEADACHE TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     Several therapies can be used along with medical treatment in people with headache.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Lifestyle changes",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some simple lifestyle adjustments can help to reduce the frequency of headaches. These include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Stop smoking",
"      </li>",
"      <li>",
"       Reduce the amount of alcohol you drink",
"      </li>",
"      <li>",
"       Decrease or stop",
"       <span class=\"nowrap\">",
"        drinking/eating",
"       </span>",
"       caffeine",
"      </li>",
"      <li>",
"       Eat and sleep on a regular schedule",
"      </li>",
"      <li>",
"       Exercise several times per week",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     While there are no clinical trials proving the benefit of these measures, many headache specialists have found them helpful for their patients.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h2\">",
"      Physical therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some people with frequent headaches benefit from working with a physical therapist who has a special interest in headaches. This treatment may be used if you do not respond or only partially or temporarily respond to medicines, or if you cannot use medicines (eg, women who are pregnant or breastfeeding). (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/63/5114?source=see_link\">",
"      \"Headache in pregnancy\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Acupuncture",
"     </span>",
"     &nbsp;&mdash;&nbsp;Acupuncture involves inserting hair-thin, metal needles into the skin at specific points on the body. It causes little to no pain. Electrical stimulation is sometimes applied to the acupuncture needle. Acupuncture has not been proven to improve tension-type or chronic daily headaches. However, people who do not want to try or who cannot tolerate other treatments may try using acupuncture. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/25/1433?source=see_link&amp;anchor=H20#H20\">",
"      \"Tension-type headache in adults: Preventive treatment\", section on 'Acupuncture'",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/56/42889?source=see_link&amp;anchor=H25#H25\">",
"      \"Preventive treatment of migraine in adults\", section on 'Acupuncture'",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Behavioral therapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Headaches can be triggered or worsened by stress, anxiety, depression, and other psychological factors. Furthermore, living with headache pain can cause difficulties in relationships, at work or school, and with general day to day living.",
"    </p>",
"    <p>",
"     Behavioral therapy works by helping you to address the stress, anger, or frustration that can come with frequent or chronic headache pain. There are many different types of behavioral therapy:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Psychotherapy involves meeting with a psychologist, psychiatrist, or social worker to discuss emotional responses to living with chronic pain, treatment successes or failures,",
"       <span class=\"nowrap\">",
"        and/or",
"       </span>",
"       personal relationships.",
"      </li>",
"      <li>",
"       Group psychotherapy allows you to compare your experiences with headaches, overcome the tendency to withdraw and become isolated in your pain, and support others' attempts with pain management.",
"      </li>",
"      <li>",
"       Relaxation techniques can relieve muscle tension, and may include meditation, progressive muscle relaxation, self-hypnosis, and biofeedback. Biofeedback may be especially helpful for people with chronic tension-type headaches.",
"      </li>",
"      <li>",
"       Group skill-building exercises help you to learn about living with pain, including ways to improve relationships and build strength, ways to avoid negative thinking, and learning to deal with pain flares. A number of self-help books are also available on these topics, including Turk and Winter's The Pain Survival Guide: How to Reclaim Your Life, and Caudill's Managing Pain Before It Manages You [",
"       <a class=\"abstract\" href=\"mobipreview.htm?41/59/42931/abstract/1,2\">",
"        1,2",
"       </a>",
"       ].",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Herbal and homeopathic remedies",
"     </span>",
"     &nbsp;&mdash;&nbsp;A number of homeopathic remedies are promoted to relieve or prevent headaches, including migraines. However, the effect of these remedies is not clear and these remedies are not recommended.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1804426231\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15026921\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/31/3570?source=see_link\">",
"      Patient information: Headache (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?26/29/27090?source=see_link\">",
"      Patient information: Headaches in children (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/12/22722?source=see_link\">",
"      Patient information: Concussion (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15026936\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/57/35731?source=see_link\">",
"      Patient information: Migraine headaches in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?15/51/16179?source=see_link\">",
"      Patient information: Headache causes and diagnosis in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/15/36086?source=see_link\">",
"      Patient information: Headache in children (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/44/21194?source=see_link\">",
"      Acute treatment of migraine in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/44/44743?source=see_link\">",
"      Basilar-type migraine",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/61/7128?source=see_link\">",
"      Chronic migraine",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/51/3898?source=see_link\">",
"      Cluster headache: Acute and preventive treatment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/63/14327?source=see_link\">",
"      Cluster headache: Epidemiology, clinical features, and diagnosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/38/35433?source=see_link\">",
"      Estrogen-associated migraine",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34615?source=see_link\">",
"      Evaluation of headache in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/49/39704?source=see_link\">",
"      Evaluation of the adult with headache in the emergency department",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/63/5114?source=see_link\">",
"      Headache in pregnancy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/34/3624?source=see_link\">",
"      Headache syndromes other than migraine",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32953?source=see_link\">",
"      Headache, migraine, and stroke",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/36/5700?source=see_link\">",
"      Hypnic headache",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35879?source=see_link\">",
"      Medication overuse headache: Etiology, clinical features, and diagnosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37830?source=see_link\">",
"      Overview of chronic daily headache",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/4/26698?source=see_link\">",
"      Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/46/20198?source=see_link\">",
"      Post-lumbar puncture headache",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/56/42889?source=see_link\">",
"      Preventive treatment of migraine in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/13/37079?source=see_link\">",
"      Tension-type headache in adults: Acute treatment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32441?source=see_link\">",
"      Tension-type headache in adults: Pathophysiology, clinical features, and diagnosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/25/1433?source=see_link\">",
"      Tension-type headache in adults: Preventive treatment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/19/12601?source=see_link\">",
"      Thunderclap headache",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/headache.html\">",
"      www.nlm.nih.gov/medlineplus/headache.html",
"     </a>",
"     , available in Spanish)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Neurological Disorders and Stroke",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.ninds.nih.gov/disorders/headache/headache.htm\">",
"      www.ninds.nih.gov/disorders/headache/headache.htm",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Headache Society",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.achenet.org/resources/information_for_patients/\">",
"      www.achenet.org/resources/information_for_patients/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?41/59/42931/abstract/3-9\">",
"      3-9",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 17, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?41/59/42931?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     Turk, DC, Winter, F. The Pain Survival Guide: How to Reclaim Your Life. Washington, DC: American Psychological Association, 2005.",
"    </li>",
"    <li>",
"     Caudill, MA. Managing Pain Before It Manages You, 3rd Edition. New York: Guilford Press, 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42931/abstract/3\">",
"      Dodick DW. Clinical practice. Chronic daily headache. N Engl J Med 2006; 354:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42931/abstract/4\">",
"      Lipton RB, Stewart WF, Stone AM, et al. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial. JAMA 2000; 284:2599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42931/abstract/5\">",
"      Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55:754.",
"     </a>",
"    </li>",
"    <li>",
"     Silberstein, SD, Rosenberg, J. Multispecialty consensus on diagnosis and treatment of headache. Neurology 2000; 54:1553. Full text of guidelines available at www.neurology.org/cgi/reprint/54/8/1553?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=1&amp;title=headache+consensus&amp;andorexacttitle=and&amp;andorexacttitleabs=and&amp;andorexactfulltext=and&amp;searchid=1&amp;FIRSTINDEX=0&amp;sortspec=relevance&amp;resourcetype=HWCIT.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42931/abstract/7\">",
"      Mathew NT. Transformed migraine, analgesic rebound, and other chronic daily headaches. Neurol Clin 1997; 15:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42931/abstract/8\">",
"      Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia 2002; 22:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42931/abstract/9\">",
"      Tomkins GE, Jackson JL, O'Malley PG, et al. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 2001; 111:54.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f41_59_42931=[""].join("\n");
var outline_f41_59_42931=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           HEADACHE OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           HEADACHE TREATMENT TYPES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           TENSION TYPE HEADACHE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           CHRONIC DAILY HEADACHE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           CLUSTER HEADACHE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           COMPLEMENTARY HEADACHE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?41/59/42939\" title=\"table 1\">",
"           Headache syndromes PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f41_59_42932="CT scan equivocal appendicitis";
var content_f41_59_42932=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F83554&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F83554&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    CT scan equivocal appendicitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 268px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The patient is a 56-year-old male who presents with right lower quadrant pain. The CT scan of the lower abdomen in the axial plane (A) and the magnified view of the appendix (B) show a normal sized appendix with surrounding induration (red arrow). The periappendiceal induration raises the possibility of appendicitis. The associated thickening of the posterior peritoneum (orange arrow) suggests an acute process in the right lower quadrant. However, the epicenter of induration (yellow arrow in A and B) in the region of the tip of the liver (L) and ascending colon (C) suggests that the process likely originates in that region. Thus the process around the appendix is secondary and not primary to the appendix.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42932=[""].join("\n");
var outline_f41_59_42932=null;
var title_f41_59_42933="Indications for diagnostic thoracoscopy";
var content_f41_59_42933=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Indications for diagnostic thoracoscopy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42933/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42933/contributors\">",
"     Francis D Sheski, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42933/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42933/contributors\">",
"     Praveen N Mathur, MB, BS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42933/contributors\">",
"     Steven A Sahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42933/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42933/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/59/42933/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thoracoscopy involves a percutaneous approach to placement of an endoscopic instrument within the pleural space, allowing direct visualization and biopsy of the pleura. Unlike video-assisted thoracic surgery (VATS), in which the surgeon uses a thoracoscope to assist with performance of minimally invasive surgery, the purpose of \"medical thoracoscopy\" is to provide access to the pleura for evaluation and, in some cases, management of pleural disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/1\">",
"     1",
"    </a>",
"    ]. Open pleural biopsy is now largely done during medical thoracoscopy.",
"   </p>",
"   <p>",
"    The major indication for diagnostic medical thoracoscopy is an exudative pleural effusion of unknown etiology. Often at the time of thoracoscopy, the etiology turns out to be mesothelioma, lung cancer, tuberculosis, or a benign pleural disorder. In some hands, medical thoracoscopy is used to evaluate pulmonary parenchymal disease.",
"   </p>",
"   <p>",
"    An overview of thoracoscopy and the therapeutic indications for thoracoscopy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41414?source=see_link\">",
"     \"An overview of medical thoracoscopy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/45/39637?source=see_link\">",
"     \"Therapeutic uses of medical thoracoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PLEURAL EFFUSION OF UNKNOWN ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Algorithms for investigating pleural effusions of unknown etiology typically begin with thoracentesis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2632?source=see_link\">",
"     \"Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology\"",
"    </a>",
"    .) Pleural fluid is analyzed for cellular contents, chemistries, smears and culture of microorganisms, and cytology. However, cytological examination of even large effusions is diagnostic in only 60 to 80 percent of patients with metastatic pleural involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/2-4\">",
"     2-4",
"    </a>",
"    ] and fewer than 20 percent of patients with mesotheliomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/5\">",
"     5",
"    </a>",
"    ]. Thoracentesis with percutaneous closed needle biopsy may be diagnostic in 60 percent of malignant pleural effusions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thoracoscopy in patients with a pleural effusion of unclear etiology often yields a specific diagnosis. As an example, in a series of 1000 consecutive patients with pleural effusions, 215 patients had pleural effusions of unknown etiology despite repeated thoracentesis and percutaneous needle biopsy of the pleura [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/6\">",
"     6",
"    </a>",
"    ]. Thoracoscopy resulted in a diagnosis of malignancy in 150 (70 percent) of the patients, including mesothelioma in 35 patients. Similar levels of diagnostic accuracy have been reported by other investigators [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/8-13\">",
"     8-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnostic accuracy of thoracoscopy, however, is dependent upon thoracoscopic technique and the duration of follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/8-10,14,15\">",
"     8-10,14,15",
"    </a>",
"    ]. In those reports in which diagnostic yields were reported to be 90 to 100 percent, the length of follow-up was often not stated or was less than six months. One study noted a false negative rate of 15 percent with a one year follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/6\">",
"     6",
"    </a>",
"    ], whereas another study found a diagnostic accuracy of 69 percent among patients followed up to five years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/16\">",
"     16",
"    </a>",
"    ]. Even after thoracotomy apparently established a diagnosis of benign pleural disease, 25 percent of these patients were diagnosed within six months as having a malignancy.",
"   </p>",
"   <p>",
"    Other studies have reported higher success rates. One study found a 96 percent diagnostic accuracy for thoracoscopy, with a sensitivity of 91 percent and specificity of a 100 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/17\">",
"     17",
"    </a>",
"    ]. The negative predictive value for the diagnosis of pleural malignancy, with a follow-up of two years, was 93 percent. Similarly, a retrospective study of 138 patients reported an overall diagnostic efficacy of 97 percent, including 93 percent for carcinoma, 100 percent for mesothelioma, and 94 percent for tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A separate study randomly assigned 124 patients with exudative pleural effusions to either computed tomography (CT)-guided Abrams needle pleural biopsy or medical thoracoscopy. No difference in diagnostic sensitivity (87.5 percent versus 94 percent, respectively) was found [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/19\">",
"     19",
"    </a>",
"    ]. The authors used measurements derived from a chest CT scan done near the time of the biopsy to choose the site of needle entry and depth of needle penetration. They suggested that this CT-guided approach be used in patients with CT evidence of pleural disease.",
"   </p>",
"   <p>",
"    There are several reasons why thoracoscopy may be successful when thoracentesis and percutaneous needle biopsy fail to establish the diagnosis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cytologic detection of malignant cells requires significant exfoliation of cells from the pleural surface into the pleural fluid, and the cytologic characteristics must be sufficient to provide a diagnosis. These factors may be absent in early pleural carcinomatosis or in malignant mesothelioma.",
"     </li>",
"     <li>",
"      Malignant pleural disease is not always accessible to needle biopsy of the parietal pleura. One report described 78 patients with proven metastatic disease to the pleura, in whom only 53 percent had costal-parietal pleural involvement [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/20\">",
"       20",
"      </a>",
"      ]. Another study found that 84 percent of pleural lesions in 203 patients undergoing thoracoscopy were in the lower hemithorax, partially or totally inaccessible to needle biopsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/20,21\">",
"       20,21",
"      </a>",
"      ]. In one series of 53 autopsies, 32 percent had involvement only of the visceral pleura [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/22\">",
"       22",
"      </a>",
"      ], while another study of 191 autopsies reported that the parietal pleura was less frequently involved than the visceral pleura with metastatic pleural disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/23\">",
"       23",
"      </a>",
"      ]. It appears, therefore, that almost one-half of the patients with metastatic pleural disease have lesions inaccessible to closed needle biopsy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In cases where thoracoscopy does not reveal an etiology and the pleural fluid remains or returns after some time, repeat thoracoscopy can be performed without an increase in the duration of the procedure or other morbidity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MESOTHELIOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although malignant mesothelioma may be clinically suspected, it is often difficult to diagnose because closed needle biopsy specimens are rarely of sufficient size to allow a definitive diagnosis. Even by thoracoscopy, the accuracy of diagnosing mesothelioma may suffer because of inadequate visualization due to extensive adhesions and the inherent difficulties in pathological identification of the tumor. Diagnosis is established thoracoscopically in 60 to 75 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/8,17,25\">",
"     8,17,25",
"    </a>",
"    ], compared to 88 percent with open thoracotomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/26\">",
"     26",
"    </a>",
"    ]. If future surgical resection is not a consideration, thoracoscopy permits pleurodesis at the time of diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     LUNG CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most pleural effusions associated with lung cancer result from direct carcinomatous involvement of the pleura. Even patients with negative pleural fluid cytology usually have unresectable tumors. As an example, one study of 73 patients with lung cancer and ipsilateral cytologically negative pleural effusions found completely resectable tumors in only 6 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/27\">",
"     27",
"    </a>",
"    ]. In such patients, thoracoscopy is a preferable method to identify the small group who could potentially benefit from surgical resection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ideally, diagnostic thoracoscopy and surgical resection could be done under the same general anesthesia. However, frozen sections of parietal pleural are difficult to interpret. Obtaining a diagnosis in unresectable or metastatic cases, using a less invasive procedure such as thoracoscopy, allows for earlier palliative therapy, which potentially could enhance survival. The recovery period from thoracoscopy in this patient population is far shorter than the prolonged recovery following exploratory thoracotomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TUBERCULOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic yield of a closed pleural biopsy is 70 to 90 percent in exudative pleural effusions due to tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/12\">",
"     12",
"    </a>",
"    ]. Therefore, thoracoscopy is usually unnecessary to establish the diagnosis of a tuberculous effusion. However, thoracoscopy may be useful in several circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In difficult diagnostic situations.",
"     </li>",
"     <li>",
"      When lysis of adhesion is necessary.",
"     </li>",
"     <li>",
"      When larger amounts of tissue are necessary for determination of drug resistance.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The thoracoscopic appearance is usually that of extensive grayish-white granulomas involving the parietal pleura. Significant adhesions may concentrate in the costovertebral angles. At other times, the appearance is simply that of patchy pleuritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     OTHER BENIGN PLEURAL DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;If appropriate pleural fluid studies are nondiagnostic, thoracoscopy may help establish the diagnosis of benign diseases and, more importantly, confirm the absence of malignancy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyaline and calcified asbestos pleural plaques have distinctive endoscopic characteristics, appearing smooth and white. Direct biopsies are difficult to obtain because of the extremely hard consistency of these plaques. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16472?source=see_link\">",
"       \"Asbestosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In rheumatoid pleural effusions, the visceral surface usually shows nonspecific inflammation, and the parietal surface has a \"gritty\" appearance [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/28\">",
"       28",
"      </a>",
"      ]. Many small vesicles or granules can be identified on the parietal pleura.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Obviously, thoracoscopy should not replace pleural fluid chemistry, standard microbiological studies, and cytology, as preliminary diagnostic approaches. Whether closed percutaneous needle biopsy should also generally be done before thoracoscopy is not clearly established. However, closed needle biopsy is indicated if there is a high clinical suspicion for pleural tuberculosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PULMONARY PARENCHYMAL DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thoracoscopic lung biopsy has been advocated when less invasive techniques, such as fiberoptic bronchoscopy with transbronchial biopsy, bronchoalveolar lavage, or fine needle aspiration biopsy, have failed to establish a diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/29-35\">",
"     29-35",
"    </a>",
"    ]. Thoracoscopic lung biopsy can help establish the diagnosis of diffuse pulmonary disease, pulmonary infiltrates, or peripheral lesions of unknown cause. In addition, it can provide tissue for microbiologic or mineralogic studies, when either pulmonary infection or pneumoconiosis is being considered.",
"   </p>",
"   <p>",
"    One study evaluated 75 patients with diffuse or localized parenchymal disease in whom thoracoscopy was used to obtain pulmonary parenchymal specimens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/29\">",
"     29",
"    </a>",
"    ]. A biopsy forceps was employed, and effective hemostasis was achieved by cautery. This thoracoscopic technique preserves the histologic structure of tissues and provides biopsy specimens larger than those obtained by bronchoscopy.",
"   </p>",
"   <p>",
"    Another report of 115 thoracoscopic lung biopsies in patients with diffuse pulmonary disease reported that the sensitivity was 92 percent for diffuse lung disease, compared with only 70 percent for peripheral localized opacities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/32\">",
"     32",
"    </a>",
"    ]. Since the specimens are from peripheral lung tissue, it is not known if the biopsies provide equivalent information to that obtained from open lung biopsy. A third study of 86 thoracoscopic lung biopsies in children (42 of whom were immunocompromised) found that a diagnosis of Pneumocystis jirovecii was made in 23, viral infection in 4, and interstitial fibrosis in 7 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/26/424?source=see_link\">",
"     \"Role of lung biopsy in the diagnosis of interstitial lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients undergoing thoracoscopy can be discharged within a few days. Morbidity from the procedure is negligible if the biopsy site has been adequately secured with staples or cautery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/29\">",
"     29",
"    </a>",
"    ]. Alternatively, one study reported successful lung biopsy with excellent hemostasis and no air leakage in 18 patients using a cryoprobe to seal the forceps biopsy site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/35\">",
"     35",
"    </a>",
"    ]. A formal open lung biopsy, on the other hand, can be associated with significant morbidity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42933/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A clear advantage of thoracoscopy over bronchoscopy for lung biopsy is that larger pieces of representative lung tissue can be obtained. As thoracoscopy becomes more widely available, patients who require biopsy for either localized or diffuse disease may be offered a diagnostic approach intermediate to that currently available from bronchoscopy and open lung biopsy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thoracoscopy involves placement of an endoscopic instrument into the pleural space, allowing direct visualization and biopsy of the pleura. In addition, the pleural space can be visualized and specimens collected (see",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      When a pleural effusion of unknown etiology is identified, pleural fluid is generally analyzed for cellular contents, chemistries, smears and culture of microorganisms, and cytology. The diagnostic accuracy of thoracoscopy is estimated to be between 70 and 96 percent, which is higher than thoracentesis plus blind percutaneous needle biopsy (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Pleural effusion of unknown etiology'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      The diagnostic yield of thoracoscopy for malignant pleural disease is 60 to 75 percent. In contrast, malignant pleural disease is not always accessible to percutaneous needle biopsy of the parietal pleura and needle biopsy specimens are rarely of sufficient size to allow a definitive diagnosis (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Mesothelioma'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Lung cancer'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      The diagnostic yield of a closed pleural biopsy is 70 to 90 percent in exudative pleural effusions due to tuberculosis. Hyaline and calcified asbestos pleural plaques have distinctive endoscopic characteristics, appearing smooth and white (see",
"      <a class=\"local\" href=\"#H5\">",
"       'Tuberculosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Other benign pleural disorders'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/1\">",
"      Loddenkemper R. Thoracoscopy--state of the art. Eur Respir J 1998; 11:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/2\">",
"      Salyer WR, Eggleston JC, Erozan YS. Efficacy of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 1975; 67:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/3\">",
"      Dines DE, Pierre RV, Franzen SJ. The value of cells in the pleural fluid in the differential diagnosis. Mayo Clin Proc 1975; 50:571.",
"     </a>",
"    </li>",
"    <li>",
"     Light RW. Pleural diseases, Lea &amp; Febiger, Philadelphia 1990.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/5\">",
"      Legha SS, Muggia FM. Pleural mesothelioma: clinical features and therapeutic implications. Ann Intern Med 1977; 87:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/6\">",
"      Boutin C, Viallat JR, Cargnino P, Farisse P. Thoracoscopy in malignant pleural effusions. Am Rev Respir Dis 1981; 124:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/7\">",
"      Scerbo J, Keltz H, Stone DJ. A prospective study of closed pleural biopsies. JAMA 1971; 218:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/8\">",
"      Page RD, Jeffrey RR, Donnelly RJ. Thoracoscopy: a review of 121 consecutive surgical procedures. Ann Thorac Surg 1989; 48:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/9\">",
"      Oldenburg FA Jr, Newhouse MT. Thoracoscopy. A safe, accurate diagnostic procedure using the rigid thoracoscope and local anesthesia. Chest 1979; 75:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/10\">",
"      Weissberg D, Kaufmann M. Diagnostic and therapeutic pleuroscopy. Experience with 127 patients. Chest 1980; 78:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/11\">",
"      Loddenkemper R. Thoracoscopy: results in non cancerous and idiopathic pleural effusions. Poumon Coeur 1981; 37:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/12\">",
"      Loddenkemper R, Mai J, Scheffler N, Brandt HJ. Prospective individual comparison of blind needle biopsy and of thoracoscopy in the diagnosis and differential diagnosis of tuberculous pleurisy. Scand J Respir Dis Suppl 1978; 102:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/13\">",
"      Pepper JR. Thoracoscopy in the diagnosis of pleural effusions and tumours. Br J Dis Chest 1978; 72:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/14\">",
"      Cant&oacute; A, Blasco E, Casillas M, et al. Thoracoscopy in the diagnosis of pleural effusion. Thorax 1977; 32:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/15\">",
"      Wu MH, Hsiue RH, Tseng KH. Thoracoscopy in the diagnosis of pleural effusions. Jpn J Clin Oncol 1989; 19:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/16\">",
"      Enk B, Viskum K. Diagnostic thoracoscopy. Eur J Respir Dis 1981; 62:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/17\">",
"      Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 1991; 114:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/18\">",
"      Sakuraba M, Masuda K, Hebisawa A, et al. Diagnostic value of thoracoscopic pleural biopsy for pleurisy under local anaesthesia. ANZ J Surg 2006; 76:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/19\">",
"      Metintas M, Ak G, Dundar E, et al. Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial. Chest 2010; 137:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/20\">",
"      Canto A, Rivas J, Saumench J, et al. Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. Chest 1983; 84:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/21\">",
"      Cant&oacute; A, Ferrer G, Romagosa V, et al. Lung cancer and pleural effusion. Clinical significance and study of pleural metastatic locations. Chest 1985; 87:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/22\">",
"      Meyer PC. Metastatic carcinoma of the pleura. Thorax 1966; 21:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/23\">",
"      Rodr&icirc;guez-Panadero F, Borderas Naranjo F, L&oacute;pez Mej&icirc;as J. Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series. Eur Respir J 1989; 2:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/24\">",
"      Breen D, Fraticelli A, Greillier L, et al. Redo medical thoracoscopy is feasible in patients with pleural diseases - a series. Interact Cardiovasc Thorac Surg 2009; 8:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/25\">",
"      Davidson AC, George RJ, Sheldon CD, et al. Thoracoscopy: assessment of a physician service and comparison of a flexible bronchoscope used as a thoracoscope with a rigid thoracoscope. Thorax 1988; 43:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/26\">",
"      Ryan CJ, Rodgers RF, Unni KK, Hepper NG. The outcome of patients with pleural effusion of indeterminate cause at thoracotomy. Mayo Clin Proc 1981; 56:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/27\">",
"      Decker DA, Dines DE, Payne WS, et al. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma. Chest 1978; 74:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/28\">",
"      Faurschou P, Francis D, Faarup P. Thoracoscopic, histological, and clinical findings in nine case of rheumatoid pleural effusion. Thorax 1985; 40:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/29\">",
"      Boutin C, Viallat JR, Cargnino P, Rey F. Thoracoscopic lung biopsy. Experimental and clinical preliminary study. Chest 1982; 82:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/30\">",
"      Brandt HJ. [Pulmonary biopsy under visual control (author's transl)]. Poumon Coeur 1981; 37:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/31\">",
"      Dijkman JH, van der Meer JW, Bakker W, et al. Transpleural lung biopsy by the thoracoscopic route in patients with diffuse interstitial pulmonary disease. Chest 1982; 82:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/32\">",
"      Kapsenberg PD. Thoracoscopic biopsy under visual control. Poumon Coeur 1981; 37:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/33\">",
"      Rodgers BM. Thoracoscopy in children. Poumon Coeur 1981; 37:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/34\">",
"      Rodgers BM, Moazam F, Talbert JL. Thoracoscopy. Early diagnosis of interstitial pneumonitis in the immunologically suppressed child. Chest 1979; 75:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/35\">",
"      Bonniot JP, Homasson JP, Roden SL, et al. Pleural and lung cryobiopsies during thoracoscopy. Chest 1989; 95:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42933/abstract/36\">",
"      Wall CP, Gaensler EA, Carrington CB, Hayes JA. Comparison of transbronchial and open biopsies in chronic infiltrative lung diseases. Am Rev Respir Dis 1981; 123:280.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6699 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-89.32.226.102-21F53BA666-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42933=[""].join("\n");
var outline_f41_59_42933=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PLEURAL EFFUSION OF UNKNOWN ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MESOTHELIOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      LUNG CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TUBERCULOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      OTHER BENIGN PLEURAL DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PULMONARY PARENCHYMAL DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/28/41414?source=related_link\">",
"      An overview of medical thoracoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16472?source=related_link\">",
"      Asbestosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/31/14841?source=related_link\">",
"      Diagnosis and staging of non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/36/2632?source=related_link\">",
"      Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/26/424?source=related_link\">",
"      Role of lung biopsy in the diagnosis of interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/45/39637?source=related_link\">",
"      Therapeutic uses of medical thoracoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/21/44373?source=related_link\">",
"      Tumor node metastasis (TNM) staging system for non-small cell lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_59_42934="Methotrexate: Patient drug information";
var content_f41_59_42934=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Methotrexate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=see_link\">",
"     see \"Methotrexate: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/32/13833?source=see_link\">",
"     see \"Methotrexate: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F194555\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Rheumatrex&reg;;",
"     </li>",
"     <li>",
"      Trexall&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F194556\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Methotrexate&reg;;",
"     </li>",
"     <li>",
"      ratio-Methotrexate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10027797\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700690",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may have unsafe effects on the bone marrow. The bone marrow may not be able to make cells found in the blood as well as it used to for a few weeks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700487",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad infections have happened in patients who take this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700871",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause bad skin side effects or mouth sores.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705933",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause very bad kidney and/or liver problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700735",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause lung problems. Closely read the part in this leaflet which lists when to call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700586",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause very loose stools (diarrhea). Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may add to your chance of getting lymphoma or other cancers.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700546",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor if you are getting radiation. There may be more chance of harm to tissue and bone.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700267",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700545",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before taking any pain drugs (eg, ibuprofen, ketoprofen, naproxen). Do not take this drug if you are pregnant and being treated for rheumatoid arthritis or psoriasis. The good effects and bad effects of other uses need to be compared in women of childbearing age.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10027799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arthritis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691829",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat ectopic pregnancy.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691928",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat leukemia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat psoriasis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat inflammatory bowel disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2889259",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop graft-versus-host-disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10027798\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702498",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to methotrexate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3860662",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Psoriasis or rheumatoid arthritis:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703823",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bone marrow disease or very bad liver disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10027803\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697242",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had hepatitis B or C, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697210",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a drug or drinking problem, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697152",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak immune system, get infections easy, or are on antibiotics, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697310",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mouth sores, stomach irritation or ulcers, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698570",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       When taking methotrexate for a long time or at high doses, you may need closer watching of liver and bone marrow function. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696742",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not donate blood while using this drug and for 1 month after stopping.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take good care of your teeth. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697790",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun. Keep protecting yourself from sunburn for at least 1 month after using this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10027804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697876",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Anemia, low white blood cell count, and low platelet count.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698243",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mouth irritation or sores. Using a soft toothbrush or cotton swabs and rinsing the mouth may help. Do not use mouth rinses that have alcohol in them.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698350",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sore throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698114",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hair loss. Hair most often grows back when this drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Kidney failure may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698227",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the lungs may rarely happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698291",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Other kinds of cancer may rarely happen later in life.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10027806\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698999",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Pinpoint red spots on your skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10027801\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694870",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow how to use as you have been told by your doctor or read the package insert.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695141",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       When taken by mouth, this drug is most often only taken once a week. Talk with your doctor to make sure the dose is right.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       How this drug is taken may change based on blood work results, side effects, and how well the drug is working.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695887",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 1 hour before or 2 hours after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may be given by mouth or as a shot into a muscle, vein, or the fatty part of the skin. A shot may be given into the spinal fluid.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10027802\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10027807\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10027808\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10856 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-D60132E406-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42934=[""].join("\n");
var outline_f41_59_42934=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F194555\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F194556\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027797\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027799\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027798\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027803\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027804\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027806\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027801\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027802\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027807\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10027808\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?23/38/24170?source=related_link\">",
"      Methotrexate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/32/13833?source=related_link\">",
"      Methotrexate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_59_42935="Etiology and pathogenesis of relapsing polychondritis";
var content_f41_59_42935=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology and pathogenesis of relapsing polychondritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42935/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42935/contributors\">",
"     Clement J Michet, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42935/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42935/contributors\">",
"     Peter H Schur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42935/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42935/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/59/42935/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Relapsing polychondritis (RPC) is a systemic",
"    <span class=\"nowrap\">",
"     inflammatory/degenerative",
"    </span>",
"    disease with varying clinical manifestations that can include compromise of the structural and functional integrity of cartilage, organs of special sense, the cardiovascular, renal, and nervous systems (",
"    <a class=\"graphic graphic_table graphicRef76071 \" href=\"mobipreview.htm?19/45/20188\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/63/26616?source=see_link\">",
"     \"Clinical manifestations of relapsing polychondritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic will review our current understanding of the etiology and pathogenesis of RPC. The pathologic changes in this disorder are described elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/32/29187?source=see_link\">",
"     \"Pathology of relapsing polychondritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The approach to diagnosis and treatment of RPC are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/47/4856?source=see_link\">",
"     \"Diagnostic evaluation of relapsing polychondritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/19/15673?source=see_link\">",
"     \"Treatment of relapsing polychondritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of RPC is unknown. Although few clues are evident, there appears to be a genetic susceptibility, an overlap with other disorders associated with immunologic abnormalities, and the potential for multiple inciting events including chemical insults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Genetic susceptibility",
"    </span>",
"    &nbsp;&mdash;&nbsp;An association has been described between RPC and HLA-DR4 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/1\">",
"     1",
"    </a>",
"    ]. Genetic analysis of the frequency of HLA class II histocompatibility antigens was performed in 60 central European Caucasian patients with RPC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/1\">",
"     1",
"    </a>",
"    ]; the frequency of HLA-DR4 was 56 percent compared to 26 percent in a healthy control group. Genotyping showed no preferential association of specific DR4 subtype alleles in contrast to the clear association of rheumatoid arthritis (RA) with DRB1*0401 and DRB1*0404 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/2\">",
"     2",
"    </a>",
"    ]. These alleles have in common a region of highly similar sequence, designated the shared epitope. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/63/23546?source=see_link\">",
"     \"HLA and other susceptibility genes in rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These investigators also observed a significant association between HLA-DR6 positivity and clinical features of RPC, including patient age, extent of organ involvement, and specific organ manifestations (such as general symptoms and nasal chondritis). The importance of this relationship is unclear and remains speculative.",
"   </p>",
"   <p>",
"    A novel DR4 allele (DRB1*0421), potentially representing a polychondritic susceptibility factor, has been described in a single patient with RPC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/3\">",
"     3",
"    </a>",
"    ]. Earlier studies had shown no association of RPC with HLA class I (HLA-A and HLA-B) antigens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/4\">",
"     4",
"    </a>",
"    ]. Thus, although RPC and RA may share clinical and immunologic features and may, at times, coexist, there are clear differences in genetic susceptibility.",
"   </p>",
"   <p>",
"    One study evaluated HLA class II allelic distribution among 64 unrelated Caucasian RPC patients to 507 unrelated healthy controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/5\">",
"     5",
"    </a>",
"    ]. The following allele frequencies were significantly increased in RPC: DQB1*0601 (4.7 versus 0.9 percent), DQA1*0103 (15.6 versus 7.9 percent), and DQA1*0301 (22.7 versus 12.9 percent). In addition, 59 percent of patients expressed the DQA1*0103 or 0301 allele compared to 38 percent of controls. Double transgenic mice which express both",
"    <span class=\"nowrap\">",
"     DQA1*0301/DQB1*0302",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     DQA1*0103/DQB1*0601",
"    </span>",
"    class II molecules develop severe experimental RPC following immunization with type II collagen (see",
"    <a class=\"local\" href=\"#H7\">",
"     'Genetic predisposition in experimental models'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Association with other immunologic diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a frequent association of RPC with a diverse array of connective tissue, endocrine, and inflammatory bowel diseases in which immunologic mechanisms are believed to have a prominent role in pathogenesis. These include systemic necrotizing forms of vasculitis, Graves' disease, and ulcerative colitis (",
"    <a class=\"graphic graphic_table graphicRef81401 \" href=\"mobipreview.htm?20/36/21067\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/63/26616?source=see_link\">",
"     \"Clinical manifestations of relapsing polychondritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is also an increased prevalence, particularly in older men, of myelodysplastic syndromes in patients with RPC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/6,7\">",
"     6,7",
"    </a>",
"    ], with 5 of 18 patients being affected in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/7\">",
"     7",
"    </a>",
"    ]. These clonal stem cell disorders are characterized by ineffective hematopoiesis and are themselves associated with a relatively high incidence of immunologic abnormalities including immunoglobulin dyscrasias, autoantibody formation, and abnormalities in the function of T lymphocytes and natural killer cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. Both diseases are usually detected simultaneously. These correlations suggest a real association, but its nature is unknown. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/57/41882?source=see_link&amp;anchor=H2301305#H2301305\">",
"     \"Clinical manifestations and diagnosis of the myelodysplastic syndromes\", section on 'Autoimmune abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    &nbsp;Induction by toxins &mdash; A disease simulating RPC",
"    <span class=\"nowrap\">",
"     (auricular/nasal",
"    </span>",
"    cartilage inflammation, scleritis, audiovestibular, and peripheral and axial joint involvement) appeared within 24 hours of an intravenous injection of a preheated multiple substance \"cocktail\" [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/8\">",
"     8",
"    </a>",
"    ]. This cocktail included hydrochloric acid, carburetor fluid, the waxy internal matrix of a methylated nasal inhaler, and tap water. This bizarre event is reminiscent of early experimental studies showing that intravenously injected crude papain could induce collapse of the normally rigid ears of young rabbits within four hours of administration, followed in some animals by respiratory distress caused by tracheal and bronchial collapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/9\">",
"     9",
"    </a>",
"    ]. There was widespread but reversible diffuse loss of connective tissue metachromasia consistent with proteoglycan depletion.",
"   </p>",
"   <p>",
"    These observations imply that RPC is not a primary disease but is a syndrome associated with multiple precipitating factors that appear in a genetically susceptible subject. The paraneoplastic myelodysplastic relationship suggests a potential pathophysiologic role for clonally expressed lymphoid stem cells in which functional T cell defects induce both autoimmunity and uncontrolled neoplastic hematopoietic clonal proliferation. However, the abrupt onset after recreational drug abuse implies that a direct biochemical insult also can induce the disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the inciting cause may vary, increasing evidence derived from human and experimental animal studies has clearly implicated genetically preconditioned phlogistic and immunologic mechanisms that disturb connective tissue structure and cell function. In addition to the association with HLA-DR4, the following observations are consistent with this hypothesis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of autoimmunity, both antibody and cell mediated, to extracellular matrix components of cartilage such as types II, IX and XI collagen, matrilin-1, and proteoglycan constituent fractions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/10-12\">",
"       10-12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Some observations support the contribution of a cell mediated immune reaction to type II collagen [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/13\">",
"       13",
"      </a>",
"      ]. As an example, T cell clones isolated from a",
"      <span class=\"nowrap\">",
"       DRB1*0101/0401",
"      </span>",
"      heterozygous patient with RPC showed specificity to a peptide derived from type II collagen that is an immunodominant epitope in a transgenic mouse model with features of RPC. Of further interest are differences found in the epitope specificity for type II collagen antibody identified in patients with rheumatoid arthritis versus RPC. Response in the rheumatoid patients was directed to an evolutionary conserved type II collagen domain that is also targeted by pathogenic autoimmune responses in murine models of arthritis but not RPC [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The prominence of HLA-DR positive antigen-presenting cells and CD4 positive T lymphocytes at lesional sites [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cartilage destruction may also be mediated by induction of apoptosis in chondrocytes. Chondrocyte expression of anti-matrix metalloproteinase (MMP)&ndash;3 and cathepsin-K is strongly associated with this finding [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The genetically governed experimental induction of features of RPC following immunization of experimental animals with connective tissue antigens (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Genetic predisposition in experimental models'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Selective decreases in the number and function of natural killer regulatory T cells (NKT cells), a novel lymphocyte lineage distinct from conventional T, B or NK cells which are believed to be involved in control of expression of autoimmune disease by modulating the balance of cytokine expression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Findings such as these have led to the generation of a unifying hypothesis which takes into account genetic predisposition, the immunogenicity of cartilage, and specific immunologic pathways important in mediating the disease process (",
"    <a class=\"graphic graphic_algorithm graphicRef70792 \" href=\"mobipreview.htm?10/51/11070\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Immunogenicity of cartilage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cartilage proteoglycans, collagen types, elastin, and the chondrocyte cell membrane express multiple epitopes capable of eliciting an immune response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. These epitopes are largely masked in the native state because of their conformational structure.",
"   </p>",
"   <p>",
"    Fundamental to an understanding of the immunopathologic significance of such connective tissue constituents in RPC is an awareness of their tissue distribution, since the lesions in RPC usually involve the trachea, nose, and outer ears, and the sharing of antigenicity.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although type II collagen is transiently present in many tissues during embryogenesis, it is subsequently expressed at only two sites: the fibrillar scaffolding of cartilage matrix, and the vitreous of the eye [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Type IX collagen, a fibril-associated form with interrupted triple helices, has proteoglycan properties. It is a molecular coupler that organizes and anchors type II collagen fibrils in a defined three-dimensional pattern within connective tissue matrix.",
"     </li>",
"     <li>",
"      Type XI collagen, which regulates fibril size, is uniformly distributed in cartilage and dominantly concentrated in pericellular regions.",
"     </li>",
"     <li>",
"      Although matrilin-1 is a matrix protein unique to fetal epiphyseal cartilage, it is only expressed in adults in auricular, nasal, tracheal and costochondral cartilages [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. In animal models, immunization to matrilin-1 can induce an RPC-like syndrome (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Matrilin-1'",
"      </a>",
"      below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Proteoglycan-shared epitopes are diversely distributed and can be found in a variety of tissues including connective tissue of aortic media and intima, the anterior uveal tract, heart valves, the endoneurium and perineurium of the optic nerves, the tracheal submucosal basement membrane, endothelial cells, glomerular and tubular basement membranes, myocardial sarcolemma, and synoviocytes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/18-21,24\">",
"     18-21,24",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    Of speculative interest is the antigenic crossreactivity between cartilage proteoglycans, streptococcal peptidoglycans, and the purified protein derivative of Mycobacterium tuberculosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/25\">",
"     25",
"    </a>",
"    ]. In this context, a monoclonal antibody derived from peripheral blood B cells of a patient with RPC reacted with a purified cytoskeletal antigen (desmin), type II collagen, and proteoglycans [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/26\">",
"     26",
"    </a>",
"    ]. Cross-reactivity of this antibody to heat shock protein 60 obtained from M. tuberculosis was also shown. The possibility that an exogenous antigen induces an antibody capable of cross-reacting with autoantigens and thus contributing to the pathogenic process cannot be dismissed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Genetic predisposition in experimental models",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rodents and primates immunized with native type II or XI cartilage collagen may develop an MHC-restricted destructive arthropathy which correlates both with the expression of antibodies specific for conformational determinants of collagen and cell-mediated immune responses which lack conformational or collagen type specificity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. It is unclear as to whether T cells alone can induce arthritis although they are likely to have a major role in sustaining the process. An auricular chondritis may develop later in the postimmunization period, independent of the expression of arthritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These responses appear to be under multiple gene control which is, in part, linked to the Ir region of the major histocompatibility complex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. This region is thought to be responsible for regulation of the expression, severity, and rate of progression of disease. An imbalance of T-helper cell subsets may play an important role in the development of cartilage destruction in this model [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/33\">",
"     33",
"    </a>",
"    ]. However, there are no ocular, laryngotracheobronchial or cardiovascular lesions in collagen-induced arthritis, as there are in human RPC.",
"   </p>",
"   <p>",
"    The role of DQ class II molecules in the antigenic presentation of type II collagen and subsequent initiation of collagen-induced arthritis has been studied using transgenic mice lacking endogenous HLA class II molecular expression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/34\">",
"     34",
"    </a>",
"    ]. These HLA molecules, which are expressed on the cell surface, can positively select CD4+ T cells expressing various V beta T-cell receptors. Transgenic mice that express DQ8 develop severe arthritis in response to collagen immunization; by comparison, DQ6 mice are unresponsive. Double transgenic mice expressing both DQ6 and DQ8 develop severe RPC following type II collagen immunization, exhibiting both polyarthritis and auricular chondritis. Older mice bearing both DQ6 and DQ8 develop chondritis spontaneously (in the absence of collagen immunization or adjuvant administration) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Expression of DQ8 in mice with a nonobese diabetic (NOD) genotype and lacking endogenous class II molecules, is also associated with a susceptibility to type II collagen-immunization-induced chondritis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/36\">",
"     36",
"    </a>",
"    ]. In this transgenic strain, immunization with type II collagen produces auricular cartilage inflammation in a larger proportion of animals and also produces an antibody response to both type II and type IX collagen. Immunization of this mouse strain with type IX collagen frequently leads to chondritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Matrilin-1",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other models have used cartilage matrix protein (matrilin-1) as the immunogen in an attempt to replicate the tissue distribution of lesions in RPC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Matrilin-1 is primarily expressed in skeletal growth cartilage during development but is limited to the nasal septum, trachea, auricular and xiphisternal cartilage in adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Immunization of rats with this protein produces severe inspiratory stridor due to tracheal involvement, nasal swelling,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    epistaxis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/37\">",
"     37",
"    </a>",
"    ]. Female rats were more susceptible than males. All strains mount a strong IgG anti-matrilin-1 response but only some strains develop disease. Using congenic mouse strains, the likelihood of developing disease appears to be governed by both MHC and non-MHC genes, and is dependent upon alpha beta T cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/39\">",
"     39",
"    </a>",
"    ]. Mice devoid of IL-10 through gene deletion develop a significantly more severe disease with earlier onset.",
"   </p>",
"   <p>",
"    Further studies using the matrilin-1 model have shown both an antibody and complement dependent basis for RPC development. Neither specific antibody nor disease could be induced in matrilin-1 immunized mice deficient of B cells [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/40\">",
"     40",
"    </a>",
"    ]. B-cell deficient mice injected with matrilin-1 specific antibody developed erosive respiratory tract chondritis. Respiratory distress occurred significantly less in matrilin-1 immunized mice congenic at complement factor 5, indicating the potential importance of, although not an absolute requirement for, functional C5.",
"   </p>",
"   <p>",
"    The applicability of these findings to humans is uncertain. Matrilin-1 fragments have been identified in the serum of a patient with RPC during active inflammation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/38\">",
"     38",
"    </a>",
"    ], and both humoral and cell-mediated immune responses were documented in other patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/38,41\">",
"     38,41",
"    </a>",
"    ]. Anti-matrilin antibodies are present in a minority of patients with RPC. This was illustrated by a study of the sera of 97 patients obtained at a single time point in their disease course; 13 of 97 had IgG",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    IgM anti-matrilin-1 antibody; positive responses correlated with respiratory symptoms in 69 percent of the cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/42\">",
"     42",
"    </a>",
"    ]. However, 40 percent of patients having clinical evidence of laryngotracheal involvement did not have an anti-matrilin-1 antibody response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Immunologic pathways mediating cartilage degradation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The immune response and subsequent release of cytokines may be responsible for cartilage destruction in RPC. Immune complexes, formed in situ",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    localized by affinity to polyanionic proteoglycans, bind to the surface of cartilage. Attempted removal by scavenger cells facilitates release of matrix degrading metalloproteinases, oxygen metabolites",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cytokines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cytokines such as interleukin-1 (IL-1) and tumor necrosis factor (TNF) induce chondrocyte production of matrix degrading metalloproteinases, plasminogen activator and prostanoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. They may also reversibly downregulate chondrocyte collagen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    proteoglycan synthesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/46-49\">",
"     46-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A major role for cell-mediated immune responses in the pathophysiology of RPC is suggested by serum cytokine profile studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/50\">",
"     50",
"    </a>",
"    ]. A set of circulating cytokines levels were contrasted between patients with active RPC, rheumatoid arthritis and healthy control subjects. Mean serum levels of monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1 beta (MIP-1 beta), and IL-8 were significantly higher in patients with RPC than controls. The profile in rheumatoid arthritis differed, showing a more generalized pattern of upregulation of multiple cytokines rather than the more discrete elevations observed in RPC. Each of the three cytokines increased in RPC is a proinflammatory chemokine; MCP-1 and MIP-1 beta function to recruit and activate circulating",
"    <span class=\"nowrap\">",
"     monocyte/macrophages.",
"    </span>",
"    IL-8 is produced by activated",
"    <span class=\"nowrap\">",
"     monocyte/macrophages,",
"    </span>",
"    acting in part to attract neutrophils. Chondrocytes constitutively express and store these cytokines and their receptors are found on activated T cells.",
"   </p>",
"   <p>",
"    Cartilage contains a constitutive and inducible growth",
"    <span class=\"nowrap\">",
"     factor/cytokine",
"    </span>",
"    metabolic regulatory network, which may function in an",
"    <span class=\"nowrap\">",
"     autocrine/paracrine",
"    </span>",
"    manner to modulate normal cartilage growth and metabolism. It may also serve a pathophysiologic role, contributing to altered chondrocyte metabolism and ineffectual tissue repair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/51\">",
"     51",
"    </a>",
"    ]. As an example, basic fibroblast growth factor, an integral part of this network, up-regulates IL-1 and TNF receptors. Insulin-like growth factor-1 activity, which is essential for optimal chondrocyte anabolic function, is inhibited by these cytokines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42935/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Unifying hypothesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Figure 1 summarizes a hypothetical scheme for the pathogenesis of RPC, which begins with insult-induced exposure of connective tissue or cell membrane epitopes, leading to an inflammatory and genetically conditioned immune response (",
"    <a class=\"graphic graphic_algorithm graphicRef70792 \" href=\"mobipreview.htm?10/51/11070\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Cartilage may be viewed as an immunologically \"privileged\" tissue because of both the conformational structure of its basic connective tissue constituents and its avascular and alymphatic milieu. Privileged refers to failure of development of immunologic tolerance to self-components.",
"   </p>",
"   <p>",
"    The integrity of cartilage in RPC can speculatively be compromised by multiple inciting factors including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      An insult, irrespective of cause, to nutrient vasculature at sites contiguous to cartilage, with an ensuing inflammatory cell exudate being responsible for tissue injury",
"     </li>",
"     <li>",
"      A direct traumatic, toxic, or chemical insult",
"     </li>",
"     <li>",
"      A systemic or localized process which directly or indirectly perturbs chondrocyte metabolism by modulating exposure to essential hormones and growth factors",
"     </li>",
"     <li>",
"      An infectious agent having a cytotropic propensity for chondrocytes",
"     </li>",
"     <li>",
"      Antigenic mimicry between an infectious agent and a given connective tissue antigen as noted above.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ensuing matrix compromise may lead to release of or in situ exposure to native or modified connective tissue antigens. Genetically conditioned host sensitization would facilitate generation of both humoral and cell-mediated immune responses. Pathologic consequences, in part representing in situ complex formation, may be widespread because of epitope sharing with matrix constituents. Alternatively, cartilage and other connective tissue sites may serve as innocent bystanders, reflecting an affinity-associated adsorption of preformed complexes.",
"   </p>",
"   <p>",
"    The ensuing inflammatory response would perpetuate enzymatic and oxygen metabolite-mediated connective tissue degradation. Cytokines released into the milieu can further contribute to the pathologic process by inducing chondrocyte and connective tissue fibroblast proteinase release, perturbing matrix repair, and inciting constitutional symptoms and an acute phase response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The etiology of relapsing polychondritis (RPC) is unknown, and multiple inciting events have been postulated. Genetic susceptibility is suggested by the association between RPC and HLA-DR4 or other HLA class II alleles. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Genetic susceptibility'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is a frequent association of RPC with a diverse array of immune-mediated connective tissue, endocrine, and inflammatory bowel diseases, including systemic necrotizing forms of vasculitis, Graves' disease, and ulcerative colitis. There is also an increased prevalence, particularly in older men, of myelodysplastic syndromes in patients with RPC. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Association with other immunologic diseases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is evidence of autoimmunity, both antibody and cell mediated, to extracellular matrix components of cartilage, including types II, IX and XI collagen, matrilin-1, and proteoglycan constituent fractions. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Immunogenicity of cartilage'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Matrilin-1'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Findings include the prominence of HLA-DR positive antigen-presenting cells and CD4 positive T lymphocytes at lesional sites, and selective decreases in the number and function of natural killer regulatory T cells. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Experimental induction of features of RPC following immunization of experimental animals with connective tissue antigens is genetically regulated. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Genetic predisposition in experimental models'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      RPC is hypothesized to result from exposure of modified or immunologically privileged connective tissue or cell membrane epitopes by an unknown inciting event, leading to an inflammatory and genetically conditioned immune response. The response to injury may perpetuate enzymatic and oxygen metabolite-mediated connective tissue degradation and subsequent release of cytokines, which may be responsible for cartilage destruction. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Immunologic pathways mediating cartilage degradation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Unifying hypothesis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/1\">",
"      Zeuner M, Straub RH, Rauh G, et al. Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol 1997; 24:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/2\">",
"      Gao XJ, Olsen NJ, Pincus T, Stastny P. HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. Arthritis Rheum 1990; 33:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/3\">",
"      Keller E, Yao Z, Volgger A, et al. A novel variant of DR4 (DRB1*0421) identified in a patient with polychondritis. Immunogenetics 1995; 41:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/4\">",
"      Luthra HS, McKenna CH, Terasaki PI. Lack of association of HLA-A and B locus antigens with relapsing polychondritis. Tissue Antigens 1981; 17:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/5\">",
"      Hue-Lemoine S, Caillat-Zucman S, Amoura Z, et al. HLA-DQA1 and DQB1 alleles are associated with susceptibility to relapsing polychondritis: From transgenic mice to humans. Arthritis Rheum 1999; 42:S261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/6\">",
"      Piette JC, Papo T, Chavanon P, et al. Myelodysplasia and relapsing polychondritis. J Rheumatol 1995; 22:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/7\">",
"      Hebbar M, Brouillard M, Wattel E, et al. Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia 1995; 9:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/8\">",
"      Berger R. Polychondritis resulting from intravenous substance abuse. Am J Med 1988; 85:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/9\">",
"      McCLUSKEY RT, THOMAS L. The removal of cartilage matrix, in vivo, by papain; identification of crystalline papain protease as the cause of the phenomenon. J Exp Med 1958; 108:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/10\">",
"      Foidart JM, Abe S, Martin GR, et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 1978; 299:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/11\">",
"      Ebringer R, Rook G, Swana GT, et al. Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases. Ann Rheum Dis 1981; 40:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/12\">",
"      Herman JH, Dennis MV. Immunopathologic studies in relapsing polychondritis. J Clin Invest 1973; 52:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/13\">",
"      Buckner JH, Van Landeghen M, Kwok WW, Tsarknaridis L. Identification of type II collagen peptide 261-273-specific T cell clones in a patient with relapsing polychondritis. Arthritis Rheum 2002; 46:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/14\">",
"      Burkhardt H, Koller T, Engstr&ouml;m A, et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum 2002; 46:2339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/15\">",
"      Riccieri V, Spadaro A, Taccari E, Zoppini A. A case of relapsing polychondritis: pathogenetic considerations. Clin Exp Rheumatol 1988; 6:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/16\">",
"      Ouchi N, Uzuki M, Kamataki A, et al. Cartilage destruction is partly induced by the internal proteolytic enzymes and apoptotic phenomenon of chondrocytes in relapsing polychondritis. J Rheumatol 2011; 38:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/17\">",
"      Takagi D, Iwabuchi K, Iwabuchi C, et al. Immunoregulatory defects of V alpha 24V+ beta 11+ NKT cells in development of Wegener's granulomatosis and relapsing polychondritis. Clin Exp Immunol 2004; 136:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/18\">",
"      Herman JH, Carpenter BA. Immunobiology of cartilage. Semin Arthritis Rheum 1975; 5:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/19\">",
"      Baker JR, Caterson B, Christner JE. Immunological characterization of cartilage proteoglycans. Methods Enzymol 1982; 83:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/20\">",
"      Glant T, Mikecz K. Antigenic profiles of human, bovine and canine articular chondrocytes. Cell Tissue Res 1986; 244:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/21\">",
"      Stuart JM, Cremer MA, Dixit SN, et al. Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum 1979; 22:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/22\">",
"      M&ouml;rgelin M, Paulsson M, Heineg&aring;rd D, et al. Evidence of a defined spatial arrangement of hyaluronate in the central filament of cartilage proteoglycan aggregates. Biochem J 1995; 307 ( Pt 2):595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/23\">",
"      Wu JJ, Eyre DR. Matrilin-3 forms disulfide-linked oligomers with matrilin-1 in bovine epiphyseal cartilage. J Biol Chem 1998; 273:17433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/24\">",
"      Poole AR, Pidoux I, Reiner A, et al. Mammalian eyes and associated tissues contain molecules that are immunologically related to cartilage proteoglycan and link protein. J Cell Biol 1982; 93:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/25\">",
"      van Eden W, Holoshitz J, Nevo Z, et al. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A 1985; 82:5117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/26\">",
"      Menge T, Rzepka R, Melchers I. Monoclonal autoantibodies from patients with autoimmune diseases: specificity, affinity and crossreactivity of MAbs binding to cytoskeletal and nucleolar epitopes, cartilage antigens and mycobacterial heat-shock protein 60. Immunobiology 2002; 205:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/27\">",
"      Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977; 146:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/28\">",
"      Yoo TJ, Kim SY, Stuart JM, et al. Induction of arthritis in monkeys by immunization with type II collagen. J Exp Med 1988; 168:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/29\">",
"      Cremer MA, Pitcock JA, Stuart JM, et al. Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med 1981; 154:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/30\">",
"      McCune WJ, Schiller AL, Dynesius-Trentham RA, Trentham DE. Type II collagen-induced auricular chondritis. Arthritis Rheum 1982; 25:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/31\">",
"      Griffiths MM, Eichwald EJ, Martin JH, et al. Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum 1981; 24:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/32\">",
"      Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981; 154:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/33\">",
"      Mauri C, Williams RO, Walmsley M, Feldmann M. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996; 26:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/34\">",
"      Bradley DS, Das P, Griffiths MM, et al. HLA-DQ6/8 double transgenic mice develop auricular chondritis following type II collagen immunization: a model for human relapsing polychondritis. J Immunol 1998; 161:5046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/35\">",
"      Lamoureux JL, Buckner JH, David CS, Bradley DS. Mice expressing HLA-DQ6alpha8beta transgenes develop polychondritis spontaneously. Arthritis Res Ther 2006; 8:R134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/36\">",
"      Taneja V, Griffiths M, Behrens M, et al. Auricular chondritis in NOD.DQ8.Abetao (Ag7-/-) transgenic mice resembles human relapsing polychondritis. J Clin Invest 2003; 112:1843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/37\">",
"      Hansson AS, Heineg&aring;rd D, Holmdahl R. A new animal model for relapsing polychondritis, induced by cartilage matrix protein (matrilin-1). J Clin Invest 1999; 104:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/38\">",
"      Buckner JH, Wu JJ, Reife RA, et al. Autoreactivity against matrilin-1 in a patient with relapsing polychondritis. Arthritis Rheum 2000; 43:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/39\">",
"      Hansson AS, Johansson AC, Holmdahl R. Critical role of the major histocompatibility complex and IL-10 in matrilin-1-induced relapsing polychondritis in mice. Arthritis Res Ther 2004; 6:R484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/40\">",
"      Hansson AS, Johannesson M, Svensson L, et al. Relapsing polychondritis, induced in mice with matrilin 1, is an antibody- and complement-dependent disease. Am J Pathol 2004; 164:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/41\">",
"      Saxne T, Heineg&aring;rd D. Serum concentrations of two cartilage matrix proteins reflecting different aspects of cartilage turnover in relapsing polychondritis. Arthritis Rheum 1995; 38:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/42\">",
"      Hansson AS, Heineg&aring;rd D, Piette JC, et al. The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. Arthritis Rheum 2001; 44:2402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/43\">",
"      Herman JH, Greenblatt D, Khosla RC, Appel AM. Cytokine modulation of chondrocyte proteinase release. Arthritis Rheum 1984; 27:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/44\">",
"      Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986; 322:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/45\">",
"      Dingle JT, Page Thomas DP, King B, Bard DR. In vivo studies of articular tissue damage mediated by catabolin/interleukin 1. Ann Rheum Dis 1987; 46:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/46\">",
"      Herman JH, Nutman TB, Nozoe M, et al. Lymphokine-mediated suppression of chondrocyte glycosaminoglycan and protein synthesis. Arthritis Rheum 1981; 24:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/47\">",
"      Herman JH, Khosla RC, Mowery CS, Appel AM. Modulation of chondrocyte synthesis by lymphokine-rich conditioned media. Arthritis Rheum 1982; 25:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/48\">",
"      Goldring MB, Sandell LJ, Stephenson ML, Krane SM. Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human articular and costal chondrocytes. J Biol Chem 1986; 261:9049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/49\">",
"      Goldring MB, Birkhead J, Sandell LJ, et al. Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest 1988; 82:2026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/50\">",
"      Stabler T, Piette JC, Chevalier X, et al. Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum 2004; 50:3663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/51\">",
"      Herman JH, O'Connor MP, Lieberman MA. Perturbation of a Cartilage Autocrine/Paracrine Basic Fibroblast Growth Factor Metabolic Regulatory Network by Osteoarthritic Synovial Tissue. Am J Ther 1996; 3:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42935/abstract/52\">",
"      Lazarus DD, Moldawer LL, Lowry SF. Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6. Lymphokine Cytokine Res 1993; 12:219.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5604 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-2.133.93.82-D9A3241E76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42935=[""].join("\n");
var outline_f41_59_42935=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Genetic susceptibility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Association with other immunologic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Immunogenicity of cartilage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Genetic predisposition in experimental models",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Matrilin-1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Immunologic pathways mediating cartilage degradation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Unifying hypothesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/5604\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5604|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?10/51/11070\" title=\"algorithm 1\">",
"      Pathogenesis of RPC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5604|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/45/20188\" title=\"table 1\">",
"      Clinical features of RPC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?20/36/21067\" title=\"table 2\">",
"      Autoimmune diseases in RPC",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/57/41882?source=related_link\">",
"      Clinical manifestations and diagnosis of the myelodysplastic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/63/26616?source=related_link\">",
"      Clinical manifestations of relapsing polychondritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/47/4856?source=related_link\">",
"      Diagnostic evaluation of relapsing polychondritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/63/23546?source=related_link\">",
"      HLA and other susceptibility genes in rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/32/29187?source=related_link\">",
"      Pathology of relapsing polychondritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/19/15673?source=related_link\">",
"      Treatment of relapsing polychondritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_59_42936="Management of hypertension in infants";
var content_f41_59_42936=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of hypertension in infants",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42936/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42936/contributors\">",
"     Joseph T Flynn, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42936/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42936/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42936/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42936/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/59/42936/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H802040\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal management for neonatal hypertension remains uncertain due to the lack of evidence regarding long-term outcome and clinical trials evaluating the safety and efficacy of antihypertensive agents in this age group. As a result, therapeutic recommendations generally rely on expert opinion based on clinical experience and judgment.",
"   </p>",
"   <p>",
"    This topic reviews the management of hypertension in infants including a suggested approach for initiating pharmacologic therapy. The etiology, evaluation, and diagnosis of hypertension in neonates and older infants are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37833?source=see_link\">",
"     \"Etiology, clinical features, and diagnosis of neonatal hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44630?source=see_link\">",
"     \"Hypertension in infants between one month and one year of age\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62144060\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data are limited regarding the treatment of hypertension in infants, the approach to management is similar to that used in older children except for the non-pharmacological management, which is important in older children but has",
"    <span class=\"nowrap\">",
"     no/very",
"    </span>",
"    limited role in infants. Decisions are based on the severity of hypertension, the underlying cause, and other clinical factors that impact on the well-being of the patient.",
"   </p>",
"   <p>",
"    Treatment consists of identifying and correcting any curable cause of hypertension, and when indicated, initiating pharmacologic therapy to lower blood pressure.",
"   </p>",
"   <p>",
"    However, clinical criteria for starting antihypertensive therapy in infants (ie, blood pressure [BP] thresholds) are not well defined because of a paucity of long-term outcome data. As a result, indications for initiation of antihypertensive therapy are primarily based on expert clinical opinion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/1\">",
"     1",
"    </a>",
"    ]. In addition, there is limited information on the use of specific agents to control hypertension in infants, and most of these data are from small observational case series in neonates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. Thus, most treatment decisions regarding pharmacologic intervention are empiric and rely upon clinical experience and judgment. Prior to starting antihypertensive medications in infants, consultation with a pediatric nephrologist",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other physician with experience in the management of infantile hypertension is recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195796885\">",
"    <span class=\"h1\">",
"     CORRECTING UNDERLYING CAUSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following causes of neonatal hypertension are amendable to corrective therapy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Salt and water overload. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/60/27591?source=see_link\">",
"       \"Fluid and electrolyte therapy in newborns\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hyperthyroidism. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/6/97?source=see_link\">",
"       \"Evaluation and management of neonatal Graves' disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/6/97?source=see_link&amp;anchor=H11#H11\">",
"       \"Evaluation and management of neonatal Graves' disease\", section on 'Treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Drugs that are associated with hypertension (eg, corticosteroids) should be withdrawn, if possible.",
"     </li>",
"     <li>",
"      Patients with congenital adrenal hyperplasia should be treated with glucocorticoid therapy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/32/15878?source=see_link\">",
"       \"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/32/15878?source=see_link&amp;anchor=H6#H6\">",
"       \"Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency\", section on 'Treatment'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/51/35641?source=see_link&amp;anchor=H2#H2\">",
"       \"Uncommon causes of congenital adrenal hyperplasia\", section on 'CYP17 deficiency'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pain should always be assessed and treated. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/7/31863?source=see_link\">",
"       \"Assessment of neonatal pain\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35114?source=see_link\">",
"       \"Prevention and treatment of neonatal pain\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Surgery may be required for tumor resection and to correct anatomic abnormalities, such as obstructive uropathy or coarctation of the aorta. Decisions about the timing of the procedure depend upon the severity of the hypertension, the response to medical therapy, and the age and size of the infant [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/8\">",
"       8",
"      </a>",
"      ]. Antihypertensive drug therapy may be needed in patients awaiting corrective surgical intervention. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/3/26680?source=see_link\">",
"       \"Congenital ureteropelvic junction obstruction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/50/9002?source=see_link&amp;anchor=H7#H7\">",
"       \"Treatment and prognosis of Wilms tumor\", section on 'Management'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20922?source=see_link&amp;anchor=H6#H6\">",
"       \"Management of coarctation of the aorta\", section on 'Procedures'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The management of aortic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      renal thromboembolism, mostly associated with umbilical artery catheters, is extrapolated largely from data in adults. Little information is available on management strategies or the efficacy and safety of therapeutic antithrombotic agents. These patients usually need to be treated with antihypertensive therapy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The approach to an individual infant must balance the risks and benefits. A reasonable strategy is to manage asymptomatic thrombosis by close monitoring of the size of the thrombus, usually by ultrasonography, and by providing supportive care. This approach avoids development of bleeding complications that may be associated with anticoagulant or fibrinolytic therapy. Most thrombi resolve without specific therapy, and the patient may be able to wean off of antihypertensive medications. (See",
"    <a class=\"local\" href=\"#H195796962\">",
"     'Duration of treatment and course'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Severe symptomatic thromboembolic events that compromise the viability of a vital organ or extremity typically are treated with anticoagulation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fibrinolytic agents. However, these strategies have not been studied in clinical trials, and data on outcome are sparse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/9\">",
"     9",
"    </a>",
"    ]. The management of less severe events also is uncertain. Thrombolysis and anticoagulation therapy are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/40/14986?source=see_link\">",
"     \"Management of thrombosis in the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In hypertensive infants with unilateral renovascular disease with a poorly functioning kidney, unilateral nephrectomy is a reasonable option, especially if pediatric interventional radiology expertise is unavailable. In one study, four patients who underwent unilateral nephrectomy for unilateral renovascular disease had normal growth, blood pressure, and renal function at follow-up 5 to 16 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H155183048\">",
"    <span class=\"h1\">",
"     APPROACH TO PHARMACOLOGIC TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H155183129\">",
"    <span class=\"h2\">",
"     Who should be treated?",
"    </span>",
"    &nbsp;&mdash;&nbsp;The criteria for drug treatment of hypertension in infants are uncertain as there are no data comparing the outcome of infants with untreated hypertension, regardless of its severity, to those with normal blood pressure. &nbsp;",
"   </p>",
"   <p>",
"    The following approach is based on consensus expert opinion and clinical experience [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/1\">",
"     1",
"    </a>",
"    ]. Management decisions are made based on the severity of hypertension, and whether the infant is symptomatic or has evidence of end-organ involvement (",
"    <a class=\"graphic graphic_figure graphicRef50321 \" href=\"mobipreview.htm?11/3/11312\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef71407 \" href=\"mobipreview.htm?38/24/39311\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef62005 \" href=\"mobipreview.htm?22/50/23343\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef76354 \" href=\"mobipreview.htm?15/56/16270\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37833?source=see_link&amp;anchor=H2915662#H2915662\">",
"     \"Etiology, clinical features, and diagnosis of neonatal hypertension\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37833?source=see_link&amp;anchor=H2915669#H2915669\">",
"     \"Etiology, clinical features, and diagnosis of neonatal hypertension\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44630?source=see_link&amp;anchor=H21347142#H21347142\">",
"     \"Hypertension in infants between one month and one year of age\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Observation may be most appropriate for asymptomatic healthy infants with mild hypertension (systolic BP 95",
"      <sup>",
"       th",
"      </sup>",
"      to &lt;99",
"      <sup>",
"       th",
"      </sup>",
"      percentile) with no evidence of end-organ involvement (eg, left ventricular hypertrophy [LVH]). Depending on the etiology, the hypertension may resolve over time in many such cases.",
"     </li>",
"     <li>",
"      Pharmacologic therapy should be considered in infants with moderate asymptomatic hypertension (BP &ge;99",
"      <sup>",
"       th",
"      </sup>",
"      percentile) (",
"      <a class=\"graphic graphic_table graphicRef76354 \" href=\"mobipreview.htm?15/56/16270\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef63856 \" href=\"mobipreview.htm?7/45/7894\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef52646 \" href=\"mobipreview.htm?7/46/7910\">",
"       table 3",
"      </a>",
"      ), or in those with mild hypertension who have symptoms or end-organ involvement (eg, LVH).",
"     </li>",
"     <li>",
"      Extreme elevations of BP (&gt;30 percent above the mean values expected for age) are considered hypertensive emergencies, especially when end-organ involvement is present, and parenteral pharmacologic treatment should be initiated as quickly as possible [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H155183136\">",
"    <span class=\"h3\">",
"     Mild hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonates with mild hypertension (95",
"    <sup>",
"     th",
"    </sup>",
"    to &lt;99",
"    <sup>",
"     th",
"    </sup>",
"    percentile) who are asymptomatic may be observed closely with measurement of the BP every six to eight hours. If the BP elevation is persistent, drug treatment should be considered. Echocardiography is helpful in assessing for target-organ damage. Left ventricular hypertrophy would be an indication for the initiation of drug therapy. Similarly, treatment should be strongly considered if there is proven underlying renal disease.",
"   </p>",
"   <p>",
"    Older infants with either systolic or diastolic BP values between the 95",
"    <sup>",
"     th",
"    </sup>",
"    and 99",
"    <sup>",
"     th",
"    </sup>",
"    percentile should be reevaluated to see whether the elevated BP remains persistent, as in older children. If BP elevation remains persistent, the decision whether to institute pharmacologic therapy should be made based upon the underlying cause of hypertension and whether or not there is evidence of end-organ injury. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44630?source=see_link&amp;anchor=H21347142#H21347142\">",
"     \"Hypertension in infants between one month and one year of age\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H155183143\">",
"    <span class=\"h3\">",
"     Asymptomatic moderate hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antihypertensive therapy is started in infants with persistent asymptomatic moderate hypertension defined as a BP &ge;99",
"    <sup>",
"     th",
"    </sup>",
"    percentile [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/1\">",
"     1",
"    </a>",
"    ]. Oral medications may be used if the patient is clinically stable and is able to take oral medications, or when the infant initially treated with intravenous antihypertensive therapy is ready to be transitioned to oral medication.",
"   </p>",
"   <p>",
"    Although case series have reported on a wide variety of agents used to treat persistent hypertension in neonates and older infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/1-7\">",
"     1-7",
"    </a>",
"    ], there are no clinical trial data available to guide the choice of medication in these patients. Reasonable choices include calcium channel blockers, diuretics, beta-blockers (may wish to avoid in patients with a history of chronic lung disease), and if the patient is greater than 44 weeks postconceptual age, angiotensin converting enzyme inhibitors (ACEIs). (See",
"    <a class=\"local\" href=\"#H195796892\">",
"     'Pharmacologic agents'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H155183150\">",
"    <span class=\"h3\">",
"     Severe symptomatic hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe symptomatic hypertension (&gt;30 percent above the mean values expected for age) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/8\">",
"     8",
"    </a>",
"    ], as in older children with hypertensive emergencies, must be managed aggressively but in a controlled and safe manner. Continuous infusions of intravenous medications should be used, as they act quickly and have a short half-life, which allows titration to the desired effect. As in older children, we recommend BP should be lowered in a controlled fashion by no more than 25 percent over the first eight hours. Further reduction to the target BP (usually either the 90",
"    <sup>",
"     th",
"    </sup>",
"    or 95",
"    <sup>",
"     th",
"    </sup>",
"    percentiles for age,) can be made over the next 24 to 36 hours. Intravenous bolus infusions and potent oral medications should be avoided because they may lower BP too precipitously, and their duration of action may be too long. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/33/23065?source=see_link\">",
"     \"Management of hypertensive emergencies and urgencies in children\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H155183157\">",
"     'Target BP goal'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For patients who are treated with an intravenous antihypertensive agent, BP should be measured either continuously through an intraarterial catheter or at frequent intervals by an oscillometric device.",
"   </p>",
"   <p>",
"    As discussed below, the calcium channel blocker",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/38/32361?source=see_link\">",
"     nicardipine",
"    </a>",
"    is generally considered the drug of choice for the management of severe hypertension in neonates and infants. It should be started as a continuous intravenous infusion at a dose of 0.5",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute. If the target BP goal is not achieved within 15 minutes, the infusion can be increased in increments of 0.25 to 0.5",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute every 15 minutes to a maximum of 3",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute. In the rare patient whose BP does not respond to nicardipine or whose BP remains elevated on the maximum dose of nicardipine, infusions of either sodium",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/52/40773?source=see_link\">",
"     nitroprusside",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/48/5895?source=see_link\">",
"     esmolol",
"    </a>",
"    can be added or substituted. Once the target BP is reached, and if the clinical condition permits, transition to oral medication can be considered. (See",
"    <a class=\"local\" href=\"#H195796920\">",
"     'Calcium channel blockers'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H155183157\">",
"    <span class=\"h2\">",
"     Target BP goal",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2004, the National High Blood Pressure Education Program Working Group (NHBPEP), which was comprised of experts in the field, revised target BP goals for the treatment of hypertension in children between 1 and 18 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27626?source=see_link&amp;anchor=H21#H21\">",
"     \"Treatment of hypertension in children and adolescents\", section on 'Target blood pressure goals'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although target BP goals have not been established for infants treated with antihypertensive therapy, we use the following guidelines for management of BP in infants, which are extrapolated from the NHBPEP target BP goals in older children:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with no evidence of target-organ damage or underlying diseases associated with cardiovascular disease (CVD), the target BP goal is less than the 95",
"      <sup>",
"       th",
"      </sup>",
"      percentile.",
"     </li>",
"     <li>",
"      If there is evidence of target-organ damage (eg, left ventricular hypertrophy) or diseases associated with hypertension (eg, chronic kidney disease), the BP target goal is lowered to below the 90",
"      <sup>",
"       th",
"      </sup>",
"      percentile.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195796892\">",
"    <span class=\"h1\">",
"     PHARMACOLOGIC AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited data on the use of specific antihypertensive agents to treat neonates and infants with hypertension. The information is derived from small case series reporting use of antihypertensive drugs in newborns",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    older infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. Given the lack of properly conducted clinical trials in this age group, treatment is usually empiric, and the choice of therapy relies upon clinical experience and judgment. In addition, the availability of specific agents, especially oral liquid formulations, will vary among institutions. Thus, consultation with a pediatric nephrologist or other physician with experience in the management of neonatal hypertension is recommended.",
"   </p>",
"   <p>",
"    Despite the paucity of data, all classes of antihypertensive agents have been used in the treatment of hypertension in neonates and older infants, including diuretics, angiotensin converting enzyme (ACE) inhibitors, beta blockers, calcium channel blockers, and direct vasodilators [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. Suggested doses for antihypertensive medications commonly used in infants can be found in the linked table (",
"    <a class=\"graphic graphic_table graphicRef63077 \" href=\"mobipreview.htm?3/37/3678\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    When antihypertensive therapy is initiated, it is best to begin with a single drug, increasing the dose in a stepwise fashion to the maximum dose until the BP is controlled [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/11\">",
"     11",
"    </a>",
"    ]. If hypertension persists, or adverse effects of the first drug are seen, a second drug should be added. The choice of antihypertensive agent is dependent upon the severity of hypertension. For infants with severe hypertension, continuous intravenous antihypertensive administration (eg,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/38/32361?source=see_link\">",
"     nicardipine",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?38/59/39863?source=see_link\">",
"     labetalol",
"    </a>",
"    ) is preferred so that BP can be rapidly modified and safely lowered based upon patient response. Oral agents can be used in patients with less severe hypertension. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37833?source=see_link&amp;anchor=H2915536#H2915536\">",
"     \"Etiology, clinical features, and diagnosis of neonatal hypertension\", section on 'Definition'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H155183048\">",
"     'Approach to pharmacologic treatment'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The following sections review specific classes of antihypertensive agents in infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195796899\">",
"    <span class=\"h2\">",
"     Diuretics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diuretics reduce extracellular and plasma volume, resulting in a modest decrease in BP. Their use in newborns usually is limited to mild hypertension resulting from volume overload or as a second-line medication when the BP is unable to be controlled using a single agent. Diuretic therapy may also be beneficial in improving lung function in infants with bronchopulmonary dysplasia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/24/15753?source=see_link&amp;anchor=H7#H7\">",
"     \"Management of bronchopulmonary dysplasia\", section on 'Diuretics'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If diuretics are used in the treatment of hypertension in infants, thiazide diuretics are generally preferred to loop diuretics because of the increase risk of adverse effects with loop diuretics. Loop diuretics are associated with a greater risk of electrolyte abnormalities, particularly hypokalemia, and may also lead to nephrocalcinosis due to hypercalciuria. If a diuretic is indicated, we suggest starting with a low dose of either",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?20/27/20919?source=see_link\">",
"     chlorothiazide",
"    </a>",
"    (10",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day, divided Q 12 hours) or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?41/29/42454?source=see_link\">",
"     hydrochlorothiazide",
"    </a>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day), and make adjustments every three to four days. Chlorothiazide is commercially available as a suspension and may therefore be easier to use in infants. Electrolytes should be monitored within 72 hours after introducing a diuretic.",
"   </p>",
"   <p>",
"    Potassium-sparing diuretics such as",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?17/0/17414?source=see_link\">",
"     spironolactone",
"    </a>",
"    are generally not useful in the management of hypertension in infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195796906\">",
"    <span class=\"h2\">",
"     ACE inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although angiotensin-converting enzyme inhibitors (ACEI) are effective in lowering the BP in infants, we do not recommend their use in neonates because of concerns for significant adverse effects.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?18/20/18760?source=see_link\">",
"       Captopril",
"      </a>",
"      , an oral ACEI, is effective in lower BP in infants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/4\">",
"       4",
"      </a>",
"      ], but it causes a well known exaggerated fall in BP in premature infants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/15\">",
"       15",
"      </a>",
"      ]. Seizures and acute renal injury have been associated with the precipitous fall in BP due to captopril [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/20/19783?source=see_link\">",
"       Enalaprilat",
"      </a>",
"      is an intravenously administered ACE inhibitor that is effective in renovascular hypertension and has been used in newborns [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/3\">",
"       3",
"      </a>",
"      ]. However, even doses at the lower end of published ranges may lead to significant, prolonged hypotension and oliguric acute renal failure. It should also be noted that all available doses for enalaprilat are based on the previously mentioned, uncontrolled case series [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/3\">",
"       3",
"      </a>",
"      ]; no safe and effective dose has ever been systematically established for use in neonates.",
"     </li>",
"     <li>",
"      The use of ACEI in neonates may also affect normal renal development because of its inhibition of the neonatal renin-angiotensin system [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/17\">",
"       17",
"      </a>",
"      ]. Although few data exist on the neonatal effect of ACEI, the known adverse effects on fetal renal development with the maternal use of these agents have led to concerns that they may impair the final stages of renal maturation when given to newborn infants. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1543?source=see_link\">",
"       \"Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based on the above concerns, we typically avoid use of ACEIs until the infant has reached a corrected post-conceptual age of 44 weeks. Although there are not similar data on the use of angiotensin receptor blockers (ARBs) in neonates, we would also avoid the use of ARBs because of similar concerns regarding their effect on renal development.",
"   </p>",
"   <p>",
"    If ACEI is selected for use in an older infant, it should be noted that these agents are contraindicated in patients with bilateral renovascular disease or renovascular disease in a solitary kidney. In these cases, loss of the angiotensin II-mediated maintenance of glomerular capillary pressure can result in acute renal failure. Additionally,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?18/20/18760?source=see_link\">",
"     captopril",
"    </a>",
"    is only commercially available in a tablet formulation. While a 1",
"    <span class=\"nowrap\">",
"     mg/mL",
"    </span>",
"    suspension can be compounded, there may be great variability when prepared by local pharmacists [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195796913\">",
"    <span class=\"h2\">",
"     Beta blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beta blockers are widely used in the treatment of neonatal hypertension and include both oral and intravenous preparations. However, these agents should be avoided in infants with chronic lung disease because of possible bronchoconstriction.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/62/36840?source=see_link\">",
"       Propranolol",
"      </a>",
"      is effective in treating neonatal hypertension, and side effects (aside from bradycardia) are uncommon. It is one of the only agents commercially available as a suspension, making it attractive for use in infants.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?38/59/39863?source=see_link\">",
"       Labetalol",
"      </a>",
"      is a combined alpha-1 and beta blocker with a rapid onset of action and duration of two to three hours. It is typically administered intravenously, either as a continuous infusion or in intermittent doses. It may be particularly useful in both catecholamine and central nervous system-mediated hypertension, since it does not cause tachycardia, cerebral vasodilatation, or changes in intracranial pressure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?5/48/5895?source=see_link\">",
"     Esmolol",
"    </a>",
"    is an ultra short-acting intravenous cardioselective beta-1 adrenergic blocker that is well-suited for management of severe, symptomatic hypertension because of its rapid onset of action (~60 seconds) and relatively short duration of action (10 to 20 minutes) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/20\">",
"     20",
"    </a>",
"    ]. It is particularly effective in the management of acute hypertension in infants and children after repair of aortic coarctation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/21\">",
"     21",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195796920\">",
"    <span class=\"h2\">",
"     Calcium channel blockers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dihydropyridine calcium channel blockers, such as",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/38/32361?source=see_link\">",
"     nicardipine",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/44/7879?source=see_link\">",
"     isradipine",
"    </a>",
"    , are potent peripheral vasodilators and are effective in the treatment of neonatal hypertension. Both oral and intravenous formulations of calcium channel blockers are available to treat infants.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/38/32361?source=see_link\">",
"       Nicardipine",
"      </a>",
"      appears to be effective and safe in term and preterm newborns, and older infants with hypertension of a variety of etiologies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/2,5,6,22,23\">",
"       2,5,6,22,23",
"      </a>",
"      ]. Intravenous nicardipine is generally considered the drug of choice for management of severe hypertension, because its administration decreases BP within minutes. Because of its short half-life of 10 to 15 minutes, it is given as a continuous infusion. An associated side effect is tachycardia, which is usually clinically insignificant.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?7/44/7879?source=see_link\">",
"       Isradipine",
"      </a>",
"      appears to be an effective oral calcium channel blocker and has been reported effective in both acute and chronic hypertension in two single-center case series that included small numbers of infants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/7,24\">",
"       7,24",
"      </a>",
"      ]. It takes effect within one to two hours after administration and may be compounded into a stable 1",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"      suspension, facilitating its use in infants.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?35/22/36199?source=see_link\">",
"       Amlodipine",
"      </a>",
"      is a longer-acting calcium channel blocker that has also found widespread use in the treatment of hypertensive children, including in a case series of hypertensive infants [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/14\">",
"       14",
"      </a>",
"      ]. Its maximal hypotensive effect may not be seen for several days after initiation of therapy, making it best suited for management of chronic hypertension.",
"     </li>",
"     <li>",
"      The use of short-acting",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?9/2/9256?source=see_link\">",
"       nifedipine",
"      </a>",
"      is no longer recommended. It cannot be compounded into a stable, easy to administer oral formulation, and can cause exaggerated, rapid drops in BP [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62145479\">",
"    <span class=\"h2\">",
"     Vasodilators",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?4/53/4949?source=see_link\">",
"     Hydralazine",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/47/31472?source=see_link\">",
"     minoxidil",
"    </a>",
"    , and sodium",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/52/40773?source=see_link\">",
"     nitroprusside",
"    </a>",
"    are antihypertensive agents used in infants that act as direct vasodilators.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195796927\">",
"    <span class=\"h3\">",
"     Hydralazine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?4/53/4949?source=see_link\">",
"     Hydralazine",
"    </a>",
"    is a peripheral vasodilator that causes relaxation of vascular smooth muscle. Oral or intravenous hydralazine is useful in the treatment of moderate hypertension in infants. Extemporaneously compounded hydralazine suspension is only stable for seven days, making the oral formulation of hydralazine impractical for outpatient use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62145494\">",
"    <span class=\"h3\">",
"     Minoxidil",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/47/31472?source=see_link\">",
"     Minoxidil",
"    </a>",
"    is a direct vasodilator that opens potassium channels in smooth muscle cells, causing potassium efflux, which in turn leads to hyperpolarization and relaxation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/26\">",
"     26",
"    </a>",
"    ]. It acts primarily on arterioles and does not produce venous dilatation. Although primarily studied in older children with refractory hypertension, minoxidil may be useful in rare infants with severe, secondary forms of hypertension. Well-known side effects include hirsutism and fluid retention that are primarily seen with chronic use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195796934\">",
"    <span class=\"h3\">",
"     Sodium nitroprusside",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intravenous sodium",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/52/40773?source=see_link\">",
"     nitroprusside",
"    </a>",
"    is a direct vasodilator of both arteriolar and venous smooth muscle cells. It is metabolized to nitric oxide, which dilates both arterioles and venules, thereby reducing total peripheral resistance, accounting for its efficacy in the treatment of severe hypertension. Because of its rapid onset of action and short duration of effect, BP can be carefully titrated. Complications include hypotension and thiocyanate toxicity, which can occur with prolonged administration (&gt;72 hr) or renal insufficiency. Thiocyanate levels should be monitored in these settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62146158\">",
"    <span class=\"h1\">",
"     ONGOING MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases of neonatal hypertension, BP control can be readily achieved with antihypertensive medications. In any neonate treated with antihypertensive medications, the infant should not be discharged from the nursery until the desired goals of treatment are determined and the potential adverse effects of the prescribed agents are reviewed with the parents.",
"   </p>",
"   <p>",
"    After discharge from the nursery, infants with chronic hypertension may require increasing doses of their antihypertensive medication as they grow. As a result, ongoing BP monitoring will be needed in order to assure that BP control is being maintained. In these patients, proper equipment needs to be arranged for home use (usually an oscillometric device) and the parents instructed on the use of the equipment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195796962\">",
"    <span class=\"h2\">",
"     Duration of treatment and course",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of therapy and long-term outcome may be influenced by the ability to identify and treat the underlying disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37833?source=see_link&amp;anchor=H2915585#H2915585\">",
"     \"Etiology, clinical features, and diagnosis of neonatal hypertension\", section on 'Etiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Renovascular hypertension secondary to thromboembolism is typically transient, with some patients requiring treatment for only a few weeks. It is typical for infants to initially require increase dosing of medications as they gain weight after discharge, then for the BP to remain controlled on the same dose despite ongoing growth. When the dosing remains unchanged despite ongoing growth, the medication can probably be slowly weaned and discontinued over one to two months. The following two studies illustrate the relatively good prognosis of hypertension due to aortic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      renal thromboembolism:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In a study of 11 infants with renovascular hypertension (primarily due to renal artery thrombosis), the BP remained normal after antihypertensive therapy was discontinued [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/27\">",
"       27",
"      </a>",
"      ]. At a mean follow-up of 5.75 years, creatinine clearance was normal in all but one patient. However, radionuclide scans were abnormal with evidence of unilateral renal atrophy in five patients.",
"     </li>",
"     <li>",
"      In a second study of 15 children with neonatal aortic thrombosis and renovascular hypertension, the BP was normal at an average age of 26 months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42936/abstract/28\">",
"       28",
"      </a>",
"      ]. However, five patients who were less than 24 months of age still required antihypertensive medication. All patients had normal serum creatinine concentration and plasma renin activity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypertension associated with acute tubular necrosis should resolve when the renal function improves. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/30/27114?source=see_link&amp;anchor=H6#H6\">",
"       \"Acute kidney injury (acute renal failure) in the newborn\", section on 'Prerenal disease and acute tubular necrosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chronic hypertension is observed in infants with persistent renal dysfunction or renal parenchymal diseases such as autosomal recessive polycystic kidney disease. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29913?source=see_link&amp;anchor=H25823482#H25823482\">",
"       \"Autosomal recessive polycystic kidney disease in children\", section on 'Hypertension'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypertension associated with coarctation of the aorta typically resolves following successful correction, although these infants are at risk for recurrence of hypertension later in life. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20922?source=see_link&amp;anchor=H17#H17\">",
"       \"Management of coarctation of the aorta\", section on 'Systemic hypertension'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H62146413\">",
"    <span class=\"h1\">",
"     LONG-TERM OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;To date, no data have been published regarding the outcome of hypertensive infants in late childhood, let alone adulthood. For this reason, we recommend that patients with neonatal hypertension should be closely followed. Monitoring of BP and renal function should be performed on a regular basis. In our practice, patients are generally seen monthly for the first three to six months after discharge from the NICU, then every three months after that. Given the high prevalence of renovascular and other renal parenchymal causes of hypertension, serial renal imaging should also be considered. There is a great need for long-term outcome studies to better define the prognosis of hypertensive infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H195796969\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and editorial staff at UpToDate, Inc. would like to acknowledge Dr. Raymond Adelman, who contributed to an earlier version of this topic review.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H155182664\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although data are limited regarding the treatment of hypertension in infants, the approach to management is similar to that used in older children. Decisions are based on the severity of hypertension, the underlying cause, and other clinical factors that impact the well-being of the patient. Treatment consists of identifying and correcting any curable cause of hypertension, and pharmacologic therapy to lower blood pressure.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Underlying causes of hypertension that are amenable to treatment with resolution of hypertension include fluid overload, hyperthyroidism, congenital adrenal hyperplasia, pain, abdominal or renal tumors, obstructive uropathy, and coarctation of the aorta. (See",
"      <a class=\"local\" href=\"#H195796885\">",
"       'Correcting underlying cause'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical criteria for starting antihypertensive therapy in infants, such as blood pressure (BP) thresholds, are not well defined. As a result, indications for initiation of antihypertensive therapy are primarily based on expert clinical opinion. We suggest using the following approach in managing hypertension in infants based on our clinical experience (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Blood pressure percentiles are derived from limited data in neonates and older infants (",
"      <a class=\"graphic graphic_table graphicRef76354 \" href=\"mobipreview.htm?15/56/16270\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef63856 \" href=\"mobipreview.htm?7/45/7894\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef52646 \" href=\"mobipreview.htm?7/46/7910\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H155183048\">",
"       'Approach to pharmacologic treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37833?source=see_link\">",
"       \"Etiology, clinical features, and diagnosis of neonatal hypertension\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37833?source=see_link&amp;anchor=H2915543#H2915543\">",
"       \"Etiology, clinical features, and diagnosis of neonatal hypertension\", section on 'Normal BP'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44630?source=see_link&amp;anchor=H21347114#H21347114\">",
"       \"Hypertension in infants between one month and one year of age\", section on 'Normal blood pressure'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Observation and continued monitoring for asymptomatic infants with mild hypertension (systolic BP 95",
"      <sup>",
"       th",
"      </sup>",
"      to &lt;99",
"      <sup>",
"       th",
"      </sup>",
"      percentile). (See",
"      <a class=\"local\" href=\"#H155183136\">",
"       'Mild hypertension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pharmacologic therapy for infants with moderate asymptomatic hypertension (BP &ge;99th percentile), or in those with mild hypertension who have symptoms or end-organ involvement. (See",
"      <a class=\"local\" href=\"#H155183143\">",
"       'Asymptomatic moderate hypertension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Extreme elevations of BP (&gt;30 percent above the mean values expected for age) are considered potential hypertensive emergencies, especially when end-organ involvement is present, and parenteral pharmacologic treatment should be initiated as quickly as possible. (See",
"      <a class=\"local\" href=\"#H155183150\">",
"       'Severe symptomatic hypertension'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although targeted BP goals have not been established for infants treated with antihypertensive therapy, we suggest using the following target BP goals, which are extrapolated from the National High Blood Pressure Education Program Working Group guidelines in older children (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ), (see",
"      <a class=\"local\" href=\"#H155183157\">",
"       'Target BP goal'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In patients with no evidence of target-organ damage or underlying diseases associated with cardiovascular disease (CVD), the target BP is less than the 95",
"      <sup>",
"       th",
"      </sup>",
"      percentile.",
"     </li>",
"     <li>",
"      If there is evidence of target-organ damage (eg, left ventricular hypertrophy) or underlying diseases that might benefit from BP reduction (eg, chronic kidney disease), the BP targeted goal is less than the 90",
"      <sup>",
"       th",
"      </sup>",
"      percentile.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are no clinical trials to evaluate the comparative effectiveness of specific antihypertensive drugs in infants with hypertension. Classes of antihypertensive agents used in the management of infant hypertension include diuretics, angiotensin converting enzyme inhibitors (ACEIs), beta blockers, calcium channel blockers, and direct vasodilators, such as",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?4/53/4949?source=see_link\">",
"       hydralazine",
"      </a>",
"      ,",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?30/47/31472?source=see_link\">",
"       minoxidil",
"      </a>",
"      , and sodium",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/52/40773?source=see_link\">",
"       nitroprusside",
"      </a>",
"      (",
"      <a class=\"graphic graphic_table graphicRef63077 \" href=\"mobipreview.htm?3/37/3678\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H195796892\">",
"       'Pharmacologic agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The choice of agent is generally dependent on the experience and judgment of the clinicians caring for the patient, and the availability of the medication with the following caveats:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Infants with severe symptomatic hypertension should receive intravenous medication to lower BP. We suggest administration of",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?31/38/32361?source=see_link\">",
"       nicardipine",
"      </a>",
"      , a calcium channel blocker, as a continuous intravenous infusion starting at a dose of 0.5",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per minute (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H155183150\">",
"       'Severe symptomatic hypertension'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H195796920\">",
"       'Calcium channel blockers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do",
"      <strong>",
"       not",
"      </strong>",
"      recommend the use of an ACEI in infants &lt;44 weeks post conceptual age because of potential adverse effects on renal development, and acute renal failure and seizures due to precipitous and uncontrolled fall in BP (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H195796906\">",
"       'ACE inhibitors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest",
"      <strong>",
"       not",
"      </strong>",
"      using beta blockers to treat hypertension in infants with chronic lung disease because of their potential to cause bronchoconstriction (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H195796913\">",
"       'Beta blockers'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When antihypertensive therapy is initiated, it is best to begin with a single drug, increasing the dose in a stepwise fashion to the maximum dose until the BP is controlled. If hypertension persists, or adverse effects of the first drug are seen, a second drug should be added.",
"     </li>",
"     <li>",
"      Infants treated with antihypertensive therapy will need to have ongoing BP monitoring. These infants may require increasing doses of their medication as they grow. (See",
"      <a class=\"local\" href=\"#H62146158\">",
"       'Ongoing management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The duration of therapy is influenced by the underlying cause of hypertension. In most cases, hypertension resolves with recovery or treatment of the underlying disorder, so that chronic long-term antihypertensive therapy is usually not needed. (See",
"      <a class=\"local\" href=\"#H195796962\">",
"       'Duration of treatment and course'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because there are no long-term outcome data on the sequelae of hypertension during infancy, we suggest monitoring of BP and renal function on a regular basis (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H62146413\">",
"       'Long-term outcome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/1\">",
"      Dionne JM, Abitbol CL, Flynn JT. Hypertension in infancy: diagnosis, management and outcome. Pediatr Nephrol 2012; 27:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/2\">",
"      Gouyon JB, Geneste B, Semama DS, et al. Intravenous nicardipine in hypertensive preterm infants. Arch Dis Child Fetal Neonatal Ed 1997; 76:F126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/3\">",
"      Wells TG, Bunchman TE, Kearns GL. Treatment of neonatal hypertension with enalaprilat. J Pediatr 1990; 117:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/4\">",
"      O'Dea RF, Mirkin BL, Alward CT, Sinaiko AR. Treatment of neonatal hypertension with captopril. J Pediatr 1988; 113:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/5\">",
"      Milou C, Debuche-Benouachkou V, Semama DS, et al. Intravenous nicardipine as a first-line antihypertensive drug in neonates. Intensive Care Med 2000; 26:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/6\">",
"      Tobias JD. Nicardipine to control mean arterial pressure after cardiothoracic surgery in infants and children. Am J Ther 2001; 8:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/7\">",
"      Flynn JT, Warnick SJ. Isradipine treatment of hypertension in children: a single-center experience. Pediatr Nephrol 2002; 17:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/8\">",
"      Watkinson M. Hypertension in the newborn baby. Arch Dis Child Fetal Neonatal Ed 2002; 86:F78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/9\">",
"      Edstrom CS, Christensen RD. Evaluation and treatment of thrombosis in the neonatal intensive care unit. Clin Perinatol 2000; 27:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/10\">",
"      Kiessling SG, Wadhwa N, Kriss VM, et al. An unusual case of severe therapy-resistant hypertension in a newborn. Pediatrics 2007; 119:e301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/11\">",
"      National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/12\">",
"      Seliem WA, Falk MC, Shadbolt B, Kent AL. Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up. Pediatr Nephrol 2007; 22:2081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/13\">",
"      Friedman AL, Hustead VA. Hypertension in babies following discharge from a neonatal intensive care unit. A 3-year follow-up. Pediatr Nephrol 1987; 1:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/14\">",
"      Lanzarini VV, Furusawa EA, Sadeck L, et al. Neonatal arterial hypertension in nephro-urological malformations in a tertiary care hospital. J Hum Hypertens 2006; 20:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/15\">",
"      Tack ED, Perlman JM. Renal failure in sick hypertensive premature infants receiving captopril therapy. J Pediatr 1988; 112:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/16\">",
"      Perlman JM, Volpe JJ. Neurologic complications of captopril treatment of neonatal hypertension. Pediatrics 1989; 83:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/17\">",
"      Guron G, Friberg P. An intact renin-angiotensin system is a prerequisite for normal renal development. J Hypertens 2000; 18:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/18\">",
"      Mulla H, Tofeig M, Bu'Lock F, et al. Variations in captopril formulations used to treat children with heart failure: a survey in the United kingdom. Arch Dis Child 2007; 92:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/19\">",
"      Mulla H, Hussain N, Tanna S, et al. Assessment of liquid captopril formulations used in children. Arch Dis Child 2011; 96:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/20\">",
"      Adamson PC, Rhodes LA, Saul JP, et al. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias. Pediatr Cardiol 2006; 27:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/21\">",
"      Wiest DB, Garner SS, Uber WE, Sade RM. Esmolol for the management of pediatric hypertension after cardiac operations. J Thorac Cardiovasc Surg 1998; 115:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/22\">",
"      Flynn JT, Mottes TA, Brophy PD, et al. Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 2001; 139:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/23\">",
"      Nakagawa TA, Sartori SC, Morris A, Schneider DS. Intravenous nicardipine for treatment of postcoarctectomy hypertension in children. Pediatr Cardiol 2004; 25:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/24\">",
"      Miyashita Y, Peterson D, Rees JM, Flynn JT. Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J Clin Hypertens (Greenwich) 2010; 12:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/25\">",
"      Flynn JT. Safety of short-acting nifedipine in children with severe hypertension. Expert Opin Drug Saf 2003; 2:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/26\">",
"      Kirsten R, Nelson K, Kirsten D, Heintz B. Clinical pharmacokinetics of vasodilators. Part I. Clin Pharmacokinet 1998; 34:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/27\">",
"      Adelman RD. Long-term follow-up of neonatal renovascular hypertension. Pediatr Nephrol 1987; 1:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42936/abstract/28\">",
"      Caplan MS, Cohn RA, Langman CB, et al. Favorable outcome of neonatal aortic thrombosis and renovascular hypertension. J Pediatr 1989; 115:291.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16308 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-961E418322-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42936=[""].join("\n");
var outline_f41_59_42936=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H155182664\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H802040\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H62144060\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H195796885\">",
"      CORRECTING UNDERLYING CAUSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H155183048\">",
"      APPROACH TO PHARMACOLOGIC TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H155183129\">",
"      Who should be treated?",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H155183136\">",
"      - Mild hypertension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H155183143\">",
"      - Asymptomatic moderate hypertension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H155183150\">",
"      - Severe symptomatic hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H155183157\">",
"      Target BP goal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H195796892\">",
"      PHARMACOLOGIC AGENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H195796899\">",
"      Diuretics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H195796906\">",
"      ACE inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H195796913\">",
"      Beta blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H195796920\">",
"      Calcium channel blockers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H62145479\">",
"      Vasodilators",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H195796927\">",
"      - Hydralazine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H62145494\">",
"      - Minoxidil",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H195796934\">",
"      - Sodium nitroprusside",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H62146158\">",
"      ONGOING MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H195796962\">",
"      Duration of treatment and course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H62146413\">",
"      LONG-TERM OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H195796969\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H155182664\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/16308\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/16308|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?11/3/11312\" title=\"figure 1\">",
"      Neonatal BP gestational age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?38/24/39311\" title=\"figure 2\">",
"      Neonatal BP birth weight",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?22/50/23343\" title=\"figure 3\">",
"      BP by post-conceptual age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/16308|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?15/56/16270\" title=\"table 1\">",
"      Neonatal blood pressures and potential treatment parameters",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/45/7894\" title=\"table 2\">",
"      Normal BP boys",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?7/46/7910\" title=\"table 3\">",
"      Normal BP girls",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/37/3678\" title=\"table 4\">",
"      Antihypertensive drugs for infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/30/27114?source=related_link\">",
"      Acute kidney injury (acute renal failure) in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/32/1543?source=related_link\">",
"      Angiotensin converting enzyme inhibitors and receptor blockers in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/7/31863?source=related_link\">",
"      Assessment of neonatal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/13/29913?source=related_link\">",
"      Autosomal recessive polycystic kidney disease in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/32/15878?source=related_link\">",
"      Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/3/26680?source=related_link\">",
"      Congenital ureteropelvic junction obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/60/37833?source=related_link\">",
"      Etiology, clinical features, and diagnosis of neonatal hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/6/97?source=related_link\">",
"      Evaluation and management of neonatal Graves' disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/60/27591?source=related_link\">",
"      Fluid and electrolyte therapy in newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44630?source=related_link\">",
"      Hypertension in infants between one month and one year of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/24/15753?source=related_link\">",
"      Management of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20922?source=related_link\">",
"      Management of coarctation of the aorta",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/33/23065?source=related_link\">",
"      Management of hypertensive emergencies and urgencies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/40/14986?source=related_link\">",
"      Management of thrombosis in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35114?source=related_link\">",
"      Prevention and treatment of neonatal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/50/9002?source=related_link\">",
"      Treatment and prognosis of Wilms tumor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27626?source=related_link\">",
"      Treatment of hypertension in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/51/35641?source=related_link\">",
"      Uncommon causes of congenital adrenal hyperplasia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_59_42937="Acute cystitis in children older than two years and adolescents";
var content_f41_59_42937=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute cystitis in children older than two years and adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42937/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42937/contributors\">",
"     Debra L Palazzi, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42937/contributors\">",
"     Judith R Campbell, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42937/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42937/contributors\">",
"     Tej K Mattoo, MD, DCH, FRCP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42937/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?41/59/42937/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?41/59/42937/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?41/59/42937/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystitis is inflammation of the urinary bladder, usually caused by infection, which can occur alone or in conjunction with pyelonephritis.",
"   </p>",
"   <p>",
"    Acute cystitis in the child older than two years and in the adolescent will be reviewed here. Urinary tract infection (UTI) in younger children (in whom it is difficult to distinguish cystitis from pyelonephritis on clinical grounds) is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26360?source=see_link\">",
"     \"Epidemiology and risk factors for urinary tract infections in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=see_link\">",
"     \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The distinction between complicated and uncomplicated cystitis is based upon the presence or absence of anatomic or physiologic abnormality of the urinary tract (including pyelonephritis), host factors, and the antimicrobial resistance pattern of the uropathogen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Uncomplicated cystitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uncomplicated cystitis is limited to the lower urinary tract and occurs in older children (older than two years) or adolescents with no underlying medical problems or anatomic or physiologic abnormalities. Most often it is caused by pathogens that are susceptible to the antimicrobial agents that are usually used to treat cystitis. (See",
"    <a class=\"local\" href=\"#H18\">",
"     'Initial treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Complicated cystitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complicated cystitis is associated with upper tract disease, multiple-resistant uropathogens, or hosts with special considerations such as malignancy, diabetes, anatomic or physiologic abnormalities, or an indwelling bladder catheter. Patients who have urodynamic dysfunction, neurogenic bladder, or incomplete bladder emptying may harbor pathogens in residual urine, thereby creating a source for persistent or recurrent infection. Many complicated urinary tract infections (UTI) are hospital acquired and are related to indwelling urinary catheters. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=see_link\">",
"     \"Etiology and clinical features of bladder dysfunction in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/50/25384?source=see_link\">",
"     \"Evaluation and diagnosis of bladder dysfunction in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of children with upper UTI is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/27/7606?source=see_link&amp;anchor=H2#H2\">",
"     \"Long-term management and prevention of urinary tract infections in children\", section on 'Long-term management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=see_link&amp;anchor=H2#H2\">",
"     \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\", section on 'Overview'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of acute cystitis in older children who are not sexually active is difficult to determine. The prevalence of urinary tract infections (UTI, which includes upper and lower tract infection) in this population probably is underestimated, given that most studies report the proportion of urine cultures that are positive among all children who present to the emergency department rather than among those in whom UTI is suspected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26360?source=see_link&amp;anchor=H5#H5\">",
"     \"Epidemiology and risk factors for urinary tract infections in children\", section on 'In older children'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Risk factors for the development of acute cystitis are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef62486 \" href=\"mobipreview.htm?10/60/11211\">",
"     table 1",
"    </a>",
"    ). Sexual intercourse is one of the most important risk factors for the development of acute cystitis in females [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/1\">",
"     1",
"    </a>",
"    ]. Sexually active young females have approximately 0.5 episodes of acute cystitis per person-year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Acute cystitis is much less common in adolescent males and usually suggests the presence of a complicated or occult renal infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/3\">",
"     3",
"    </a>",
"    ]. However, a small number of sexually active adolescent males develop acute uncomplicated cystitis related to risk factors such as unprotected intercourse with an infected female partner, unprotected sex with male partners, or lack of circumcision [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Catheter-associated cystitis and UTI are some of the most common healthcare-associated infections reported to the National Nosocomial Infection Surveillance (NNIS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/5\">",
"     5",
"    </a>",
"    ]. UTI accounted for 12 to 22 percent of healthcare-associated infections in pediatric intensive care units that participated in the NNIS survey for 1997; 77 percent of these cases involved patients with a urinary catheter in place [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risk of catheter-associated UTI (CAUTI) increases with duration of urinary catheter use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/6\">",
"     6",
"    </a>",
"    ]. It is estimated that the risk of UTI is 3 to 5 percent per day of bladder catheterization. Other associated risk factors for CAUTI include female sex, severity of illness, cardiovascular surgery, multiple trauma, diabetes, and multiorgan system failure.",
"   </p>",
"   <p>",
"    Cystitis is a common complication in patients with bladder dysfunction or neurogenic bladder [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Prolonged stasis of urine in the bladder predisposes to infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=see_link\">",
"     \"Etiology and clinical features of bladder dysfunction in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/50/25384?source=see_link\">",
"     \"Evaluation and diagnosis of bladder dysfunction in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the normal host, most uropathogens originate in the gastrointestinal tract, migrate to the periurethral area and the urethra, and ascend to the bladder, where they stimulate a host response. Bacterial adhesins (pili) and other virulence factors, such as hemolysin and flagellae, are important in the pathogenesis of acute cystitis in that they offer a selective advantage to the bacteria that possess them. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/46/16102?source=see_link\">",
"     \"Bacterial adherence and other virulence factors for urinary tract infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of these virulence factors coupled with the propensity of bacteria to adhere to the female periurethral mucosa may explain the increased incidence of acute cystitis in females compared to males [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/9\">",
"     9",
"    </a>",
"    ]. Other factors related to the lower incidence of acute cystitis in males include the antibacterial properties of prostatic fluid and the drier periurethral environment and longer urethra in males compared to females.",
"   </p>",
"   <p>",
"    Catheter-associated urinary tract infections develop as a result of organisms ascending along biofilm on either the intraluminal or extraluminal surface of the catheter. Additionally, failure to maintain the integrity of a closed urinary catheter system provides access for organisms to enter the bladder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Infectious causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystitis may be caused by any pathogen that colonizes the periurethral area and urinary tract (eg, bacteria, fungi, viruses, parasites). Most causative agents are common enteric bacteria (",
"    <a class=\"graphic graphic_table graphicRef54955 \" href=\"mobipreview.htm?21/20/21837\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <em>",
"     Escherichia coli",
"    </em>",
"    and other gram-negative organisms account for nearly 90 percent of cases of uncomplicated cystitis in older children, adolescents, and young adults. Pathogens other than gram-negative enterics such as",
"    <em>",
"     Staphylococcus saprophyticus",
"    </em>",
"    and",
"    <em>",
"     Enterococcus",
"    </em>",
"    species can cause cystitis dependent upon the patient's age and sex [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/12\">",
"     12",
"    </a>",
"    ]. Enteric pathogens that have become increasingly prevalent causes of acute cystitis include",
"    <em>",
"     Klebsiella",
"    </em>",
"    spp.,",
"    <em>",
"     Enterobacter",
"    </em>",
"    spp., and",
"    <em>",
"     Pseudomonas aeruginosa",
"    </em>",
"    . Most children in whom these pathogens are isolated have underlying conditions or comorbidities.",
"   </p>",
"   <p>",
"    Adenovirus is an uncommon cause of acute cystitis (typically hemorrhagic) in children without underlying medical problems [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parasites are also causes of cystitis. In Africa and the Middle East, hematuria and cystitis may be due to",
"    <em>",
"     Schistosoma haematobium",
"    </em>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/14\">",
"     14",
"    </a>",
"    ]. Although usually the cause of vaginitis,",
"    <em>",
"     Trichomonas vaginalis",
"    </em>",
"    can be a cause of lower urinary tract infections in sexually active adolescents and adults. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/38/15977?source=see_link&amp;anchor=H20#H20\">",
"     \"Epidemiology, pathogenesis, and clinical features of schistosomiasis\", section on 'Urinary schistosomiasis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immunocompromised children, those with indwelling urinary catheters, and those with anatomical or physiological abnormalities are more likely to have infection with resistant organisms, fungal pathogens, or even ubiquitous viruses.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immunocompromised&nbsp;host &ndash; During prolonged hospitalization or urinary catheterization, immunocompromised patients are susceptible to healthcare-associated infection, including cystitis caused by enteric pathogens, gram-positive organisms, and yeast (",
"      <a class=\"graphic graphic_table graphicRef54955 \" href=\"mobipreview.htm?21/20/21837\">",
"       table 2",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Patients with impaired T-cell immune function can develop primary or reactivated adenoviral infection, which often present as hemorrhagic cystitis. Hematopoietic cell transplant and solid organ transplant recipients are at risk of developing hemorrhagic cystitis due to reactivation of latent adenovirus or polyomaviruses (BK, JC, and SV40) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/15-18\">",
"       15-18",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical presentation'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/7/44151?source=see_link\">",
"       \"Clinical manifestations and diagnosis of JC, BK, and other polyomavirus infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Catheter-associated &ndash; The most common pathogens causing catheter-associated cystitis are",
"      <em>",
"       P. aeruginosa",
"      </em>",
"      and",
"      <em>",
"       Candida albicans",
"      </em>",
"      . Funguria is particularly common in patients who are taking antibiotics or are immunocompromised [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bladder dysfunction &ndash;",
"      <em>",
"       E. coli",
"      </em>",
"      is the most frequently isolated organism in children with bladder dysfunction, unless the patient has been previously infected or colonized with another pathogen. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Noninfectious causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noninfectious causes of acute cystitis should be considered in patients who have urinary symptoms and sterile pyuria. Noninfectious causes range from chemical cystitis related to bath products or spermicides to systemic diseases such as Kawasaki disease, systemic lupus erythematosus (SLE), Sjogren's syndrome, and Beh&ccedil;et&rsquo;s disease.",
"   </p>",
"   <p>",
"    Sterile pyuria is one of the many clinical manifestations of Kawasaki disease. Patients with autoimmune diseases such as SLE and Sjogren's syndrome may present with urinary frequency and suprapubic pain secondary to interstitial cystitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/61/12248?source=see_link\">",
"     \"Kawasaki disease: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8330?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Beh&ccedil;et&rsquo;s disease is a multisystem disorder; urogenital involvement consists of genital aphthous ulcers, epididymitis, urethritis, and recurrent cystitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/18/298?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Beh&ccedil;et&rsquo;s disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A number of drugs can cause noninfectious cystitis. These include",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?18/7/18549?source=see_link\">",
"     cetirizine",
"    </a>",
"    , ticarcillin, and various chemotherapeutic agents (eg,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?37/62/38886?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?20/14/20711?source=see_link\">",
"     doxorubicin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/32/13833?source=see_link\">",
"     methotrexate",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with acute cystitis may present with dysuria, frequency, urgency, enuresis, abdominal or suprapubic pain,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hematuria. However, these lower tract symptoms do not always indicate an infection. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Fever and systemic complaints generally are not part of the clinical presentation of acute cystitis. Fever &gt;38&ordm;C, chills, or flank pain suggests upper tract infection rather than acute cystitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Clinical presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations of hemorrhagic cystitis range from microscopic hematuria to extensive bladder hemorrhage with clot formation and obstruction. Adenovirus cystitis is characterized by the acute onset of dysuria and frequency followed by hematuria 12 to 24 hours later [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/13\">",
"     13",
"    </a>",
"    ]. Upper respiratory tract infection may precede urinary symptoms. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/21/39257?source=see_link\">",
"     \"Epidemiology and clinical manifestations of adenovirus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptoms of dysuria or frequency are often absent in patients with neurogenic bladder. In such patients with bladder dysfunction and urinary stasis, a change in the urinary sediment",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    odor helps to differentiate between acute cystitis and chronic bacteriuria due to colonization. In addition, in acute cystitis, the number of pathogens isolated is &ge;100,000",
"    <span class=\"nowrap\">",
"     CFU/mL.",
"    </span>",
"    (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history of the acute illness should include documentation of the patient's temperature, urinary symptoms, vomiting, recent illnesses, antibiotics administered, and sexual activity (if applicable).",
"   </p>",
"   <p>",
"    Information from the past medical history should include (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26360?source=see_link&amp;anchor=H8#H8\">",
"     \"Epidemiology and risk factors for urinary tract infections in children\", section on 'Host factors'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic urinary symptoms &ndash; Incontinence, lack of proper stream, frequency, urgency, withholding maneuvers",
"     </li>",
"     <li>",
"      Chronic constipation",
"     </li>",
"     <li>",
"      Previous urinary tract infection (UTI)",
"     </li>",
"     <li>",
"      Vesicoureteral reflux (VUR)",
"     </li>",
"     <li>",
"      Previous undiagnosed febrile illnesses",
"     </li>",
"     <li>",
"      Medications (see",
"      <a class=\"local\" href=\"#H9\">",
"       'Noninfectious causes'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Family history of frequent UTI, VUR, and other genitourinary abnormalities",
"     </li>",
"     <li>",
"      In sexually active girls, whether barrier contraception with spermicidal agents is used (such methods predispose to UTI by altering the normal vaginal flora [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/21\">",
"       21",
"      </a>",
"      ])",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Important aspects of the physical examination in the child with suspected UTI include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/10,22\">",
"     10,22",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Documentation of blood pressure and temperature.",
"     </li>",
"     <li>",
"      Growth parameters (poor weight gain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      failure to thrive may be an indication of chronic or recurrent UTI).",
"     </li>",
"     <li>",
"      Abdominal examination for tenderness or mass (eg, enlarged bladder or enlarged kidney secondary to urinary obstruction).",
"     </li>",
"     <li>",
"      Assessment of suprapubic and costovertebral tenderness.",
"     </li>",
"     <li>",
"      Examination of the external genitalia for anatomic abnormalities (eg, phimosis or labial adhesions) and signs of vulvovaginitis, vaginal foreign body, sexually transmitted diseases. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/29/26072?source=see_link\">",
"       \"Vulvovaginal complaints in the prepubertal child\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation of the lower back for signs of occult myelodysplasia (eg, midline pigmentation, lipoma, vascular lesion, sinus, tuft of hair), which may be associated with a neurogenic bladder. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/62/33767?source=see_link\">",
"       \"Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If the history and physical examination suggest the possibility of urethritis or vaginitis in a sexually active adolescent female, a pelvic examination should be performed, and cervical and urethral cultures obtained for",
"      <em>",
"       Neisseria gonorrhoeae",
"      </em>",
"      and",
"      <em>",
"       Chlamydia trachomatis",
"      </em>",
"      . Nucleic acid amplification or nucleic acid hybridization tests are acceptable alternatives to cervical cultures for",
"      <em>",
"       N. gonorrhoeae",
"      </em>",
"      and",
"      <em>",
"       C. trachomatis",
"      </em>",
"      if such tests are available. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/46/42728?source=see_link\">",
"       \"Genital Chlamydia trachomatis infections in women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=see_link\">",
"       \"Diagnosis of gonococcal infections\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/51/37689?source=see_link&amp;anchor=H7#H7\">",
"       \"Sexually transmitted diseases: Overview of issues specific to adolescents\", section on 'Evaluation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sexually active males should be examined for evidence of urethral discharge and epididymitis; if present, cultures or nucleic acid amplification or nucleic acid hybridization tests should be performed. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/51/37689?source=see_link&amp;anchor=H12#H12\">",
"       \"Sexually transmitted diseases: Overview of issues specific to adolescents\", section on 'Discharge syndromes'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/18/18728?source=see_link\">",
"       \"Genital Chlamydia trachomatis infections in men\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/39/32376?source=see_link&amp;anchor=H13#H13\">",
"       \"Causes of scrotal pain in children and adolescents\", section on 'Epididymitis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=see_link\">",
"       \"Diagnosis of gonococcal infections\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory evaluation of the child or adolescent with possible cystitis typically includes a urinalysis (dipstick and microscopic examination) and urine culture. With the exception of evaluation for sexually transmitted infections in sexually active adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/23\">",
"     23",
"    </a>",
"    ], additional testing is not usually necessary.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Urinalysis &ndash; Evaluation of a urine sample may reveal the presence of leukocyte esterase",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      nitrites on dipstick, or white blood cells or bacteria on microscopic examination. In the correct clinical setting, these findings are highly suggestive of UTI (",
"      <a class=\"graphic graphic_table graphicRef82157 \" href=\"mobipreview.htm?27/28/28109\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Rapidly available tests'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urine culture &ndash; Urine culture should be obtained in children in whom acute cystitis is suspected. The isolation of a specific pathogen and susceptibility results are necessary to guide therapy. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Initial treatment'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Viral cultures should be obtained in the setting of hemorrhagic cystitis and in immunocompromised patients when a bacterial pathogen has not been isolated.",
"   </p>",
"   <p>",
"    Most fungal urinary tract infections are due to",
"    <em>",
"     Candida",
"    </em>",
"    sp., which is easily isolated on routine bacterial media. In unusual circumstances, specific fungal urine cultures and sensitivities may be necessary to identify a pathogen in patients who are immunocompromised or have an indwelling catheter or urinary device and in whom routine cultures have not yielded a causative pathogen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Radiologic evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiologic evaluation (eg, renal ultrasonography, renal scan, voiding cystourethrogram) is not routinely necessary in older children and adolescents with uncomplicated cystitis. The imaging indications and modalities for children with complicated cystitis vary depending on the clinical scenario; imaging may be indicated for patients with suspected recurrent cystitis, confirmed recurrent cystitis, or cystitis due to an unusual pathogen. Additional factors that favor imaging include a family history of renal or urologic disease, poor growth, hypertension, or failure to respond as expected to antimicrobial therapy (in children with confirmed bacterial infection).",
"   </p>",
"   <p>",
"    Guidelines for imaging the urinary tract after UTI in young children and children with upper tract infections are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=see_link&amp;anchor=H15#H15\">",
"     \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\", section on 'Imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory confirmation is necessary to establish a diagnosis of acute cystitis. Quantitative urine culture is the standard test for the diagnosis of urinary tract infection.",
"   </p>",
"   <p>",
"    Acute bacterial cystitis is best defined as significant bacteriuria in a patient with an inflammatory response (ie, pyuria on dipstick or microscopic examination) in conjunction with urinary symptoms (eg, dysuria, frequency, etc). (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Laboratory evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    What constitutes significant bacteriuria depends upon the method of collection. In most older children and adolescents with suspected cystitis, culture is performed on midstream (clean catch) urine samples. With this method, significant bacteriuria is defined by the growth of &ge;100,000 colony-forming units",
"    <span class=\"nowrap\">",
"     (CFU)/mL",
"    </span>",
"    of uropathogenic bacteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link&amp;anchor=H17#H17\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Diagnosis of UTI'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some experts suggest that growth of &ge;10,000",
"    <span class=\"nowrap\">",
"     CFU/mL",
"    </span>",
"    from a clean catch urine sample is significant in adult males and adolescent males &ge;15 years of age since the rate of acute cystitis in this population is lower than in females and often is associated with underlying urologic abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=see_link&amp;anchor=H17#H17\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Diagnosis of UTI'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/7/15479?source=see_link&amp;anchor=H5#H5\">",
"     \"Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Adenovirus cystitis should be considered in children and adolescents with hemorrhagic cystitis. Viral culture is the most sensitive and specific method for detecting most adenoviruses. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/21/39257?source=see_link&amp;anchor=H17#H17\">",
"     \"Epidemiology and clinical manifestations of adenovirus infection\", section on 'Genitourinary tract'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/40/37513?source=see_link\">",
"     \"Diagnosis and treatment of adenovirus infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis of polyomavirus cystitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/7/44151?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical manifestations and diagnosis of JC, BK, and other polyomavirus infections\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most fungal urinary tract infections are due to",
"    <em>",
"     Candida",
"    </em>",
"    spp., which is easily isolated on routine bacterial media. However, fungal cystitis should be considered, and fungal cultures and sensitivities should be obtained, in children and adolescents with cystitis and indwelling bladder catheters or other urinary devices, who are immunocompromised, or who are taking antibiotics and in whom routine cultures have not yielded a bacterial pathogen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of urinary symptoms (dysuria, urinary frequency, urinary urgency, enuresis, abdominal or suprapubic pain,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hematuria) in the older child or adolescent includes the conditions listed below. The approach to the child with dysuria is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/29/43479?source=see_link\">",
"     \"Evaluation of dysuria in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bladder dysfunction &ndash; Bladder dysfunction may be present in the absence of urinary tract infection (UTI). Bladder dysfunction is a frequently overlooked diagnosis in children with urinary symptoms and a negative urine culture. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26360?source=see_link&amp;anchor=H15#H15\">",
"       \"Epidemiology and risk factors for urinary tract infections in children\", section on 'Bowel and bladder dysfunction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nonspecific vulvovaginitis or vaginal foreign body &ndash; Girls with vulvovaginitis or vaginal foreign body may complain of dysuria",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bleeding. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/29/26072?source=see_link\">",
"       \"Vulvovaginal complaints in the prepubertal child\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vaginitis &ndash; In sexually active females, the presence of vaginal odor, discharge, pruritus, or dyspareunia suggests vaginitis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1881?source=see_link\">",
"       \"Trichomonas vaginalis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=see_link\">",
"       \"Bacterial vaginosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cervicitis &ndash; Symptoms and signs of cervicitis may include purulent or mucopurulent discharge from the endocervix, intermenstrual or postcoital bleeding, pruritus, dyspareunia, vulvovaginal irritation, cervical motion tenderness, cervical friability, and cervical edema. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/64?source=see_link\">",
"       \"Acute cervicitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urethritis &ndash; Urethritis must be considered in all sexually active patients with signs of acute cystitis. Urethritis can be caused by",
"      <em>",
"       N. gonorrhoeae",
"      </em>",
"      ,",
"      <em>",
"       C. trachomatis",
"      </em>",
"      , or",
"      <em>",
"       Ureaplasma urealyticum",
"      </em>",
"      , as well as routine uropathogens, such as",
"      <em>",
"       E. coli",
"      </em>",
"      . Symptoms of urethritis caused by",
"      <em>",
"       N. gonorrhoeae",
"      </em>",
"      or",
"      <em>",
"       C. trachomatis",
"      </em>",
"      typically develop gradually over several weeks in an adolescent whose sexual partner may or may not have urethral symptoms. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/51/37689?source=see_link&amp;anchor=H12#H12\">",
"       \"Sexually transmitted diseases: Overview of issues specific to adolescents\", section on 'Discharge syndromes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Prostatitis &ndash; Although it is an important consideration in men with symptoms of acute cystitis, prostatitis is rare in prepubertal males and infrequent in postpubertal teenagers.",
"     </li>",
"     <li>",
"      Epididymo-orchitis &ndash; Clinical manifestations of epididymo-orchitis may include scrotal swelling, pain, and tenderness with erythema and shininess of the overlying skin. Mumps is the most common viral etiology. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/39/32376?source=see_link&amp;anchor=H21#H21\">",
"       \"Causes of scrotal pain in children and adolescents\", section on 'Orchitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nephrolithiasis &ndash; The majority of patients with symptomatic nephrolithiasis have flank",
"      <span class=\"nowrap\">",
"       pain/renal",
"      </span>",
"      colic in addition to gross or microscopic hematuria. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20266?source=see_link\">",
"       \"Diagnosis and acute management of suspected nephrolithiasis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urethral strictures &ndash; Symptoms and signs of urethral stricture may include dysuria, urgency, frequency, hematuria, difficulty urinating, and an abnormal urine stream.",
"     </li>",
"     <li>",
"      Neoplasms &ndash; Neoplasms, such as neuroblastoma, pelvic teratoma, or Wilms' tumor may cause urinary symptoms by bladder compression. Additional findings in patients with these tumors commonly include a palpable mass on",
"      <span class=\"nowrap\">",
"       abdominal/pelvic",
"      </span>",
"      examination, hypertension (",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/15/9463?source=see_link\">",
"       calculator 1",
"      </a>",
"      and",
"      <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/33/9751?source=see_link\">",
"       calculator 2",
"      </a>",
"      ),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      neurologic symptoms or signs. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15609?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical presentation, diagnosis, and staging evaluation of neuroblastoma\", section on 'Clinical presentation'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/12/2249?source=see_link&amp;anchor=H11#H11\">",
"       \"Presentation, diagnosis, and staging of Wilms tumor\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial treatment of the child with acute cystitis depends upon the patient's age, the etiology of the disease, and the antimicrobial resistance patterns in the community.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Bacterial cystitis",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Choice of agent",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of antibiotic therapy should be guided by local resistance patterns, urine Gram stain, and, ultimately, urine culture and susceptibility results. Factors that increase the likelihood of a resistant isolate include whether the host is immunocompromised or has other underlying medical problems (eg, neurogenic bladder), or is receiving antibiotic prophylaxis (for urinary tract or other medical problems). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=see_link&amp;anchor=H5#H5\">",
"     \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\", section on 'Antibiotic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Select oral antibiotic regimens used for the treatment of acute cystitis in older children and adolescents are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef67989 \" href=\"mobipreview.htm?3/37/3676\">",
"     table 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/25\">",
"     25",
"    </a>",
"    ]. We recommend that empiric therapy for uncomplicated acute bacterial cystitis in children between 2 and 13 years of age provide coverage for",
"    <em>",
"     E. coli",
"    </em>",
"    ; we suggest a second- or third-generation cephalosporin for these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We recommend that empirical therapy for uncomplicated acute bacterial cystitis in adolescents (&ge;age 13 years) provide coverage for common uropathogens such as",
"    <em>",
"     E. coli",
"    </em>",
"    and other gram-negative organisms.",
"    <em>",
"     S. saprophyticus",
"    </em>",
"    also should be considered. We suggest",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?40/23/41336?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    (TMP-SMX) or a cephalosporin for these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/26\">",
"     26",
"    </a>",
"    ]. The most appropriate first-line therapy is suggested by local susceptibility patterns.",
"   </p>",
"   <p>",
"    Parenteral therapy occasionally is indicated for the treatment of complicated cystitis caused by multiply-resistant uropathogens, or for patients who are allergic or intolerant to available and appropriate oral agents. Patients initially given parenteral therapy can be switched to oral agents after clinical improvement.",
"   </p>",
"   <p>",
"    Empiric therapy for children and adolescents with complicated cystitis should be individualized according to their clinical status, underlying problem(s), and previous culture results and susceptibilities. Empiric therapy for upper urinary tract infection (UTI) in children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=see_link&amp;anchor=H6#H6\">",
"     \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\", section on 'Empiric therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Second- and third-generation cephalosporins have excellent activity against most gram-negative uropathogens, but are not effective in treating",
"    <em>",
"     Enterococcus",
"    </em>",
"    and",
"    <em>",
"     Staphylococcus saprophyticus",
"    </em>",
"    .",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"     Amoxicillin",
"    </a>",
"    ,",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/26/34214?source=see_link\">",
"     amoxicillin-clavulanate",
"    </a>",
"    , first-generation cephalosporins, and TMP-SMX should be used with caution in patients in whom",
"    <em>",
"     E. coli",
"    </em>",
"    is suspected, since increasing rates of resistance to these antibiotics have been reported in some communities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/27-29\">",
"     27-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Either",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?33/49/34583?source=see_link\">",
"     amoxicillin",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?10/21/10581?source=see_link\">",
"     nitrofurantoin",
"    </a>",
"    will treat most isolates of community-acquired",
"    <em>",
"     Enterococcus",
"    </em>",
"    . However, nitrofurantoin should not be used in male adolescents in whom occult prostatitis is suspected since it does not achieve reliable tissue concentrations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/7/15479?source=see_link\">",
"     \"Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fluoroquinolones are useful in the treatment of",
"    <em>",
"     S. saprophyticus",
"    </em>",
"    , a urinary pathogen usually isolated in young, sexually active females. However, the safety of quinolones in children is still under study, and fluoroquinolones are not recommended for uncomplicated UTI [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/30\">",
"     30",
"    </a>",
"    ]. TMP-SMX, cephalothin, or",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?10/21/10581?source=see_link\">",
"     nitrofurantoin",
"    </a>",
"    is an acceptable alternative for the treatment of",
"    <em>",
"     S. saprophyticus",
"    </em>",
"    cystitis. In a review of 524",
"    <em>",
"     S. saprophyticus",
"    </em>",
"    isolates recovered from the urinary tracts of female outpatients, 3 percent were resistant to TMP-SMX, 1 percent to cephalothin, and 0 percent to nitrofurantoin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Clinical response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing effective treatment with an antimicrobial agent to which the infecting pathogen is susceptible should have clear signs of improvement within 24 to 48 hours.",
"   </p>",
"   <p>",
"    Urine culture should be repeated in patients who worsen or fail to demonstrate the expected clinical response during the first 48 hours of therapy. In addition, imaging of the urinary tract may be necessary to evaluate the presence of upper tract infection, renal abscess, urinary calculi, or surgically correctable anatomic abnormalities or obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The duration of therapy depends upon the age of the child and the clinical scenario. The duration of therapy is longer for complicated than uncomplicated cystitis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest that young children, male adolescents, and children with recurrent, febrile, or complicated cystitis be treated for 7 to 14 days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/32\">",
"       32",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=see_link&amp;anchor=H11#H11\">",
"       \"Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month\", section on 'Duration of therapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest that the first episode of uncomplicated cystitis in older children (older than two years) who are afebrile be treated for five to seven days.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The duration of antibiotic therapy for afebrile older children with presumed cystitis has been the subject of several meta-analyses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/26,33-35\">",
"     26,33-35",
"    </a>",
"    ]. Review of the meta-analyses suggests the following conclusions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children treated with a single day or single dose of antibiotics have decreased cure rates (resolution of bacteriuria and lack of recurrence) compared with those treated for 7 to 14 days.",
"     </li>",
"     <li>",
"      Excluding trials in which the short course was one day or less, the cure rate was similar among children treated with antibiotics for two to four days and children treated for longer (7 to 14 days).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, a number of the primary studies included in these analyses had limitations (eg, inclusion of an unspecified number of children with asymptomatic bacteriuria or recurrent UTI), and the results should be applied with caution [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Fungal cystitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with funguria are merely colonized with",
"    <em>",
"     Candida",
"    </em>",
"    spp. and are asymptomatic. In patients with an indwelling bladder catheter, removal of the catheter may help to eradicate funguria; if the patient requires an indwelling catheter, placement of a new catheter may be beneficial. The new catheter should be changed if signs of colonization recur (eg, isolation of",
"    <em>",
"     Candida",
"    </em>",
"    spp. from the urine without symptoms).",
"   </p>",
"   <p>",
"    If antifungal therapy is indicated, the choices include intravenous",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/12/201?source=see_link\">",
"     amphotericin B",
"    </a>",
"    , oral or intravenous",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?25/43/26297?source=see_link\">",
"     fluconazole",
"    </a>",
"    , oral",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?26/46/27365?source=see_link\">",
"     flucytosine",
"    </a>",
"    , or bladder irrigation with amphotericin B [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/36\">",
"     36",
"    </a>",
"    ]. There are few controlled trials that compare different antifungal regimens, and almost all therapeutic management decisions are based on past experience [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/36\">",
"     36",
"    </a>",
"    ]. The treatment of fungal cystitis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/49/15128?source=see_link&amp;anchor=H11#H11\">",
"     \"Candida infections of the bladder and kidneys\", section on 'Treatment'",
"    </a>",
"    .) The Infectious Diseases Society of America (IDSA) guidelines for treatment of candidiasis, as well as other IDSA guidelines, can be accessed through the Infectious Diseases Society of America's Web site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Viral cystitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of adenovirus and polyomavirus cystitis is supportive. Reduction of immunosuppressive medications, if feasible, may be helpful. Controlled trials of the treatment of viral hemorrhagic cystitis are lacking; in anecdotal reports, antiviral therapy (",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/59/12216?source=see_link\">",
"     ribavirin",
"    </a>",
"    or cidofavir) have been tried with variable outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/15-18,38,39\">",
"     15-18,38,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of children and adolescents with uncomplicated cystitis have no long-term sequelae and little risk of recurrence.",
"   </p>",
"   <p>",
"    Children and adolescents with anatomic, functional, or immunologic abnormalities may develop chronic bacteriuria, recurrent cystitis, or progression to upper urinary tract disease. Recurrent upper urinary tract infection may lead to chronic renal scarring and impaired renal function. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26360?source=see_link\">",
"     \"Epidemiology and risk factors for urinary tract infections in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with asymptomatic funguria, progression to candidemia is uncommon (1.3 percent in a large series of adult patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?41/59/42937/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/49/15128?source=see_link\">",
"     \"Candida infections of the bladder and kidneys\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Immunocompromised patients with hemorrhagic cystitis due to either adenovirus or BK virus are at increased risk of developing persistent infection and hematuria that may require surgical intervention. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/21/39257?source=see_link&amp;anchor=H21#H21\">",
"     \"Epidemiology and clinical manifestations of adenovirus infection\", section on 'Infections in immunocompromised hosts'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk for dissemination and multiorgan system infection, which are associated with increased mortality, is greatest in patients with marked immune dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of antibiotic prophylaxis to prevent recurrent urinary tract infection in children and female adolescents is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/27/7606?source=see_link&amp;anchor=H8#H8\">",
"     \"Long-term management and prevention of urinary tract infections in children\", section on 'Prophylaxis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/62/41961?source=see_link\">",
"     \"Management of vesicoureteral reflux\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/24/5514?source=see_link&amp;anchor=H11#H11\">",
"     \"Recurrent urinary tract infection in women\", section on 'Prevention strategies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/58/38818?source=see_link\">",
"       \"Patient information: Urinary tract infections in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/58/38818?source=see_link\">",
"       \"Patient information: Urinary tract infections in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The distinction between complicated and uncomplicated cystitis is based upon the presence or absence of anatomic or physiologic abnormality of the urinary tract (including pyelonephritis), host factors, and the antimicrobial resistance pattern of the uropathogen. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Terminology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for the development of acute cystitis are summarized in the table (",
"      <a class=\"graphic graphic_table graphicRef62486 \" href=\"mobipreview.htm?10/60/11211\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Epidemiology and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cystitis may be caused by any pathogen that colonizes the periurethral area and urinary tract (",
"      <a class=\"graphic graphic_table graphicRef54955 \" href=\"mobipreview.htm?21/20/21837\">",
"       table 2",
"      </a>",
"      ).",
"      <em>",
"       Escherichia coli",
"      </em>",
"      and other gram-negative organisms account for nearly 90 percent of cases of uncomplicated cystitis in older children, adolescents, and young adults. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Infectious causes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Noninfectious causes of acute cystitis include chemical cystitis, interstitial cystitis in patients with autoimmune disorders, and drugs. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Noninfectious causes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children with acute cystitis may present with dysuria, frequency, urgency, enuresis, abdominal or suprapubic pain,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hematuria. Fever and systemic complaints are usually absent in uncomplicated cystitis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The history and examination of children with suspected cystitis should focus on risk factors for urinary tract infection. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Evaluation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26360?source=see_link&amp;anchor=H8#H8\">",
"       \"Epidemiology and risk factors for urinary tract infections in children\", section on 'Host factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urinalysis and urine culture should be obtained, but other laboratory studies usually are not necessary unless cervicitis or urethritis must be excluded. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Laboratory evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute bacterial cystitis is best defined by the isolation of &ge;100,000",
"      <span class=\"nowrap\">",
"       CFU/mL",
"      </span>",
"      of a uropathogen in a patient with urinary symptoms and pyuria on dipstick or microscopic urinalysis. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Noninfectious causes of acute cystitis should be considered in patients who have urinary symptoms and sterile pyuria. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Noninfectious causes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of acute cystitis in older children and adolescents includes bladder dysfunction, nonspecific vulvovaginitis or vaginal foreign body, vaginitis, cervicitis, urethritis, prostatitis, epididymo-orchitis, nephrolithiasis, urethral stricture, and neoplasm. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The choice of antibiotic therapy for acute bacterial cystitis should be guided by local resistance patterns, urine Gram stain, and, ultimately, urine culture and susceptibility results. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Bacterial cystitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that empiric therapy for uncomplicated acute bacterial cystitis in children between 2 and 13 years of age include coverage for",
"      <em>",
"       E. coli",
"      </em>",
"      (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). We suggest a second- or third-generation cephalosporin as the first-line agent for these patients (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Infectious causes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Choice of agent'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that empiric therapy for uncomplicated acute bacterial cystitis in adolescents (&ge;age 13 years) provide coverage for common uropathogens such as",
"      <em>",
"       E. coli",
"      </em>",
"      and other gram-negative organisms (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"      <em>",
"       Staphylococcus saprophyticus",
"      </em>",
"      also should be considered. We suggest",
"      <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?40/23/41336?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      (TMP-SMX) or a cephalosporin for these patients (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). The most appropriate first-line therapy is suggested by local susceptibility patterns. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Infectious causes'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Choice of agent'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The duration of therapy depends upon the age of the child and the clinical scenario. Young children, male adolescents, and children with recurrent, febrile, or complicated cystitis should be treated for 7 to 14 days. We suggest that the first episode of uncomplicated cystitis in older children be treated for five to seven days (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Duration of therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of children and adolescents with uncomplicated cystitis have no long-term sequelae and little risk of recurrence. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/1\">",
"      Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/2\">",
"      Hansson S, Martinell J, Stokland E, Jodal U. The natural history of bacteriuria in childhood. Infect Dis Clin North Am 1997; 11:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/3\">",
"      Johnson JR, Stamm WE. Diagnosis and treatment of acute urinary tract infections. Infect Dis Clin North Am 1987; 1:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/4\">",
"      Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997; 11:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/5\">",
"      Langley JM, Hanakowski M, Leblanc JC. Unique epidemiology of nosocomial urinary tract infection in children. Am J Infect Control 2001; 29:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/6\">",
"      Stover BH, Shulman ST, Bratcher DF, et al. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control 2001; 29:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/7\">",
"      Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med 2002; 113 Suppl 1A:67S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/8\">",
"      Elliott SP, Villar R, Duncan B. Bacteriuria management and urological evaluation of patients with spina bifida and neurogenic bladder: a multicenter survey. J Urol 2005; 173:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/9\">",
"      Schlager TA, Whittam TS, Hendley JO, et al. Comparison of expression of virulence factors by Escherichia coli causing cystitis and E. coli colonizing the periurethra of healthy girls. J Infect Dis 1995; 172:772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/10\">",
"      Chang SL, Shortliffe LD. Pediatric urinary tract infections. Pediatr Clin North Am 2006; 53:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/11\">",
"      Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002; 113 Suppl 1A:14S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/12\">",
"      Gaspari RJ, Dickson E, Karlowsky J, Doern G. Antibiotic resistance trends in paediatric uropathogens. Int J Antimicrob Agents 2005; 26:267.",
"     </a>",
"    </li>",
"    <li>",
"     Cherry JD, Chen TK. Adenoviruses. In: Textbook of Pediatric Infectious Diseases, 6th, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.1949.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/14\">",
"      Brouwer KC, Ndhlovu PD, Wagatsuma Y, et al. Urinary tract pathology attributed to Schistosoma haematobium: does parasite genetics play a role? Am J Trop Med Hyg 2003; 68:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/15\">",
"      Hofland CA, Eron LJ, Washecka RM. Hemorrhagic adenovirus cystitis after renal transplantation. Transplant Proc 2004; 36:3025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/16\">",
"      Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/17\">",
"      Boeckh M, Erard V, Zerr D, Englund J. Emerging viral infections after hematopoietic cell transplantation. Pediatr Transplant 2005; 9 Suppl 7:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/18\">",
"      Erard V, Storer B, Corey L, et al. BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis. Clin Infect Dis 2004; 39:1861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/19\">",
"      Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000; 30:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/20\">",
"      Orth RW, Weisman MH, Cohen AH, et al. Lupus cystitis: primary bladder manifestations of systemic lupus erythematosus. Ann Intern Med 1983; 98:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/21\">",
"      Hooton TM, Scholes D, Stapleton AE, et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000; 343:992.",
"     </a>",
"    </li>",
"    <li>",
"     Wald ER. Cystitis and pyelonephritis. In: Textbook of Pediatric Infectious Diseases, 6th, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.554.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/23\">",
"      Huppert JS, Biro F, Lan D, et al. Urinary symptoms in adolescent females: STI or UTI? J Adolesc Health 2007; 40:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/24\">",
"      KASS EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 1956; 69:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/25\">",
"      Hellerstein S. Urinary tract infections. Old and new concepts. Pediatr Clin North Am 1995; 42:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/26\">",
"      Tran D, Muchant DG, Aronoff SC. Short-course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: a meta-analysis of 1279 patients. J Pediatr 2001; 139:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/27\">",
"      Prais D, Straussberg R, Avitzur Y, et al. Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child 2003; 88:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/28\">",
"      Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003; 88:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/29\">",
"      Mehr SS, Powell CV, Curtis N. Cephalosporin resistant urinary tract infections in young children. J Paediatr Child Health 2004; 40:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/30\">",
"      Bradley JS, Jackson MA, Committee on Infectious Diseases, American Academy of Pediatrics. The use of systemic and topical fluoroquinolones. Pediatrics 2011; 128:e1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/31\">",
"      Karlowsky JA, Jones ME, Thornsberry C, et al. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Int J Antimicrob Agents 2001; 18:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/32\">",
"      Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/33\">",
"      Michael M, Hodson EM, Craig JC, et al. Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. Arch Dis Child 2002; 87:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/34\">",
"      Keren R, Chan E. A meta-analysis of randomized, controlled trials comparing short- and long-course antibiotic therapy for urinary tract infections in children. Pediatrics 2002; 109:E70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/35\">",
"      Fitzgerald A, Mori R, Lakhanpaul M, Tullus K. Antibiotics for treating lower urinary tract infection in children. Cochrane Database Syst Rev 2012; 8:CD006857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/36\">",
"      Kauffman CA. Candiduria. Clin Infect Dis 2005; 41 Suppl 6:S371.",
"     </a>",
"    </li>",
"    <li>",
"     Infectious Diseases Society of America. Standards, practice guidelines, and statements developed and/or endorsed by IDSA. www.idsociety.org/Content.aspx?id=9088 (Accessed on October 15, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/38\">",
"      Yusuf U, Hale GA, Carr J, et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 2006; 81:1398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?41/59/42937/abstract/39\">",
"      Faraci M, Cuzzubbo D, Lanino E, et al. Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant. Pediatr Infect Dis J 2009; 28:55.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6012 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-64F316EBC0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42937=[""].join("\n");
var outline_f41_59_42937=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Uncomplicated cystitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Complicated cystitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EPIDEMIOLOGY AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Infectious causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Noninfectious causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Radiologic evaluation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Bacterial cystitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Choice of agent",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Clinical response",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Fungal cystitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Viral cystitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6012\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6012|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?10/60/11211\" title=\"table 1\">",
"      Risk factors cystitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/20/21837\" title=\"table 2\">",
"      Pathogens cystitis in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?27/28/28109\" title=\"table 3\">",
"      Tests to diagnose UTI in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/37/3676\" title=\"table 4\">",
"      Rx cystitis children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/15/9463?source=related_link\" title=\"calculator 1\">",
"      Calculator: Blood pressure percentiles for boys (2 to 17 years)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?9/33/9751?source=related_link\" title=\"calculator 2\">",
"      Calculator: Blood pressure percentiles for girls (2 to 17 years)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/64?source=related_link\">",
"      Acute cervicitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/1/27674?source=related_link\">",
"      Acute management, imaging, and prognosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/7/15479?source=related_link\">",
"      Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/46/16102?source=related_link\">",
"      Bacterial adherence and other virulence factors for urinary tract infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=related_link\">",
"      Bacterial vaginosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/49/15128?source=related_link\">",
"      Candida infections of the bladder and kidneys",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/39/32376?source=related_link\">",
"      Causes of scrotal pain in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/40/21129?source=related_link\">",
"      Clinical features and diagnosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/18/298?source=related_link\">",
"      Clinical manifestations and diagnosis of Beh&ccedil;et&rsquo;s disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/7/44151?source=related_link\">",
"      Clinical manifestations and diagnosis of JC, BK, and other polyomavirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/15/15609?source=related_link\">",
"      Clinical presentation, diagnosis, and staging evaluation of neuroblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20266?source=related_link\">",
"      Diagnosis and acute management of suspected nephrolithiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/40/37513?source=related_link\">",
"      Diagnosis and treatment of adenovirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/35/26166?source=related_link\">",
"      Diagnosis of gonococcal infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/21/39257?source=related_link\">",
"      Epidemiology and clinical manifestations of adenovirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/47/26360?source=related_link\">",
"      Epidemiology and risk factors for urinary tract infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/38/15977?source=related_link\">",
"      Epidemiology, pathogenesis, and clinical features of schistosomiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28793?source=related_link\">",
"      Etiology and clinical features of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/50/25384?source=related_link\">",
"      Evaluation and diagnosis of bladder dysfunction in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/29/43479?source=related_link\">",
"      Evaluation of dysuria in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/18/18728?source=related_link\">",
"      Genital Chlamydia trachomatis infections in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/46/42728?source=related_link\">",
"      Genital Chlamydia trachomatis infections in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/61/12248?source=related_link\">",
"      Kawasaki disease: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/27/7606?source=related_link\">",
"      Long-term management and prevention of urinary tract infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/62/41961?source=related_link\">",
"      Management of vesicoureteral reflux",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8330?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/62/33767?source=related_link\">",
"      Pathophysiology and clinical manifestations of myelomeningocele (spina bifida)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?37/58/38818?source=related_link\">",
"      Patient information: Urinary tract infections in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/12/2249?source=related_link\">",
"      Presentation, diagnosis, and staging of Wilms tumor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/24/5514?source=related_link\">",
"      Recurrent urinary tract infection in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/51/37689?source=related_link\">",
"      Sexually transmitted diseases: Overview of issues specific to adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1881?source=related_link\">",
"      Trichomonas vaginalis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/29/26072?source=related_link\">",
"      Vulvovaginal complaints in the prepubertal child",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f41_59_42938="Tinea capitis - black dot";
var content_f41_59_42938=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86628%7EDERM%2F86686%7EDERM%2F86627&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86628%7EDERM%2F86686%7EDERM%2F86627&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Tinea capitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A round patch of alopecia with overlying scale and \"black dots\" at the sites of follicular openings is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Tinea capitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A scaly plaque with associated hair loss is present on the scalp.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Kerion in tinea capitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF6AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5wx82fSq7NlzxVi4IRiAc1VOWORWrZKQ9VZjlRnHNPdiChAAPpT4pykewAAnq1TNbfufOXGBz83epGOSN5mxMNqN0PpSGERXDKuGA6YpitOwOGO1uOvAp8e0RhRlsth3HYUWGXATPaqPJ+VSVLH1qTT0tYBtcyC4YHyyozz6VIzW9pfwmGXzYY+STwD+FVJHSS4jlEpTc+4kcbBnrSWgCwhm8zny7hcn5h39MU1gLR0mjwWkBXZ/d9alnMbQNCsm6SNi3mryZPc1CIppLfIi3O3A5wRSAt6bpE11Ym9ZkjtvtH2bzGbkNtzjFWNwumt7fzNzp8qIDwaoWDPDBKhkUIGyVJ+63rirFnPbwyzzzysziMmNYRg7+xJ/u0DLF0txfag+0vLLGMnauOgrRgv7i7jsYrhTHFAhRGj4zk5yfU1n6ZGWsXuyFZwwQ5JXGehHtWtCBbSQw30Jk87nByAnvQxonW2EVubu4zcQRkbyo4BPbNQ6ffL58yPGgtplIeMDJVexB6A0jx/Z8FpIriKRRJ5ascDr29aWWGFbMvsO+SQbghxtz0AFQyi7a6tHp8M0Fum5pV6ONx257GrOnXn2qJzCg8zDAgNgisfUiDauQ4WSLCKgGN/rz7Vc0u8gbaYAj3CgAMo24OPun1oZSehp3MqxpbWiu0ocK8iSR7WV8clT6elENtczSpLBP5e3GxWbB3dxms82tzOXuvOaW5ib5s5GxD0JP9K14JA9ojXMD7oVG9V+Uu2eHzn06Ubu7AoXouI7seTC8ZY58oSbvm9R7d6110u4WxiLFlOQzyOv3T7ehNQWsV1Pf28cMQdZ3AUM2dg6/MfWtS/mmnlks7reYIpdjBWzlu2T3Aqdb3Gc/rWn3FlO80KtAsi/M7fNx/Ssc6cUZlZxIhYE456evtXb3UUbwyTyLJFExAUMM+cP8M1y+oWl9YyGazmcLPlCmednXP0oWoMhkFxHABPCHE4DxHOQhPTgdB7e9R2u+YLZ2M4Ek7BWDAqhYHjOeR34p2o2eoHUzYQ3imJSGM6HC5IHJPoM4qaxsI49UkWS5eZmQbR18w9CQ3THXBqydjf0NNRFpPGVsTbwtnLyhAdvUDHJqneJGVha7kjVRMVXymGN5OfmHUjHem6rBJpcBhnmVWUfKD/KqGsBri3jeyRN5iA4yeeuCfXvU3Q2bFlrLStLbmJ1SP5UCvkD1JYdqp60FecCIRjbH+8nxhuRwFA4x0/Oq2mXdvawLdkNFOD5fkyHAYkctx1FQx3InlhtbeQJ5kpSSQrkBSeSB7D+VFgQkCpBqcbWwb7OIlZ0lcHax+8QRxj0HXFOBktLvKDzYY5N3l9cAnt3xV5dJkaMzLFbG3hLMmQS8voX5wAfQU+7gng0pfNlClU3oqkEKTyMN/MU7AiBUibU2a4ltbKK4hkCSY2KowfmO3vkde+aorHcpC0unKViYqrucDOR6ev8AKqcOl3FyA7pLK2QEJ5Ud/wCddFDexx2L2jeWspcMqGLDREA5wfQ96m/YbjrctwXCT2DPqFsqzMYovPJ/1y8nDfQDANajpBPPJPbbbOyjUMyq3KDvk+5rEnjmsrmzJTzlQrLulX5AxXoAOox0+tXo47ud5r66iiCxKkiKEwhbOPmHTnPU0N3BK2xvadMy3xnk2mZowIJs/dBHOTjnIra1JLS9svs8a+bmL5D3BU8GuZt7q5uQiQQ7zg7nlyR15+gHTit/S7SRNZQ28axu8Z2pBJhcDkkg9QOtS2Xbqc+uiMTHNHMrLJiRFdwWUEkEY7+9QW9wmnK8XmSwTZbDhNyk/wD1q6uSSF725RYDNPcoEcyKAQ2P4ccofpXP+IrRUitlsVR7ouwLgsAePf8AKnuGxgSzardW3l+TL5OfMcgYD+4wOT1xngVX1e4iazgjUtG8sWzyQNxyT976kYrrbu6vLPSCQG+UiPnAeLj7xPQjtivK7iSaW+NwzyeSzFlmB5I9Pagm6OqbT5IY2LXEMU7qFjjU/ebGMegwBzS3lwYoDG9rCZVVVlMkeZHcdwwPAIx+VZOYBo9wF1PfdHCR2xiO5RnJZW6ZB4PrTrPUtjSwNYStfIFY3HmZEY/2VHGT3JNaWIvYXUrRvsNxL5sQaGQRq4YmSXcASPouOvvVlXt106O4hjWRwyLcFwQCR0O33HWqltdNa28uIg7SIRiaMNuVuc8+h6HtVm9MDNdC2hRd23aPvZ45/wB0daBWLk/iaeKEJZGNdyKhUfMHQMdoH90qagsRvnWaJioKr5oIyxbHzVk3FvDb3MbRkRKo2FgOHYHOPrg16PpVnGlsGtZ2GUHysMA4HOcilLUqKs9DkdSisrbW7e4ji87Towjzxq+N+TnB9DVe51KC/wBQ3CAmCIOSuNxZT0Az6dM1Y+wLePMfkjlXJ8tjjepPDD1FRsDCkVtePHaQopiV/LyQc55I5oi3uhvsXLK+ZGma+ug5KiEkoCoQ4xx7Cse8uPOlktYXjXC8OTgPz39eKv6hqek3EUENrG4dV2kbcbyOTzWZYXNsdNuRLHIdRdwsOGACAH5gwPXI7iqfmSTXMttap5j/AL+d4WDRFsANjgg+1UrO3lF3HcTNIr53iRj82QMgDHc0qafJe3M0drDyo++Gzx/KrM1xb20NssLAzqCrp/Cvb8T707W1IuLEm/VYLyImO68wuWBDknHcH8a5+aMRSXExnCKp3IuOZG3Y49Ksahcwi9VoJiQVG/d69wKqfZ5b2S5aGMLBDtGP7u49aG+g7W1ZNc38qAv83lHGCe596tRSQrpBtsOJJ2MjEj72Og/Olj02aztna5ddso2rGwB3Z7/p1pZxBFp0QEgaeJiCyjIFGq1EkmPF7BbafHp8xjkTmRvl+YH0qm0gvXkJmXEYG1MYyPTNMu5jcQxShDuI2tJs2j8DUv2OFrWKSN9p3bcdSTT3C1ilPcwy+cbq327wAhXnbSCSEiFo1Mu1v3gb+Iela14qWztassTSMuSW4KewqGOaCOZ5orMIEUcEZBPrTWjEyCeSIsyQQ+UsjZVd3AHoaKraveT3UsNz5CoCNoVBgGilcRyrMSBnn60n3V+tPmbf0AAFOijjMDvJKFZR8qY60xEccbu3y8kc1ftVS4jSLeA5POe1ZxD43cjNWrSCQMso+WMd6ACa3MbEF8sSeBUkYBwEyRj5tvr7066KyTRxqpRf7x7+9XrOyd7VAk4CyuQVXrgU7DM/7TJFIHEYRemCM5qe7ijdYpYX371zjGMGoJZE3BYmIUNtweSatxyWHkATCd5eQVU4Vff3NSwIZAQRJAuEx8xz3q4LiWa3aGND5ZIkYnk8e/pVaB40ilRJlIPzEFeTWnpot7y3LXG6NUyplVCRz0DChK40Pmt1uYykRhS3Tc6FPvYwOp9PSqljAGIjSQAscM5HAHarFhYyea3mwLNGFILK2AV9RVecs1wwUHy14GRjj0qWUiaOSaznmt0LhG+WVByCK17ya6t7OC4jkEqMPJ9WYDkZ9+aztMtIJLp1vLvyECFxIQT24FWLEW8drm7ucSs/MY5KjHDU9QKIuZoJN8kSxEryGU4/L1q+twLS9D38uEMSyp5YyP8AZJxRq7HUb+Z4mLsw6FcfKB94/wCFQWCyxtKzxF3C+Tsb7rA/XoKi2o7mhpYtr28itr26lSBwZIxGMkk96VY4bUOhdlxKVjITBbP8VQwW+6SVy5huFb5Y4B8qjvz7VI9vJbSLKzSzSR/vGG4fcz0/E079B26m0GsmEUFqJgAB5jluWbnJI7D29qLQtJeySTs8VtE331Q5Y9uPeqVpb302ycKrRszRjYw3rg5IPcfXvW5B+6Ektohfy3EjRzc7x6E/4VDLVyzpsol1AzGK4ZUJVZUXhx649RWzOq6ZbXEc9o5hDeYGOSyFv4j6jpxUulwK+lmWSKRFCM+0nkZ5/wAmqmlWM97eKb+aQW6Eukbdxjj6j3qfQDOnlurkQWZR4rGElnc5HmN/dHoKwr263XE8gk2RgEvlwcY6AY966u4tJ9YlS3QRebGS6jzAEcAc8njIGBXHXqzwy3aC12LMCvlDklf8c96oCib6WKEF33EKAAPkLKevTqKu3t6/9m2UatEYIyVWPGAPVvXHNR6NcafDq1ul/htn34PJ3fd5ABzhsnrUmqWLLa6csRkuJSJJDasu5YFLZ4I/l2q0Q3Z2H6lpElohivY3W9ZleOAnJCEAr9QetQxalHDpe2JB56SAykvjA5BG2rlvNJJeRnUXeTzwEkkkzHjOBwcZwAABzVd7aGee8tYYfs0IfdtTncM4X5zk+v1pNWBSuV3urK5055Lq0mkmWTdEY3+V4wMFWHbBwc/hVrw1ZvezySeXHudTt8xggU9Qf/rVqRxCa0h022iby0LGRzGFDORgMT14+vWoHjktrYQoP30gyQr8BwOpxQ3oCLOmJcCZEhnMMR+ZZCcbXHGMHrgc4qXUZY4p/ItHE0TffYqM4HGQO2c9elNsdKk+zpcTuwlKiR3ToMnB696gu9Ut/NSzgjEssbL8xABc54Qn09qltIuzZsxS7mVJNieWm0wtJkgk4B44zxTtW0GxihW6jkjLSTKSp/5a/wB5VPp3NZlzetNbz6jBbqhhZU4PzNngjbnrnnPanLrk06TTyK0l6uEgCjaIznAyMc/hSQeZrSSJBKYYI0KKoAYnIRTj7o75GavQ3FkZh/at15Ee/O/Ydu0Z+Uj6Y496ytEt5FaO5nnN0zy8I6qmTnqD1x39sVswaTcG8lkitpLoPN+9eUkmRiPlXB/nQ3ZWHuy/aXTXGneXZWRWefAjlRuAnRt3oMY5p11dQ2dxDa2zlpY4yx5CgtnGAe/GaoWl5Np0U32W4htkuAY3QDdIoBxgZ5/Kot/2OxkCRma4nLbGEnDjH3Wz0I60rai3K7Xk093Pc2y/Z5pnVB5jhdh/vZ/D9afqGotqkps7eLNrCVMp4DBhnGPes+5huF0r7RL5EJmCsjiQMx/wFY8MzW0LSRefYhcJcSOdzOT1ZePwpxSCTdi5rUFy0zP5skcbsqqrvu3OecEdxXO2sKpbXAvFXEhz5h4CkZyuB0z+taUup26XaxLG93Gy/upf4w7H7wI649DUUZM9rd200R+0RBgNwwwTglyOxHb61dkQ3YraQltf3JXU3lEPlYPlgbyAOAD9ai0cNPcyW5lS3jmX5GK8EL0Ugevc+1W3uFktWtYyftYXEhLbQ5BxgEDAFM02yuVu/IhZwm/YrhciRuCQD2o2C1yXWfMngs4Y1EcaoyvKwyWzzyfTjgUzRp7axjjuZzLHCMpIqEbnPfBPTtW3JpOLh49QZ7aWYlcOSqK3qx7ZrmGQxsFIRoJJWQRjLYGcE+/1oVmx2LpFvqAlSyjMrnawlmOH3E5JRfXjFdNpNyLYWMZv8OGMbxucyDjv2x1ANYOhlNP1P7QjL51sDhHOXUexH8RHArQ0q2fXtUW/ZVitlJMsaf6yNU7t6euM0MEh9kY4JWeN3ldGPkpOgQqT2x3A9qx729OmW06SRwXRuF+d5F+dCSCcfljNafim5I12CXT4TKQFcqzZHvn25z61ljTJdQsYbwPA5857dXV8gkfNgg8/SkloDdjm2tZbi/Y2at85MgUZOwemO+KsobkzJBb2vmrbLkqw3ADqx98/pV6e+u9MnhubJ/KeImPzgP73XJ9SKW5jaOSR7eERjoWWTdk4yckU72B6h9p1D+y5ZYGht7Elo57eFgrMeu0jqQPWsZbVWUXMKmSPeQspON+Oq49RnBq1LHZW1lM0jSNdy4EKBQFCn7xY/wAqNFifynFxK0FpEvyvjOGJ4z7E9TV3voQ1YtXmlW8mhz3CrH58bKCVJJ5yTgf7PeqXhyy3x3Etw8osciN3HQnPTH0rUmtYp7RpIbqaHTzIV2OSVeQDkcdaylvpVhmgkiEUO/KpGdo+tVotSdWP1afTpLyUGUtGihIZOeB6EetV442h0zFrG0gb5JGI4GemPen3sEt+ZHuQySomVkIHzYHc1Npkr3UFrbwSLEzZSYSA4Q9iKT1HsyjeiWEQQ3DFoYhwmeMmpjCTA25wJEIYREYZs9x9KNSZrKRrZJopxvwxHOD9afFDeM5jQ43jbucYK+1JXKvcTULFbq3lvd7CdAMqzcn3zSade7LiNruH9yygFT1YetVWF1GsltMm4Occ9Dj0NSysl6oWeQr5CCNFIwQKaIK9xdypcF3QmJWIiU9hRVvURLY3MdrKIJ0jQHchz1HrRT0C5xQ+U5PSmjqx7Ggggc0gNBJMN/yqwOG4FTZZJVhDnygwyM96gG5o1ySccKKljt59sjiJvkI3H+6aALsq20lyNoYgkKM8fWoJhi6eOz3YX+6ccVLI/mqFkA2xNv8AM6M2femHy0hfYyLIjbtxOWf2oGXLa0SG288FMq/ltnkg/Sq+8iUeV/qwc5xyx9qqs/mN5isEDnJXP3T3rQlMPlo67C5X5mz8p9OOxqQLyfYFtfsn2tGXJmZ1iy28jhd3pUMd9dRWclmJwkDEF40Aw59/WqdtZzz3HlxyRIBG0pMjBVwBnGfWtDTZYvLaUwQTeRh/Kl6uPw60DLFpO62yZVAsXCj1yelJdwyrGkiypJFINybDluv3WHYinaeTLa3dz5fyq24kL8qHstQz3qRbfs8fA6n/AGiKnqUlcI7t7NYWeLYQWcZUFWPQZp2nrc3CyzFFEYBUyEfcJ6cehp9h5N6EMztNeyMYvLcbY40xw2fXPanWokFrMrKzPANkZH15z6j0pgRrK32aBmO1UOASMgH0p100b3YM+TuUOQrEr17+xqXb5VrBceWgEjHMYzjGMZNTC2aYwCO3Rmz5e9jt3HBxgd+vX2oA1LK9Z9Re7tLSM7n3RxoMqMcYGeox1qW7s7kzu88scUaRtM5R1+cZ6Aeue3WsyxtpdNQXML3AKbgJY+mQOVq1ZyQzTWM0ixzzTbmjt2GY1fogdT1z1PPepsh37GiWI02F7eM+YGddykcgdR+RroNJtYnitoZvNjjZTJIwUOSCPlwvv61yGrae9h5djLZI12+1g8U2UUsSzAKOv07Yrb0xb2bVBHMZcJHsjRAACwxhfyoaVik2dHYxT73dJiHCiPfJ8wZR/d/nV3WdQsLq08uBHmkQEtIGwx49u3tWVNrcMFvCrlHW8UxsqniNd2DzjIbPUjioVghtrZZbSJpQ0hK4JZgBxgD29TUFCaVfCa3trVy1leJGUVHXPlpySRgdx1NYV9dm+kEmmrJ5yKfmyMn3q9ZzMutptmHm26kh0+RnOT1Y9T/SsfWobdHubyGR9pCuFRcqjHOQfWmJmFZ7JJ/Kto2N5K6iPKgqmDnJPcHniuh0TVzYpPqSedcQFQJo9n/Hs7ZDEN6d8dMViRubOURSqDI0JkE8LCQRqw6MOgbGT6gmmFV02GGM3jkXJEksLE4ZG6FsdSRzj2q1sZtaly2PmFDIySo7L5mHZmeXdxjPU47d89Kn2zpeGF7V4IJ5dxiJJXIPzJux19u1Mlur+DSdKiWKaBN0klvIWG0k/wASjsR+dBnuTbQwJNK8iEuu45Cg8tj6n9aTY4xsdrazyW9n5NnBmB4m8mZGzjP3Q2fuke/pWbDcztaxw2wSOWPIeSIcsTwcn1HftVgwSSafBNeq6SyorlQflIPGSPXg1oeH444ra6Qxr5TozKG6sCen55qbmlupUispIpo11O4YQFdgUd2/n2z6VnF9skjwWkETtFtWR0BByfvfXjgVa1PUrhXf7RCkwRAkULD7mOmD1IxniqmrRxrBvJEKTKHUK2PK9s9MHPSpTHysqvLc/arlJ2ZXim2PK6bEwRkZA6Zp9vstWEszMt3F88JU8A9c/iK1LizittK07yp5P3oCHzPmCt1wD1x04NUfMt4Q6hRPJLICVk5J2ngY9c9Pan1E1od1pWm20VxFezmGGCfmFCcqh759CTzUupXsthcS2lzKjQvG0ilW25HU/n7UyztreG0d9RhNyzKPLdmwN2eSF9qydQh/tW1uZLye3YWrGOMs/wA6kAc7evI/CpkNK9ifTbeCa2bVJJA0pmIEbfMoz0K9/SqvjnU7VtQh8qCEqEYtEh2BWGCWf1YHoPeo7mC9Ri/lfaBLMn3PlKnGAQo6+tYGrWn2XUhJc3TSNFKGbAA+fHGQRzimrg0SSSwLZSeWZnlDpKm5QdsYOTkemeazL6eG5meO9ZrtLjJxypTB6r2xircUDXd99it7RlvrdP3sirh5Oc8KeO9Z09skUoltUAvImJdZGIye6qB2q/MlCWd3cBlit5BCNrPGkuMcdMN0z1+tOnh8+2aOK4HmS5DvMCC4yARx7jmlhiW1P2iYM6RHciRkMI2I+XGeOv6VYsIHkuIY/skzTOQz5barKWGwA9uetF7isPt7YnQzm3EL5wckhieo69BjNXbC8uIZoXtYJcgb4WDglV74HfIzV/xNNCbKK2mSH7UGH7yByQ5GQ3PQ89CO1S6bAtsmZrlN8E3lsDjMKqM/jkZyBSsNMz/EmorqNtNmOS3uigfD5y69AOemKranp4aSKaBYI/IWNfs4+8SF+9nr1ySKXxXJZSXMOoMvywTEm1mOGaDHBHvnsKwLC7uri7tnime3MhIQ7OWQ8BQx6k5xStcLrqTxaqk2p28awIJFdgZFkIUue5YDIUeldJp8a6RrC29/dS2jNhpIoWDpIh/5bIeh5HINcfe6de6bc3CRPJG8DEq4JV4x9D15rWu7uyS3RmijeWZSVCg/KwwS2TjOccfU1pYls15bh7GK8vYFSaO3uG3SZ/1qk4VsY4HqfU1BBKdT8+5lRbeWfgyRLkIAfQdhmsUSG4WYiVy4IBtIyQEhJBxz79q1NPtiHjljnEPBCsW6Y6kgflR5AvMv3Onw6pFBZpOpKSqtzIi4TA6MV65q3HZ20tk9r5UcMqHyZWQcD0b3zVa0tDHqIBaSaEz7o5JSAWyP48d63Li+b987xK10oKqI4yxVT6+n41G41ocxdaJEyPNcRqDEvlsyjKt6EGue1dIYbjyrfCI0eGi3bgW6810F9f3F9bS2Omb/ANwCWjjUtuKj0/rXOSPNqAtJJYFhSYFFkRcKHHcn+dXbQluxV0+e4TSNQ01ZAkEkiStEeVcjow9CB+dOmsVazLlyWxuCjk8dQRVmfURbWfkjycQthVWPgqep3dcVBZvJdXEcCrHJ5mRlmwQD6fhV6E67lSzkngd1jJVJYyHc/MAD2p9pq7aRfS3O1J2Zdrb/AExgYpkMsrJNDbQs9nao8s0Q4YDpknuOlQWttHq0yrd3CWoGMuyExL/vEc0bBchklFxA0qApKrfM3Zh1B+taFjcFmGZJWiCASvJyA319KjgcvY3VoktsYk4JIxnaeCp9KksZt0IieQpblhvQD72PWmgJ7syz6YkVpK8qROWEBXgf7QPWizkSezuxKyrf7QrxPHkuB/KkmuNl7JLMHWE5ZAhxt9KTUZY7i4Msd00k5UFXxjI9PrT8xboz5o3huoucO2DtxRTri9mnvI1GUUAD5hkmipsi7s5EYI68iiNdxOGVT15pNuGPPQ4pFByQKZkWYVRrZnD4ZWyR/hT8ShcvKAkoyct1qqymNsHn6VqSCW4sI4/KjjESc8YY+9AFWBtw8lySGHy59e1SQW8U2YyRHKCBknOfXFRQ4dGjLYJ5Dt0FOtCI7wA7cE/ebp9aYxk8CwzmIyggEgtUjKF2pKuOMh15yP8AGppFSByytHcNJldwXAX6VUkdw/l7RuUbcVLAuX7RtfruUpENuPpV1bh7jVJJIrdVtnb/AFQGQF9P61DqFnHb2sbRzQyoSN4WTLg49P0rYsPsd1YqkZghuFVxGrFvMf0BxxnPSkMzEmENxLCkp8ocYJIDEdMirjxtDKkV5btEigO7EdNwyKppCFg2S21yLwuR5jDAPsB61PePC+nBhO+9GEbwOSXOB1+lLcaHWEqw3gKMcLubOeuK0I5459PaOOJ45kJdSpxvTvk9znsKyrWKS6t9sYiRIQCfWVmOOvsKsi6nAKlp/tMI2qikFdvY59fpQBfuxbNp6xyXOxkbDpglSMZBz0z7VRniuGudzSbmjj3BjxhcdMdjitG+0obre1s7XUDejas6TlSDJjooHt60ttdklbFwk3zklYcZLkf3u9IdyIXVqdOWKIvsyVbfkAZ7AZ696z7WF5NQUI4WFSXTb7Hqta8OlPe3lwfMRYAh2SyHaqEep6A8H8qow+ZGD5j+ZiTqvBx7e1DQ0zbuJJBbrO7RbVP7tNgDE4wST15B61BZSXEfkvamZEO5WlBPzkdQD0Bx+VVZ9Re6l2CJmeQjksPmUcbT6H6U3UAIIY4VD+XG+5o8kAORkgDt7nvSKR0yLHLdG3XbI0DBY2SUEOmP1yeT9Kh/tSSB53sXxDIgRo1+XjPdvrWUA/2SEwqjxyZ3sg+845C8cqMH8aIreKTfJfI5AAQRiTaB6duKkoltr68urhUVnw0fl+bjIQ5xwOpxnt1qJbxFkEWUlnT5WzwoAyOn8WetSfaXsLRrQLbeTNKGYOu5lIB5DdRVe9hhXRYVRWa9mmZic4ZUA4Of84xTQmPsrC3KS5imkvX5jSJAqFfU57fSlj0ky6bP5kGJN4RbguMk/wBxQeMAdT2qETboIRcwukiIGJO7JHYHvjFaGoSfa7WFZIYhIgHlrBJtVAvVsdy2QPwo3EzOg043d1iORo44yEaaXLCIkYAz057Vr29jcR2wtp4Wa1A/dO7bT36ehOOuarJMLSWOWRJJQ6CUIR8jNj5ePTr1qfTLy8lg+z3KQpubG6ZvnXJyAM8Y/lSY0zooNYS2VQXkEcS+VHPJ823HIwBxnrzV+4jaQW1xp8KkSx+WXkbau7ByzH16+1YekM97EtkVRLeAuvmNjAJJzJxweeM1rpZ6XZzGBLz7VbkBnuIV425wVI/hINS9C4vQxZdJ1O/uXkt5Y55PvpJn7yjr+Hb606CG3ljnt7qKc3Ji2rChyqkfxHPpXUw3FncajBa2M0QjAkwYmxtXGOo4564qSPS50t2Ntp0ZhU7HWRiFZexz1PPNTcfW5wshu5VjhMvmR7g0YPBDE46Hiuh0K0/smxi1C9CJcQP5kSNgb13cnP1rQTTLa0sxe3UdqlwWKmJ2J+X1Ax+R71Q1v7Ndaf50Ny10kP3IplUNjoVIB4HfNNag9Dak1yHU7l5F+ezaQoEU4IKjAL9lBNUFNveJFIxbztrNHHGm0hixDB2PX2NLpl3byaRczzPY28Rg2C3UhyEAICjHQk9+TmlsNYkiEcU0S219s81WIC78cEEemMH2P1p2JTJNfn1Gws4H2okESqTKjYKMvBAPBPGPzri5/EEFwryGWVp9zHywmQ4Iwfm+grR1/UpfEV3Is0V1ISuMEhWJydzKO+RyFFZSR21hdeaFSXykyRt3bl/2v5YqkiG9itpdlNcXcN3psj7hl2klIAXjJ4JycVtJf5luNOvEimIw8UwBGCed3sevtWXpGmrfyCW1nVXbcwi3bRxztBPQY7mtjRvsyTeTcR3M+EJKIOTkcjAGWPce2KpuwaNmZfWAtr2zit4pIxcAF0clQjj+IE8YraEUeDNItzM6JtTccCRvT2x1Fa1vaQXcNrc6n5xW1YOIh96Nc/xA+2DjmpfFdgwuCd2Z7n/VJnBY5+UqOlTcqyObg0W/1Czt7m5leaDJ2neDs9RgDg5zTAsbO9qFiF75bMjNIR5wX37MecetdQ1y2laMkQQ+a3+tcPtw3TGB3rB1KzuLKSDz7P8A0jG+No2yxJ6/Tg00BgaaLvU763h3vHEr7N7AFg2DtAz0yTg9qmuo2jlgjmzJ5Rw7A7QpHOD9PUelOfUpNKdYZkS2UtwQCVIPXH9aqPNLI73eEmtWlIJkOI5CeOAOQO9GwmK+rGWKWO6zcRy7Y/PbLFQzDDDuW4p/k282nJNPFdPLE/kRTBsB1BPylD0PfjpVbTHKsqxPAhZy4ZxgLs+7he5JJ/SrNq82Iywm2JIQPkH3j/e9Dmr3M2a2kQJBPPLc2cysE3GRhy444K/w59as6tpkduyXWw20E5YRru3HqMA4+vFUdDuru4sL1za3l7cSRssjwtyFXsy/09qzbu9uxHBO8JWyTgSKcFm6gZPHHoKT2CN7nZ20c9rqEKzy27NPbZlfAKxxY4wv97jrUMt5N9qvjDctCpx8/O5+wH5c0x7+Szt/tM6wB7tQsfzBiqY6HHSsu/1lWvbcTrHvQD94EJBHPykDqaSS6lu5l20CWF/L9s8+ZApk8y3fJz1U+hweoqQedcaBHIYrQW0U213U7csw64znnpkUyOe6nUpLIsUDTCE5GBtJ4Ptis6ESQ6okFuJnYRNFGrAMHyeR/wDXq1oQ7tk0BtZXSXUTiGOPyVjj5kbBJ4H9az7iynVZrtYEWPcAy8kgnt6/jV28hsobSdsSRXFsw8ktyzDupA6YPQ+lV4rmOV1KO080yguHPB7kN7U1roJlbTLR7qa+Nsv2cm3aSeMvtCxjBIGfvdqmWWWCW7gCOkN6MvCvA4Hy9evanarJElvGGCl5H3rGV5T6d9uKz7rUGEkluziWJ+Q7A5XA6A03poIjjaFbiT92wZQoBbu2cHPtW4NIZYLu5e5jQxDftPWX2WqFjBb3MUjSHYAQQSM7z0wKimml6JJumi4QA547UhkE6lSqzk7D8ytnPBqcW0askgmURnhWB6GtVLa2ureW6njTFsmZNjbdzH2Pp7VzV9mOKEhHAlJOSOAOwFNxsHMWYyxvgruCR/KirOmadDcw5up/Ll2F48fxj0oqRXORhhLSA4yvU56U5hGqhkJ8zB3DHAq2gKRFM71YZJ9KrxXJiZgFUseOemKokghZFlRpRlAeQOtTXV3LNM7biARgfSlFo0g3q6E+lQSJIhBkUgZ7jigCxbm2jglWZWeVl/dkdFPfI71JGqqjRyr8yjcp7n2FV4JWMxwqM78cjp9Ks3SwJAzEMsofGc8H6Ci4yW/s2tlheOdLmKQBldBg59KiiAlZtqnzACcnsPUmpNPZ2C+UHGCFZhzgH0FWZb02sN5DBKBb3WEfKgu205x7UtwKotCQQ7Jkj53B3D2rTuNk80dxBG1vHCqIfLGCpHQ/j1/GqtlJLHb3kEcaBWALO4yy+gB6Crd5P548+1inQhE5K5XPQn3oaAjubnyphIjyNhw4lY87up4+tZ08puXeRmG5369CSeprRRbaOJYb6PbLI3M8gJ2ofvAgd6kT+z7rV7cXJmFgshR5I1G9kA+XahOPTv3pFXGadqMsWnm2bDI7Extt5Ungn8RUlhPvjltYrbzridRHGxGDHg5JX3Pqa0Ly3Kw+UGjSNIy6sMMSwOFXjoSPwrFu2mH2cXSfZ1WParqf9aMnJ/pQw0NiK8eCATupnd9wWN2bapIwWJB5NZ9rK1pbsUh/fbgG4IAz6+oI6YqL7YfM2R74UXAck5Oz0HtV+3gudT02XDNIqMr7FGBDk4GW9M44/GkBdspLqeK3tfILwTSMNoXaqEHG4nvjnrUty8STFtPvVla1cR7VGUCAYGT3571VubW+0qw1G1vYpGkt5jAF3llR24JGOp/xpLi2nsYpLK/SO2w4jknEeXB28rx1/wAaAHwl5rmBXQEWyFlj42leSWJPua0pRAjRW4zLaTRATmJfmjIORz35HJ965+1khNvfq+9pFQLCkqkbcdenQ+1dHoi6XdaTaxSztp8pkLySOGZGYj5V+XnAH8+lSVzEkdq1qVSOSN4seb5qHG7njcPTt+FXwsMcqTzQwtsXLLnayjsPcn3rK065TTb94LpVuAuY45VJ25z19SPattUVoJd7W4hxnK9XA5yCR69qTRa8yG8t1Nyv9nOVidtzh8Bo5MZxk+npVK5s0tIEvJhLNNLJhEI/Nyfc9ulStprm7MlnC86nBk8wFhH/ALx7H6ZqzqUEptZVuJvnQjeynfuTrhT/AA/Sp2Ha5gSXUs14jXhuHVdy7UYfMo6LgdB7+lWJLeZpUkt0RnC7yquMID3znmrEaw/Y4QJV818F5m48vn7o9/eqV9JDDdILSJnhh5beeXJPUD0+vWne6CxqXFxFNo04gFtFLbt+8lu35nyNu1F+nYdMdazdDvb+1SeJLNbyN+WLRkiMjowPrjpUdhHNb6ncm3MTojkxyyA+WF3AhiPTPrxU9/qsklxdxonnzMNryISAecs4HQ5P6U2iTq9AWT7FGzwpPZf61vLP+rX29eSMjtUt9bwGQx2ZH2tmXfGowg+p+tcsgNjbl4Wa4RcISjFVG7qvv7+mK1/D13ctcCaEJ5jKWMjZY5zghl9KTNIo6Hw4fIubowizQocyPjO9vbsFHqK6G/nuVtrF7eQwx3QVXAOWI55UenbPvXHzSx2envBcxvGZwDG0fQup5/Q59as6vd2Utnb/AGXUfMuUZYpAWJcKw5K9gBjtUtXKL41aOJr5B/qtoULIuSQDwuO2M559KwNZuGnuT9ol854wGLRvhGJPGcce5z9Kbd6abK1uJfMl4dpY/MIJZQByfaqNxqjolrbsVh8uNnKCPbGueQenzE9R70IJaD7S6MBd1MMtv5XlR714jkznKjsc55PFRay10/2dpkfzJI2JDD96SO4OOAePyq5qjXUWioYrdUW3VZ5mdl2tu+4Bxkt7VnWeoz3kU1xc3FxudBE7Rx7ioP8AC3OQvNVa5k5EC3E9zCk1s3lLa4iVRliBn7+fX3p9wg1AjZIpaNt0uOGKj6dcn0qFNtlNNaWiNPECW3woVkHPG49MHvUr3RksmvbWKGNwzRTMpCthsYAHfGM5qrdRbbixNBYSxSQhV2ODGWbIb1BX0FdfaaxFPqU9xdGO3F0iv50aFmRzxuAPAB9OgFcbbR37W32pEinkHzKSoMievHTpWqIBeIkiW6+c4XDrMM4bgjHUdzikOx0Wm6ghe9t3R/LgLJ5w5EvTH3vugc8DrWfb/Z7jVbWMGWSGNQJCBv3tnJKgZwB09qdZSRRWk7raSfY3tWH2YuHMeH2qc9QpOSaqz3ps7510ie0iuIYi48hVIYkjI3YweKlDRq3UV1MJdO0yKJnMhuPmcOEI5PzEdO3Pfiq1lPNNqUYu4o3uQ5RwCV8tByJB647j0pXuhf2rW7TzxPbQNMJljIyzYwCw6DgZzxWfaSRm5kvbra91Km88kCMdCQO5x+GKYItatoG97hIQ87IpYzoAqjJ/hU9M/wAqxINMMGoNHcJ5MaoCwYbsZONx9PrXWTXctjfQQ3k5g8xR8rAuCccSKRyQemKp+JdNKTzXFrburTpiSOQ7yDxjnsfX60rjMjUbS1i1IJE63NvBOdoi6OgwRg9e9ZF/esnnLENqRk7kQHOOxb1NNspo9Putz5EwYkzAcKR1Qiq0F0JJdQhhaHMjKT8x2cHgD169OlWmQ1qamnxHzFvQl0vl7S+FK5jx9/dkcfSsaz1OWK5ispokKO/yLt3MgB3D8T69cVqWy3NnpcUUqxmK4fdIUHmtGD0yOwGDwKxnkj0+6eWGMymGMsWfjc7AqHUe3YU7km1rur3VxfWtqpjXgr2jgjH94n27/Sq/9lxxWck8d5aziHLyukhGAcbWQ993UfSqmgSQToReTLEzSJG8kiFsqTlmYDsPTvmtXUdIgvvEU266toUEbT26xptjcDrhf4Qcd6cSW7GaGtriOWKGUKqKHVmbgHucdz709na4nt0sMQgrhH3/ADADqSfzNU/skZvfI8wTTFSpd/8AVoD6evB/StjTbQJaSQ293FG7BJAVi+UsuflOeccUnqXexj6gqvesLCWe6iVDveRRGXPc49KSAWptjPkrMqkMBwT9BXVeFba+1CW/yNl4EZiGAAVTwT6EVRvIEgsbyG7VGnBKpOF3FsH07cU0yTnCkSXCyiVjMg3hpDnd6VXHkyQbPIMo3khwe5/hzVkSRStCrADHAYHbg+9VY1n/ALTMYAnj8wgRr8qs3t/jTuKxLpcRSC4kEZdIjhizdFPBA96SWSKznkhtrbcvDBpRhlHpWpp1jD5Mkl3MYolUyiNRnLZwF/rWXfTRTXJeac3E2M+nPYZpvQEN8xmgywAiIIVG4OOuaLOCKa9hbVZZfsi/Kqxjkn056VUG83qMMEvnC5yFx2FWptXuby/a8vWBbAjygAAxx0oTBq5au5Et1hjX93CJMxq3Lbfr2oqmIvtE+QkkhzlcjOaKdw5TmxeBUK7AR3pZbZ4xFJGjMjrkNjIJ70lutu0YMnMgByDVxPOQbYJxjZxz0z2oIKm/YoeMBQw/I1d8x4NRtS5huUUCTbKMpn0IqjtdUV/veXwR60ssjERsPulcHA6UDJ45Gk1K4dYIEaUMAoGETPp6VsX+labaztaLevdFDGTPGv7sqVy/XnOePwrnBK8z5lkRSo2r2rQS2naK3Fs6CS4jZ2UyA429sdvai4Fe6kjivJDZkLG5BjUHOB7+9J5IaBBE/mXJbmLHJHse/vS3VrNCokbbLuwC0an5COx96nt5n/1YZR5zbZHchWAxzj0/rSbA2NPjNk1rHHcolo3zTnAkCv16d8dMVJ51vc2dw91LHbCNSwZUO6U5+VVA4B9e1Y91NDaRL9hV8oR8z9U/D3plnPMsTxQTiR7sYlikXAUg5GCe9CAW9RTZ2sik/OzFtxyCc0huLafUEaSOWDTuAwj5cDjdgnv1xTbSEzuwY5SMFuTgDHWnpaho4Ee4iaJ3y2zO5R+I60hmzN9kNtLHYs/kMrLG0xwwQnhMgenWkEpVZ4HEMrG0ECrImcdD8v8AdYHv3pmiafDqOqNb3k8dlG8bPGfVgOMAZ+Y+9WZ5YbOSSKWOU3g+UDOQ+ehOOhxQwIdbjsob1ZdPRzbRrHEx6EygfMR9cdKr2gjlnuo7ecwWxLSJJIpy+Pux8fX86ms7a8vZJILXMgiiadz5gyAPvM3YelT296TMm+KFbKCRZPJiTCy44A46+5zSAj1ueaSYW25pmtVCM6HgyfeZ2PsePwpZZEZGuJpXYSyLLDEyF1lfPIZu2BzjvUd3ZG6lne1Q2cQYB1kkJQZ55b0+tPt9Q+xadbwkLOse/axXJ543D0A7GkBYuVutMmaxntZfPYiJQBwQRnHvnIx3rQ+yxx2qpcOkEduhYzKN/mynB24HdRx6ZFZlxq91eRpZZ88RxgRCNMupHcdx7+tO0dhcIYLpt7yFY9xYIqjurEjj69aTKRraaZtQuAoW4dIwJAUAI25yeB0PetvVtRnFq32e7gMhUR/ZivzKinOS33ST6CsO5jntoZUguEljZiS4BRR6LnvgVe0y3W/ulEZTdGmQHjO6YgdR6etJou5o2F3dQlUaSK4SMeZIxDAN/sU6/WXUrhN08SWxIIEZI2E/Xr9am022muEjzIYoFJJkCjacZ4b0pl5ButnlWF5kkLBVyS4AHHTsKSLSOdurtrO/uSQJGaNly3AXjAYAd6yGKNAGMp+0T5eZm6hQePp9K1rloN8lo9vbyArxOxIaNuxXHX8aqT6FdC5t/PG2NWVZDkEBW5B+houNontLy5s5hGY2QvCFQqQAiZ+9juDk8HrUulyE39xCiMI2VlQbguBnucHPc4pyyLHcsvk27XIXPmIOWxwD6Ac9qtw2hk1GNsSRxu/MwG7YvcDscUXBImfShPAIbKVftEkqpHannBBzvPYdqvs/9mJOjKq3MaB3cnI5ODj29qjniuI7tUgngeRgfKk3BBgnGSOx6Ej3q7Pb/aFNnJsmlVc7403MR1CkjggelIuK0GCYRzrFqJhcP8xDrlSSOCD269ac7+W8qy2qzNsAjcrllPc5HXGMehFadhZWFxdXAuyiRkJGgcbhu9PQe9dBDb2tlo0ZtxHLI6EuwBAQgkY55wB6U0kM84vfMmDLvCbgI2Ct8zeqgduOuO1VTHc3WmWMcozH5gjgm+7kA4K5PBx61s6tp8UIkBCSMsisSp+ZQeuMVQfSJWRrh2YxqwjVC2cDqAF9PpU9bDcOxTuRqDwXNtPA8FnJL5bzk7Iw4OAc9G4/KoriKLTriNbNt8cRCyOw/wBaw67T3Fad9FMpkgZ4rnC+VGsrEeST1x2UA88cmsWGwnaRmnkWJVyolV/lOOo+hp37GXs7rUvz6xAftcNqdqSqGVSdoPruHt6VWs47F7qGJ4Z4DcxbZX3FyF9VHv2FWTpKz3gmKxuFJ3IkoAkz94q3sBU1tJYQSK1paiaR2Kqsj/NweOmMde3BqloRJMz73/R5US03QQDgOsmC2P7zDjJ6VP8AamtbST7BCUKkFgZeEb16cn/GtnXFdLWKO8t4GQQkFCdojk49Otc/dvcrpz2LK32uQ5kPAyB0+nt7UupewgupIr8IbnMU4BkeL/ln6Yz1UHr+dbMEkZt3uWgWVoH2iGNNoYnjcGHBxx+dYFnIj2e196Y4VwgPTqfXFOgzLMLeCaWMlw4WLovHUr+tMi9tTXl1Ka6mmH2iS0tpISNsbFl2jA7duBmqlreG3mmVZILfzogvmFifLU8cf3t3pWzpenxS2kcEflSXM3zMWUgY5yMk4x3qt9jhtXkW7IaMQgwBlBUgDBXjkHHIPrUlW6lh76W4T7FdESMEVY7mduTH2CAfdAPfPNbOq6uIY1t5orYNBuhmZcgtzkHjjPHPJrHv47Sy0uN7tVmkkUbQRzj+Ek544zkHpWPe6paZEAZo7bO395yUHtjgimItXVppuo2dxJDGzTb8bWfBJIPzH1HvWBDYtaXvmTr8sKBHVCA2z2Pr710Vrd2mmW0plXfeyjnAPAP3cHsf6VYu95Z9sDIxjKBl+ZCrYwMdS3H6UW1uPTY5GJbqUC3huGMbE7mJyzqex9cdqsajZ+dNcW1sJW8qRMgDD8Lxx0wfWr9vbvZOJo1cKZQjPFhpMjrtz39quXN7Hah3Z5vIkjKRCYYkGWyQcZwOvQ96qO2pm0cSLuWKNoxGql2KueSevT2q8Zbq81ON40MMVuAQXXHydyfUU2/SIatKsspaAgECBSS7DoPr2rQ02xkuLaW6imtFeI7hbSSgSMMYKp6+pFWiGXoEmV5xdJDPE+5pHj5YZPQdunp0qlOrFofJuv8AVptUA4+XPRqktftMdvab5DaxuzSRAYKbQefz9KluJlGptdqkEQmQB4hH8oYZ4A7A0PUrob2lau1lLFdxPHM4R1aJlyQPr39ar27R3kkwVvMmlViXMf3VPODWGtvdIghhSLzcmTbncyrjge1bvhWfy5LhLz5N9uWkPTPt9c0hGFeWMwDhoU3Fwd454+npVA6WUuH2vtbb8qkYBXPOK714JEay0+wliaV91ytwx2mPCnepPtjNclBs1LVGtlu1S4Ks/nzHbvbrtB98cUWQ7mbDbs8UzJKRFCw3qT3PGRT47Oxu9620kMXkLuIYfNI31qWQwafOWu7dnWQAlWOCQe9UbeNEUSwxsQjHb8vGe2TVIllfUljt7wGOALlPlAPCse+atWyxafa+cYopi6cBxkBvWo7aBp5I92WByCPeolXzZZYoxLwGyCuQFFJ7gWdL1V4d07OizKeAB6+1FPjuLGcW8MiqJEU7jjH50VV/MV/I5JbWa2DKUhdZUyGJztH+NQW7sjnC7yRj6U6eHy027y7gbj2GKWS2ktbZHcKPPHy884+lBI4Sp9kljlL/AGjOVx93H+NRGSVIztwiKACe5zTIYmlkSOMB5H+UZ7Grd7G1nH5E42ykDHf8KBkTi1kKJCWC9TI/XOOR9M1d1T7PbyWFxbZlD24WUn++OCRVS3hKwJPHiSUNsERXOM96ZHF+923BbywfmUcEUr2AmgmnwYUusxOdxLt+p96uQxw3s6xu8KR48oSzDBGf4jjqMZrPliWGfahRlYbhk5wO2feprSOGW3JhlUXTHb5W3nb6g9/pQgJrm1OmrIH2P5mMMHyF6jn36VYltZp7eO7W3eNASGzjaSB1UfSlsEaUzPJ5O+IA5lbheccir9xpN9N5cksSrllVljkGE3LkA85BwM/pTGinpkMUktssysizc4PR23YHPZfWp5zLa6jqEdx5EggR4oyudisCBuXHp2qrMluJ4N7mKBl4JywSPON20c574qG2kZLx2hlJjb7kjZUOoPPHv6VIGxpc9kt1bXZIN2jbgjN8rrjOdwxhs9aqXF4v268mMqeY6kRmIjaGY/eI7cZ/Gq2r2ktohKTI0M6h8ng49h9aXQYbWWSFQkrSrOqhcAiZDj5fZqGBYsN9v/aA8okSoYpVYZKpxyfxxV0Wd1Np8MVvDIykM7kjCkjjOe2PTvTZbP7FLexmIx36zhd8zFfJUEnHP3s9Pwp2msHtmiia5a4mz5zRgAKmeMc88/kKQ0VkWSNt1sw/1aq4JyGb0x0IHvVuzjgNveW1zHNHePHkNGoIOOcN7EelO/sm7ubJbmG3YRInljBzgDOTgds1BGyM9y1xIyuIjs2LgBuAdwPOMDFS2VuLZC5uTDcQxQwqJPs8UiLsDMBu5PdvrSy3Vzb6gwlVN5bLRdFbcetTQ3MkmnSW86HYjh44ycYB549CR3qrPbMZWQmbcy9sEc9jnkD6UmylEtSrukVZlWJozyNxOSCce1dBp6zz241FpGmlRgB8xG0DtkdKxbPT7m5hito4WIQ/KgOc8fyrq7O38rw/5ck0cJDjcpY7ZOOp9aTZUVbc0jdYkZFHkb4yZWRtw3Y4GBwDzirdoLiaBYYnVEOfnyFbng/gaTw7pc9zA6xWp3H5i7uOF/2sdf8A69dBBohjMsxQNIcLvQ4UcfdA7YpK5qrHK6npttZuVu3jbyyNrx4YZ7c1zV0xtWDPmWMHzHjB/h7fSvU7/QCUa4+1SERgYdeMDPTBFcsmni5vwrsBEoIxtA3c5waTVjRK6MyzhtFEc0qmFEUsE27lBPQHvirjWFuNItDGJWcvlYTIMl/p1wfyrbvdLW4kS1ktvLd325/2fetaz0q2UwxxDEhOGkfBGBwOnt2qrCSSOX0/Q7tZ5XuHSUzf647MqNwBKZPU5AGRxXUQ6fFZxLJbWsNuJCGHl8Mp6Yz2rca0toDLbRzK/wAyb+CNu7+5/UVrGxDRbotkcMe2MsBks2OcZ607C5upxt54YgKAruZ5ZAzEPkcHqKmtdGezuWgeNXRAQtwDlWbsPrW/JDLbTO8DSPCRt2nCZPrkdPpSC3tJbHy2iddriR2wSw9MetJLuVdmUNDttS0iSKRBBIkb7GZcF2Hc47Vg3WjXphtEnEQOUVjE4LBR2YduvWu/lsFa7tBcW1zNFCmcNxsUcjcR1+lQXFlHqFxG8do1yYTt2EEKgPsOuPXtTcRRbucRqHhqymurk2UiLJbc5c7s55IPpns1czehoyHnhSSMEuQGGA3Tp/F+Fez2WkPNZtDFE1vLHnypWVQPf5jyfpWNb+HLOOaSW9VX8slnCEBGPc7aloE9zzKXS1e2E067Qw2mNBjA6n9KXQLa1fUHkuRDDEj+UfNcBtpQjB9K63WNLWOyBRZEmlcCMq3yj0/DFYtrpVjKs6RYS4kY7lkXerAdfm6g/T1o6g1daGTq+o6ddQyQWuJZ0kEXypzsA5Pp6/lXMX8tzbxS2s6B5vKCQneGyM5BYj0FdJa6XeR3F9BbJGXC7gJyR9cf571kX8DWVxGGMasgaXBGcjBG3j69atIwejMuxkjJWaW4eAFcHKkrKe+Me9LqH2WC4t10uZ7i6Yoyoh4jyclc9eD1qOK+n1SzTLWytCqW6bcLIEHGcdM46miMR6Swewle7t45ATI8RR95HIx6U72M79DsdMvbyOK4ZruKG9TcfLkXCMfQcYz/ADrHu3uLu4W3uInjvIxiWWQ5iWMDOCO3/wBeqlvdSalqH2ufzZW2bGRlzgr0GB0HTmro2RXN2ryM0aqI1DP8oDDkuRyfYCpY9tCJdQe4hFjcCNViVxHIg3Me4BPp6YqtqOnuZoHvFd4yWi2ycEsFyThewrorBLOC4nyivEqDMbvgOccE+w6+ucVSSW3lkvLeQmSeO2byJN+NzhgWYDsCvX8KQ2mEFlLYSxXMscbhlAeG4yyqAByQPrn2rYTS7hpp5zIlubeJWigMmFmQjt6DBOM81mSwGFV1BHb7O6EphgdhxwGB6ish/FV4tu7OFP2rClHQHY4xkqO3+eKVx2LMUVveb7bZKGkdDFAhx3O5s9AcAVVv7u1jQxQx5K4G1hwuP4vetW8iEWkzzyujSSN5a+ScNyMtuFYkPly2rJbwSzSxKGlYLnK5AC56YzyTVITJLPSHvLcyQ3b3MjkARRKGYKcnvzn3FUdKCw391camzW1oUJBxl9xO0Yx+JP4102kyXMEp1PS45YZbTMz3A+7hhgqfT0rmbyZxbXlrG0eboZaJCWdXV8ggnqDk9KvYzaLdrcWUU32e6Ee5MZdTlDjoVHuKo3AlS5F1J5kayOTGRggjPv8AlVGGzhvbidCfKZlxGuMksMce3etYQecFjjWVpFbykGfwCk9j+lO99QtYNOvbia7nnWRzJOfLkc8FB6g9xinRXs51SIAWyMjeW8rsdj46E/55qrpcJgbUILpWW4DbdjccrncCexBxVpTDc6a5uQFjTJDjjaTyc+p+tJsY++1XULlxc3MahVlZGKELjjOOO1ZUcFxfaiu2BVeQ4RHPy+uAe3tUF9K89+84eSS0kZQWbGfu8AgcVZnvYUguIVRZzOVSKVgfMiZTkEfypxDfUbqMpjnh+0AOsqE5J3Mgz396mlaeK0g06Le7ygOFi+bce341RtriYSC6nhDHhBIy0kJmW/JeMpJHlxuk2b/Qqe1NbktWRJpshtLySOR3WXO10YcqehBHYipry1lT93HmJ42KsVb7wPINULWeFrl5TM+98l2l5ySfzP1qe6YrPG1vIETd5ZIOQxx3p9BFecJbwxhUL4JEhHBx70VYNsIo7wSSbkHAdTlSw7A0UcoHHuxlKDjI4HvVuS28qG3LhpWb5ioboM9KWWeCOSImENsP3egb6024m3TyuybPl+RF6CgQ+cRxT+fZMAvXa3BFJLG8kMVyx8xZPkJPQH09jTnEdxb2UB8tAGPm3GDkA/3vUD2qvHIU8yISDyQT/D1Ht9aAOglaw1G/kSCVdixKI3uW8vAA7Y75HWsMOYphKWV96nd3I9c0+8CmZlit2ijkwQMZOPapXspbGUCVNodN7BjltmeCfQGkBNZw2bR+ZcvIEWIqO4aX+EH0GP5VTO+3vma1wHV9sZQ52k8Zz/WmhPOfZAWw77lhXt75rQ+w3WmXMqB7Zy6iORPNV8gjP049ulIBtjFFHI/2tH2gFW2cktyMk/Wi7eNJoTvBKoM4Oct3AxVQzNcMIY3KRkgAk/qa1P7QsIrsrPZQSW7KtvtiUqdo6srH+InGTzmi4Cx2nnzQ3KkyGZ2CxuMFlIOSCeODV6F7RNSEGozNDbwQbPkTc7tjCgD6/wAqwlvJpI0tmT5Y23Llufbr0A9K1D9tv5IC3lSOF+UbR8jNnh/UnHGaQya4ewhinmit0aRw0YjZ/X+Invj24qqAkUlvcW82bguCQFwFYDOR6+lLdWpRI7gW825gVbemBn0A9uackVwUDKf3qjIiVCo8vHb64P1pAT6q0N3DZPIl7cSgbXuJnx5hXqqjrgdqLKOW5uF8qRdmd2/njPc+gyMelNMRtrg3sDhkG2VRIM7Se3px6elbenWMscsF1eRRMt3EZVjjbYvDcggd+/FFyolDULiZWcCOePOA43nD49QKtXMDS21rPOsjFlzvYABgOoz3/GruposcUcEannc5Dcgjscnpx2q3pUVza21szs7KG3bFbgKT93pxms73NUjG0K2uRqazpGJkRQjKwyAp6AittLCBY2eaPzGDnOwbvy54q4WuBekwQMiOGZkAyuf4T7kVo6fbyGzE91EJkRhJtVQpZiOGJ/LigaRRtZBFe7hb7YUCg7SN2OvHp+Na7aYb6VJUQBnUzMJBsjO3lgD6fTvVmxsi0DzXoL3UreZIegJPANStaTWKwi8kilghOxQD1J5waLM0S6mt4fS+ii+1wzGBPuoFxvbnOeelS3E0lrMJLeK43ddrvuVpGzyfqayIrq8F1LIuYUxlkY84HoBxTJ9TumgfZBLjcArAAknHQf40eRUY66mybw3YgaWXzHYDMHOFfuMDlulXYIFu4UjeJCIxlgRg59apWgnsdOG3ycqAicZaTIyST9TWxC0BijIBWREzLl8HPU9ulMe2xHaRML7zZ5kKHB3Yzg47+1WUHnwyIIy6RnITGOvoar6akd7qltYWcTLCjmSVpGyW9FJ9M11moQRi4ZGKmRQAzRg7R/s0JX1QX1sYbBI7MNdRrbrIcGWIljGScLn64xmrJZsSwrcra28YyCw3Hd6DPf1qrNIluuUYtt+bB6HBzRNPFcRKrsJPn3sQOQDzgmnfoNLW42B2uLhvMuJXdgQsa5AX34GKfbL+8neV5Q4GDEDnGOh+nvVhrNZES9CBIQ21fmxhu2R3qEXMkUziNUFwR5buRuBAoKtzbEkVwt5E/wDpLxSyLsB34G71q9cST21skV1es2xRuliYhQT345qnp1tBI0izxbpG/vL0+lW0inhJtYYI5rc8uo4yfc9c+1NXsTJWdi9PGh0cxzTLcQbNqndjfnufeseDTWldWuZbhdvzBlONp9iT09qeYpr25ltzCkEEY3RhJOFIP8PuK0rO4EZEVy15OXJYYA3E9/bHFKxNrKyKHi/R7K2WyuBOsyTYVt2Awxyc44rhtSaO3vjcQyrt3eYkcIJSPsMe/rXaeI0u9Y2OttttoSGVlPGB1U+v1rFl8qeEFoZLWWbdDECwC4bqOOnH40nuOCcYnFateWrRSQaotwsu7fvjGQQ3XHp6+9cReRxtLLPO7zQCRoIwDy3GVY+2a9UvvD1neWMklkURgpUBmyML1GfUe9ec6ta3N7KEBV5SOBAgGWA4OBwT6mgTSepn+XYwaSivGr6gSfMEK5AUYwT6EZORUBtvNeMQz3VzF8xhbpG5A+8B7cjHWqstzNEyW04BjAOBgZ3dOvXBxVtLW/e4ElxJJuhhOxVGQuOoUDgdapM55RY5LWWB3a0nkhfyx50Q+bzB6YA4Bz0qxAq3lpEr2yRYkLFw+3b1GcHkfQ9apXuoKbXCJskiXaZg+zdyOCO5B71Ib/zWENmpmYoN0lxzl8diP0z+NDEkLfOqRwq28weUF8zOMnOc+9Q2Vrs8qVkfbdEgDJ5Yen4Yoea5uoGilt41AiYnacNnPOf9rAwKn0CSaWaKGLzY4oAS7RLny1I4PPOaVtSkbV5Bd6jKkd3IsKKgcrIQB7ewpmoWqLbyPDHC8UiAMxJaRXHWT8TwDWdbXMrXT2s7viVsPM67jx0IPv1xW9Z+cVEmlzRvKVETSP8AfRgDng8LgZ5pD3Oatftbhke3SSfhnSQ4Awec89amN/c2FtOz22I7r5l5CI6ZxkAc4rQa0ZL9zet9nl2GNnQh8yHkFvwPNP1LT45S0tu0b22Sm3PzORjgentReyCxSTUXSwvpUvFtY5Yth53CQ4HyrxjOK56ZZtPaM7hGyjax6n5/QduK17/SoFhVku40wzqEAODgZAI9c8fhWZYi3Rg93HKwGHfaOWfPTn2qiGtbkcMU00zTN5jzDouzkjseOQa1bW38yc2Ukbmby2AkjUsJHGW/LHfsK0BNDbxTNEvl3UUm6efdwyYwEUfzrKv74ieBbUzW6ISmE/gH19CDTRL2KFpJLNqAEiO7FcHJ4cA4PP8AWpdSRk0+K3WFtisfO6jJJ+WtSwktG1dLia1Z7Rnw9vE/znKncQ3bnBx0qRpAVVIZEuReSY+yvycf3Cev4ihjRlCd5tAh0e1tozKlyZ5WIBZyBhR/9aqcFs2r6uylltyhLOMYCYHIqFnFlqMkkCyOqSbTHn5hg9M+vvW/DJaJprXTEJG/zBc/vXYn+Q71a1JemgzWLNLaCGGwk860IWRpNuMA+1ZupTMLiOBSs9tbA+U20H73JFXNQkl8mOcSxS5+UJGw5yOCR7VB5QtbmaFWU4QSbmO0NxyBS2Hujnnz/rSAc/KSRjHPQetWdWmtfLiFpukg/vFMEt3zVy483V76N1h2xRgBVUYVFHXNVJrSUTXtrGTMkH7xCpAUA8596q3YnqMlWVrMOsqeUg4XHA+tFJPJALKAOOW52gc8etFIRQmuUmtN5t4MBQpw2GH0FMuILa3QxXKyCbKsjhgflI7iqtn5LyN5xVcDIDZ59BU8cpa0ljWKNmcjJIyyjtg00IjniaVfMSP5doG0DnjvipbFbaNibpC5xwVbG09jjvSxXN0zSIrN52Nh2jDMPSrLsttbyLHAshXaTheVPrn19qNQFWe6MpuZ0kntXba5ZcKfRMjpmqheSa4kikVgwzuR85XB4U+wrX1K1uBZyWwuWEUDiUwyDaRkA8/7XPFY8Uh/fecrySTYPm7snFIB1o6JcRuxdhypVVwrLnkZFaFzseG1htdrLKD/AAjKseCPyrKhvJ7Oa2lhkKy253RsD91h0NWtQef7QlxOQTKPNRlIX5ickgfWgCSWy8vS2Y+WzcEndyo6YA/rTob2A3yJH5S2uNq+YnmOuT1z6/4Veggkvo0naCSSTasUWzDhiBly3fgd6zLyzc6gsFuUuNnIa3O5WHakBY1wWMkMTWYn88LgyOAN57tjsPStHVbaaKaD7LF5bLAjTOjd8DJY9N3T6Vlt5k7qWkCyRjbmUABW9PpWpa6bda+YbGxRFuYUJn82fAJ6lyD/AEpMZBayy3CXc955zW6SYlZMB2Zhhcn0OOtQRfaJ7hpjvaRTsQ8javoPwqDE9v8Aa7ORysM4G8Do+OV/DNaUK3wtYY7V4JFZfMHlHncvrnqfpSGgyGu1geRru1hKl1iXaRzgrg9+2a1JZzaRLCifuomZ0i+95aE8Ak1Qt0jurR2u5JlvlkJdlQMxQ4x8o6nOfzq3p1tKkKqokyAYixTBfnIDA/1pMpLU27YQzWk0ksruZFXZHkEDB5HHQ+nrVmeWO5YQ6dOYQjx74JepGOGJHYHt1qna6XLFueaSOOWEBvKDAsc+3f8ApS3VnCdTYCYSI6b/AC7YnggZCknnjvWfMapHRaLbvqDQiYq82HCAMQoxxnPpW3bzSaXaRiMDzd4QnAIU9CQO/HrXN6ZKqRxFImmZskoJCqRk90Pr6g101vvmsUMsKrIjEo6ghgfXn+VJmkY23L9vbwNxFK7uo+Zj0z2rOmhS5v42iG5oF8ycseN5NTWjO6ytGwUAhQwBIfHU47Z70yWURX8sksJiVyG2RDcrD0+nfFO5ok7BcXEsJMU8aun3twb5ivYY+tWJw66g3mFDcJggH5B9arAm5kaWKLdEFwi4x8/94+v0rRFqbdo7khZCvBIPzL7HPWmUlYsWCyLLLcSKphkXYzlwVTnJ2+npVTU54VMP2czS+YWVZyuUZuDgH9KNW1dLfT0srW3EkjNmRpRynfgepFSadp6h1LfOMfIAcIpJ/nQ9QS6mtpVybd0aGNVkK7XbqS2c8A+lbYuG8oN5x2JJuKY2hz9KxpfMS4igslQyRkF5BgYz1PvU11PHDatIwlZ1f5HYgqR3HHf3pi5bu6J2RroRpGUjV2LbTwuPUmn2VnPNMHjIWDHzOxxnHAVR3NWNJ0vUdUhiuY4xFCVwN55AHStaUaj5Udo8TRxQrkSbRtHuv19aSSkJ1EtEyuyqSguYbto0ycOVXjpx6/Wslpo0zK4CJ/Bzkj61tvG1+6LklIPlwTkr6fh7Vi6nBNHqpjjTymXogGcfh/WlOXIrlUtdC/Zapa2oiW5kMJKsSzLgYH3ff3q4uqRrNLDpcqOlwPKLMcc45bPasXTbCO+n23OW8wFeTk8VLJpIsZY0jhdiMtvReCo6n24rGOIbdiZcly/58FtdRxsv7wDJkUB97Advb3q0l39sZvNkKsDw2duF/u4FWIrOymupJ7GeMqyBBI7nKeoArOFk0JjaQlhISAP7pHvXSpCTi9Rb2GW8tD5E0kdtGeCo4znpjuKc2lrLpbXkyxzrArF2PB99o7E+tRjUGa1e2swpJOXducH0ArWvvKvdEaCOVraKRArqBk+hB+tMUrqyPMvFPhkx2r3EDlI3K70DHoe3H86858QWbpdsiRyJAnE3lEEoPUete63t3Da6cN214AnlqQTuXHAGO9eW+LreKxUSojNJOpBSP5lB9qhlxfRnD/2baebOrzRZdcC4OSAB0yOozUVpeTaZbNHA3mo2MY5CMM9vQjOfWtn7LdWJ865JwsexsR5BQ9QDWNptrcm/WW7CiznDW4kI+7kcEgc8VUTCa1K2lSwy+bbTweYZt2Zl48sgZU+vXgirMKE4R5n8hQZTGUJKEDOTgdOcZq9c+HZxp/2yOSO5jikMMxhOMN2B75IGRWVatDcGe5kmZPKBVQhOXbjGV9+n4U2RazNG2h+3Xlo+AHlkzuJ+QjOc+gA6YqbVTBZX4uk82RNrbQ2FLN0yyj9Ky4r67hjCxfZ03MS0m1lYew7fhUguZYjBO4gDmQqfMwxJ46jrg+tIlXNFBFd2y2trHcZjZZDJt3ZwOee3WrdnZCynMllK+54THcRsxU+6nPQN2NUdGlcavMYbdh5qZESZVS3Tg5xmtK4NzZ2wWRI3WS2ClsksTuzznrgcZpdSlexaubSBYlvt4a0EhDqMM2NuT9cZANZ6SW/+om3yPG5P7g5jePGV3H+8O1Ur+YXFmk9hCqCDCzvk/MC2BgfQgZqS1vwb2OOSH96QAJEO0SxjjaR36dabGtyteAwCOOSJjcSDeiSL84PY57/171Ult4FWaKV2WdUA8rcSpZuuPcUakrLfKtpJ5nl3AeJlyQo/un0PbFan9nrPZzyTKElEm5HJ2gk8/L+R+lGxLVzBe2ISC3ld5IHfC7n2DIHXmpZLq8+0w6VaMiLHG65jUSq4bls+p9+1WjaWqpuuGufMXBVFBdG9R6imWsOnyzSytL9hkRG2R58xnZRkj/Zz71S1E0ifTVudP09pZPIR5N6Mrn5sYweMcADB96mstIR2t/IeUO8RdTtyXbBICnsOPWp7uQXFjZK6ROZAAL2fK5VRzGueoGcVl30l2bUARmSK2OIQG+4vc49B1qvUkrXWnLcNbSxAJPM+05b77Z4K/wCNMcwxvcwvM819by+VBEEP70kjJz0HNT6xOLiG0uGlfIUZ2DaIyOmMfnWZNa3WoPLdq+XRRI8+cHn+VC8hNE8VheW+oX9s8JgmjQmQtgmMDqKWZ7bUdOK4nk1YTK6BMFWiC/Pn6cVSdbqOQrGJBdKPMLlsnb/d96itoLixdr1FYoVMasBjcSORigRPJfNfqdOtpvsmmozSeXnI37fm+brzjpUNtNPMsUbBXKqI0JGAQOcE1cGllNEtriAl2kfOzbwhPG361Yv9PtNG1OPT57v9wxQXcyR7jbt1Krn7xA61WqdhCeJLCxR4LiEXkcu1RJFcADBxn5fY0U7xhp95B4hkt5L1r2HMbxTsch4yg2H247UUPVisefbu3UZxmtIRw2mx4WNy4AOQMKp9/WoZ5YW8s+WgkQbWCDhh6n3qMbxDKVztJAwTyKSYF691Ka51qe9uTGlzNjeIhtG7GOMVNZy/Z4XlmlJWfgg9Rg1mxqLwIHnRJMbVVhjoOpNTWrRTu0d4GztyHzgKRx+VO4FyBJ9WvLiCwt5555PmWND2HUn1qlOsiwiGaJkeIlckYLexq1HcW+Ejg86KTACbQd4bvgjqp9KZLeTsiWMzyNDG5bEgw4Y9T61IFKOE70DKcsAy5HFaDwC+gkdSFmiAXCqTkZxU1/FLc28FxLPE8dnEtuiKuHKjkHAHTnqaZLDNa2EKQMCbthhSwLbs9QR0BoAVGubGdA6rBsXYzxng+jD+tbej3I0jXPMglAV5QvyrnzSoyOo4HtWRGs1sPtF3ctayRbsMybxLIDjZ9eT1qvMz3MsrxJPHAX3IobdtOOxNAGj4iubFddm+xGT7JOwd2HY56D9fzqrHfTwA/ZW2+cDExT723+7+Xeo5XleEm6t9sjooicrsyF9B0IPc1qTxraPAowYpNjztGmCo4JUeg/nSZUTPdpTdvPdbGkkxIiFsn05PY8VekhEMxjnlYRSKHdVBHlOTzx7e3rU2oaaX1JjAIZ2dd6i3G5dueAcdDjrUsbxRztPNbqqO4KRZJCqDjZ+OO9TcpK5XtE3XjQnYfNO0uev1z2HHWt6aaATrGGmgaTlxINyg9gDTbRbdbqQ2+12YP5kmcISxyFX6Dim3Uj2MMPmow8w/KkgxlOxB7c1L1LRoafEtyt2J5vMkijaOIx/6zfwQcHkjtW/pFmj2YUWaquMu7cOMdT7Vk6fbSl8/ZVikZuHByVHcA55rorKXYZg9w8bHHyt0I7mpZqkzas9Lto5ZSIdocDb5fO8+gNNjlSO0ubSMsZFfcwYZ246DNJZvKrqZJRgDcv4deKWSIbGcRnDZOe/41JukRwtLYQxwyxtHI5DFWH8J6Y9sU7Uooy4Ns8nkKRhiMEMRzgU+EyXc0dtPc8SoAC3JVR0Ga1o9IMdkC+Wt0Y4OenufQVdrovmUdyfw/plvLpZwrGQHdLNu4XnsPfiteGGG2tY4hAksgB2v3JPcn2rAjhWCSCC3meSSVSTGvAznJHvwM1qrdJGU2svyqG2DJ3DNEUkYyi2YN1p0TTCeOItl1G4tkZzksf73Q5qdL6C604vCi+bK5TjICHOOB9KbKrPDfJE0cQt1M20yc8nOB+tYwvgkwit5vLaZA4ULlVAH3seval6FXvozTaOZ5owTEY5SQCh5+U9DW4NMb+zJZSku5Dgo2Sq5/u1h6czRusUuFDsN5k4II5yvcV1kOt3lx/o087OzArFD94c8knjmhb6jndWsdnoV7ZRaTbfaGVWh4VOmX9h6VPq+om4gIADwyELGqsPmbv8AiDXlkwjTUyDI7NIzMAzZC+x9K6O1uzDJaLMWWCJvO2nqD6VUVY5/q9nzXCK5u5LxollEcrMzOjAEqVH8VZ1gWltLqWZ8SA5NwzfMfYVf08B76aWc5aZS+ScEnPenagbW1H2iMxMqNhomHAx3PrUzhzWNrpe6V0lmlmsVnIV2+VZGwqkdq6jTLh43haceYgBTOM7Tn7vv1rgL+eW+SWaxSJo4MFVcYU9TgE9D1ra8MeIItQFssmxLyGczeXIdihSBwSPTFZRgouxnVi7G74n+w2jECKKCdUBILHfz3bHFZ+n+GJtRdpTeNIkbEN83HTqBRqtrJdM0sMkbWkrhnmikDBsdm9xyM1p2uox6eo+zEMRCrqwG0vzjB9KbepPM4x916mVNZ/ZLicSovmIQvTqK19NdLiKWWIIrY2ksMgEdeKj10rczeaJleVgDIingfSk8Kne16OjB2wo4OMckV0RWho7uN2Z2qeQk1p+5aZFcMYgu71zu7gc8H2rj9XWGe/uri+eWBiVkt8IBvToMj9DivQre0dbr58x7JftHnSHDPgfdPtXNahPaX9zM7wzXkRLIouMYU+2OmD3qGn0GmmeT+KxMmk2tqqkz5LbIGyEB52t/hWDAk1tYQyxWzBVYSOxG4uc8EA+gH4122tLJc3DJtOyNWw8eDzjkGuQuzbzXzmJZFs44BEVZyXDheSc9Bz0o6hK2xgaprd5aXMz2d2hin/eMYVKqSeOVPQ9qSxHnW87KnkspG3nJcjqf8+lTf2LduLa4kJCS8wp5fLqDgnjPI9K0I5rLDizjleRCRKUjzGwHQc96tJnO2jF8mWZFgiYN5nJwc5I6k10fhrw9JqOnG6umQgkRhmbGcHA+vNZ+mXRjuvN+VrhkIRkA2RryCBmugsxCuiuplkUxbS6ZBAU9+fX26VA1d9C5f6dbW04isWkW0IDN2AdfQd+cjNVLrz1mtoru1KNJGTbq0gwyE5JfHQnHA9qn0LUpL+y2SPGBA25VLZLAHjd+NVUuWt5bhWj3W9xE55GORyCPYE9aL9Cn3KVnYrZG6t9QSPY8G/znJwuT2B+nHpWHPEFtjiX92T+6U9QcckH+76iukvdQGqaXb2sxllcrtM7JksR0XnoOnPXil0/w0Ll4IU2usYAlcPuLOQeAewHtTvYjcxtAguf7NRpZJGjZi6BBhTKCOc98DI61qmOO0Nvc3VvcNbMWCB+MNz0rQ8VyW6aYlpbRhY96eYF4IYDDYx27msfR5xJqUqRgSWsEv7lrp8rt6sdvQ09w2GLJKIZpp4ZN+4tsMq71iI5dfcVk20S3TRo4QPuMm8Lj5ccFm7/StDUtQgur2eWTdDDOGaOVV2ocew6A9PSltpYZLlVSHY0SbiBg789sjg0XE9BmqW1ra2yBredo0GYk80tuY8swHQA+3pWLptzHNNMJJJYLd1ZW2nJY9QtdPdeIRDtuIRGfs5IQxrgBecgnr3IwOtc7Z+YLq5m8mJWlG9VVcIhI4IHtgcVZO5ZjihubLdFLHDbq6gxkZbIHGR165rNlZJogyRuockFUb5XGehrRurNxBbXssjy3F7veSQfxYb7wA5HXnNT3lhNplrdWgnRJtgYFhxIh9PfGDQtxaHPLcpJqqy3P2mUO4EnzcntgfQYq5q+m3ccUzrI3lxS+Uqh9zeucfjUUd1HBYJZp80KSGcuU+cSEYIB7j0qTw/arqOosj3jW0UYLSPJzlfTHqapMlrqMPm29nGL9JntpAQpHy7WH8a+uK66fR7zV50nvPCVzf3ThSZ7e6EUVyccMUPOT3xWJFdbrMB4PNK3JSK7c/u1xz5Sg8Z7k1f8AFNsbjxMut2vimwtJmKSRq0jjy2AHC4HI444pyEjn/E1zqkmtSLq1mlndwRrstkHCpj5V98DpRUWsTzpeQ2097BepDulSaPO1mfluTycH1opDsclFbSSWk88Y+WEguc+pwBirltare+a0R8sRxlncnHAHPHrTIRbwmJbpCyzIP4ioQ54bjrUF1IUbyE8sohOHAxvBPWggbEsK7y+9025UqvJ9/ar8MdtDqoEsE4tmQ8A5bBH3s9xVzSg8Ake2idZJY5EZA4K7CMEYPvVF/PljjE8yoIRt+Zjnb6DFIZUW3UGQncGRgcg/w9Pzq/FfrbMDc28V7K+7zDMWyV7DIqjaECeQOCS4wh/u89fpikmCPdDBZssN2O/PagDZshG0iNG0nk7R56Rt8wjz90etOQW8do8QAfzJXUDG2UR+pP5cUyORRbWqrJJtSckoB0H+ev0rYCQt9pvtSSQziQPDKpyk7DtjoopoDFFk0likUxcQKxlSRmChgTg8dyenFWVXAxcqI7KNwVty3O3PP4e/ftWdqjm4QKg3rEpLkdFJPQfias6PqEMEd0b2Fp22oVJOcBTx9e9IZoappwfTTdW8qlYXAO5zwhPynB9896baXEM0XkzStbu5VvMJ+Rl9COo56Vdh1Vbq0W3+x7pRjZ8m4FQcgH14qjNetaan9otkhkluAdiooIUHoABwDSZSRNcCeBW+zsXMZy+SFEY7E+ufWoGmIZVDbnB5OcqD1wKnsYl1KSOJ9guFBV4pm278ZY4P8OB2pYEgid5ZGZUOSuOTtx19xUMuOjLFvKM7UhEg2bdo+Uq55yB0Na9uj+UtvLdh0c+YIA3GR/npWDpm9ZohMXtVlJCzbSSFOQG+me4rpbOyiXTI57wQyS+YUAbIwR0I9RSaLXmO07zY721WPzoN5x8pyQRXQ6fYu1y7TyhmJwWY5yfesLw8xlmyzGEKCsYIzl84xXVWNs6Whd2URMcnBycjqahrqbQsmTFfMv12nbGi7MKdqn1Oe1aGoqRYSBSTIPvFTwg7AkdaNLvLmA3FpbS/6Ps3OCoBK4xnHfntWdA0bajNZvBLboxCkHhtwHTn1689KEaX112NLw61sL0/bYyqAbdo9cda6C4vvs1jcWkTuVmIGG5yme3pXKRad5dp5spVUjfYyFiWx3IxVmFvtTXMUMrTlSNrE4Kc9OevFNaDlZu5pI0f2kxW7b/Lz+86AetJd75bbMK7TjKserfQVnAzWrouFLBSMx8g57+5q/pbPbmVriNt4+6FPtmk5W3G9NUcZp7XMeuyw36nZP8AKpORhvXNdHplhZ2ID+e00kpYbwTwmcFPZs1papdafdJIc+Y5gCoyHAZu+e/Hf6Vn+HUW7S4DrNPbRH55IT91c/e96mKUdb7kVKik72sEtqHnZ4CzRjLrIxwz44PXn2962re4FlBDPEjxSIPkcc4PoT3z6dqx9Ve3s5opFkaUXH3VTsB39utdDpGgag+mveXgf7PCA3ykHcT2HvyK2jqHPGybY/RrW3kttQnu8peRuH5OVwTkfUVq6U66kRHcIoYTq7KOOM8kHvxXI31+tnHHZXtvcJ9oGftcLbiCOQNv5DFVZddv7dYpoJBLEqEs4tzGQR0I/rRzpPUrkvex3Ymltr+UtbMiRyOic5G0Hj9DWLrGqWdtp7WRlxI7b0lBDBT3U+oxWHF4gn1C1djeS3TSKqyzsfLdSeMAdMe/pVHWNsr/AGXSJNrQqP3QUuZR3INS5JqyJUddTU+zXRj01rifZYTN+8LnBYDnp6cjmtnw7M+lXNw9tHFIShhCHHOe+f61xlhqEsVwI7l/LeBHDLg4UYycAj8PetzRmvFhFmx8qOYjzJJ1wsY25GCPY5rNwd9BXve53tno8a2s9xdXjs8oDGFCu056rheMD86zv9AUu1tBKsAXHzMAS3asGRJ7J9pkDoDt3IxYEHofxrTiubGPTJC8oVwQypnueuatQXUOS2t7mnbgfZ2faySOuDuO449BWppcE6mO5jYRGRdgRQMqvqfU9a52zvHu4RPKxWMHaueCwHUgela4nlt0ikt4ZnLYJG3cQO2BWt10HNWViXWdVUMUtmYMvyc/e443ehBrG+zxRwyQ2CG4UJmSQ9A56jPf8K0Utrs3c8DxgTMOigcEnvS3VlLYrALqJkQE8wtn5s9xSYlaOiPOdd037Hbm5kwEIbCDg/Un1riJXMMjsiM0qLmSNlG4rjgj2xxXoviKYTQXttKSZApI/wBoeoFeb6+BNFGzlw6n5GA5Ix0NQ3ZlyjdXI0v4oWi/tC/u4XtEZDDbDLNnkL6AHPJ61zGrzahLb29lKVWykc3McYwuGxjLY79qtqiT7I3EguEXIZsAFTUkUV1bpbKU85VbJ3kYU55Ab/GqUr6HI421Zc8N6Yk1gwknaJoypZQPvgngnPv6VbvI2N3KgXewRmkZVwGXgBQOgXP41RTUkjABXesZwW8o7lUsCB6fj6VcS7lv2EqwvbxRxmJ23AknOT+GO9J9hxZcsraOxsLhL2Dy3MzCKSOUKCcDCgD0zUDXMk0kItZWlmAMKoeTGBy31FaWs6hZTEWc8RjjtwAZAPmD7eAP5Z/GuOSK50y6do2Ty3UNuOSRuHb1+tKw3LQ7LQ3Qwi5S4jecTZWFo+MHI+Y10y3N9Zaal15QeNITORtAKOOAUboQOeK86fUDDDHLbbYoJnVTHGuWZlHzFvr6flXZf2/DBpi2mUS3cF4t7fIeeV7kA0yDl9btZ2ubW4tElkE7tFuGSSSMnPpisi7kxa/Y7WeOcxtjYFIyMZOW9AeCPWr9w8k9w9zbny4nHkxCLLgPjqT2yD19qwNLnNldl5yrgMwfyzltp+XFNCbuT2lxLbGSXUtwiYCNkixuAbsM9PrVd75xYOlvGWWOTKzZ2tGCT8pA4wfWnalPDJMkdxJO8a/ICnUnHuMGm6cZLa3nKx25tUcrIr/mOPSqFIQxPFo7/a90SM48tACQ565zUtg6SvDbzlbaF5Nr3J5MS8EnHsOav6XcQ3dhdeeypdGNYG83llA53Kp6HgDPpWTMElmfymklmZGZ0VOFGMDPq30pom/Qcs81tcsbW4V7W4kJDvwduePpkdRV3W70Xs0UtvAQqIqNg5A4x17VjtZmCzjt5A3zucMB9we/vWppoQ3F0sKExhVzCWy2z+/x1xQwRUtNKuSJZG/dxjnJ6Bh1FU9ReGO4jkiby0KZLSPyr+vHX6Vp3sqtatsdgoJ6tgAZ9PoQarixsntbhGuDcW8CiRZFU5PY/hnFOK7CkRaTrjadYyCa2tLmA5aKK6jLjOeWUevvWgviWceTfXOgaKIGYqjmEkqcfWsGARwx2v23iNCBlTk7c88U668plKQS7owu5VY9PQH0OKa1JK+pXn9r6sbh4ooGlITy4U2xqAMZA96Ku6tp9npqwSWuo/a5XCsV8rbjI5AOecHg0UWA5YR/uo2lO5X+VTnkYqxdT2hOz7K0RUYz94k/jUSmGWEg8TB8jd9wqB/OrdxeQvbOyiRSyKp+YNkjp9KbELd6iDp9paxSO8Nvl1DIBtJ6j35qWyV7mSE3w/dRxmXZMSokXPAUjnntWfGPNSMybAm4BpG7CrsKs7xwM73KIhG1QSYwDng+g61IETOskVyiwgopO2UfeRf7vvUlzbTWLx20QWSchZU2cnDDIA/qKVFlgieSC5g864ZkEDcMIx/Ec9M0QRyTQQywXTR3FuDscnAGDyAe3rQBDGkskzyo7MAC8gPBHqCKtRxtdi8eCUxwwJuCk8c+g/GpbCwurmwdF2LM0nVnA3AjOCc8jNVLWGFo3jMzxygp8hHBAPJz2x2HehjNXS9KM+lvcPPaxwSLli7H5MH72B1xms0wpFqN1DYp54kXZHgEls9x/hVh7yCS/ljG+C0PyKuece/tkVqNZQWt1FqEEErWwlULHcHazgryFxz2PNJ6j6GbpVqrX7QxK5yhONxRgO+KntQlvdM0kLvIhO0MMbSTwTjpj0qwEhs9SUSmZUlOXEOWZRnpk9DQscSXX2iOZ3hJIbdwRznGPcVLZaRJffavPe6LiWSVQ0sir69V9jVJTFHLGwjfynQMyt0xnqM9f61oreCK4HkJI1rgl1Y7Scjge3PeqMTyPd26zFZQpOzzM479PbmkNpm+s0ljuigureQMqnfGuTCM/cUnkcH6VPbXSSWwhZmLB8pDtI467iegPTGPWqyxLGwjSJXdmBbPDYIwDn3x26VoQ6dC3msl2qeXkTPIcMy4B2L9ORQ9gWgmnXzlmntoxGqPlk+9tGfvfnXbW05OlBog4CgKwJGAc8kD0PFcbaTQm5jgJ2RBCqrFgAEcgOepB710OlSyWsb2K7JY5GDF1PtyAfSoN6dy/cz5kiEEu/zBjeRgHHQU47BqXnM5aPhmilOXQn7xU+/rVNo84RtrBJM5UZwPetMh2t5I4x84fdGzDnHufSkjpsRalCIHghiZ4XI3tvOTycggfTrmr3hyyFyftS3H7mKX5ok5c565HoapXVnGltG13M09xvztA/hI5ye1PjQQNtjkiQlQ67Gw6qOeMfjQiGrqx3euiOezjjDRCFQQmxMGI9hXnMmoXE18ba5nSy4C73UgAevHciumm320c17BeR3lr5avKrZ3DPTHvXEXc96lzcXIAgDr5TKwz8hHX8emaUlzaMiFo6G1oHh+HXNDuZtHvlOt28hYRO2wyRjurHr7imaZqEqySR61AySEgho0CliPVRwT71y1hdzWcf2izkkhvIpi8Sj7oXHJx35HStbV9Y1PVrGzutaCGbcdlypxJKAO4/u9ulRtHRaobT5rX0Zs37vLHNf2saSzq3nbNp2wxrgbPbPXqa6BfiHetpVtFDEsqonCxYRVOM8Z6t9a5TSTfWVtJNPMEBgwkEo+SRHB4x/e7isXTsafGLqYCVGkClFyWjUjqe2e2K2WtmZtK1md5cC81CxsL+Vwba0YrvZQct159T9KoXuv2lm8u2YXZlQiMBSPvclcHrzxiuak1QrFchxcpCxG2AYZSgHyhs8j1yK2NKuNJ1J7JgGW/lbaYNmPKUd4m/vHpntT5h8ziZGlKgsrmX7SUvJJf+Pdk2r5WMk7u3IAx1rajaFdEa7MqeaikrEhKvz06dh/Ko4IbK/1e4t9FjlEMszJCJ34U4PJ9eeCa0b7w6h1i0XZJBcN8kiOwHzdCD/Spi77FGHb6xeaiga5bN1C20siYCp3x69jVnTNVbbE94zm3B8tpGPzYJzWwugWjSB5HaCOBikkGQfnB+99K3bmygFkiY+0LKnL2UWVJB4JyOgFXZhdWKk3iuxW+sYrFjLDBA3nPJHhd7/w++MDn3roV0q01GxjvWhKXiACQW4AjB9B6getVLm1tZH+xwQ2a3csgxNEmI3XAHTrj+RrpDpUNo8Meo/LEg+ZYmII9QQP84p8jvcV1FKxmQ6ZcNPCqmPOesmcYHU8VrW97dm6aCCTy9xwzqBnaOtEUjNCWhci33koAduAT0/Ko3d7dzJI6mWTkcfdGaY3Jy3NSCVbNIWdZVnuSS8jAEyAdAT7VX1O6ght5PtG6Ysv+qbpz1wat2LRxXZKxh5WjO7zCcHP1rl/G0M81zBZRld7pvYRZxnP3fpSlsZwipSszjtUuodgeNF8yOUiNzyPLwQ2foTWDfadGLLzGRXWcbpAh6fQ+h9K3tXD+dbxyrbrAzrETH8uB2z/AFrF1dVsvtcUJVbbLMsbDaqn1z29u1Ra2h0yZzDWjvNJNYweY0ShWDIWDA/dz6UmnWbIUh8n7N97zPMUFfMAz9Oe1U7bVpFu5blmeIuh2+UGXYSOmR1yKf8AbxeNKFnuXihVdjkH72P4h39M9qpeRyS3EhggWKOCbbM0rEv5mY2jBwOezZHT6VHJHb6bdXEa37i5mJjZdnyMB0DenAxkfjUF+7T2TylGecY/cyLwMHkD+L/9dQ63bTG0W5YAzSNvQCX2GA2eOP8A9dFmTdI1NW1F/stzHKqsZT9oWfO5lxwAD0wPUdqpW4jeyjW6V5LmJA8ZXgDuM+g5rnYbtru/iS6mcKo27pBwy+g/lW5arEjLK0jNIcRCJh8uB90k+3FAbm5pKo+kq1tcPOF3SXCEqoQnq/PTsBWbstUBa/aJLJmCsyOd7DqF49KztUimhh8iE/L1Zcdc+h7iq2nqwnaMW4VhkMJ84IxycdsUAX5J7i0hVbFbg2clyHhWbkFgPmyOn4UuoX13Fq0a2k1hEu7bJ5NvtjJIzyCDz1HFXfIeO2il3iVyTgI2Sh46AdOPWqU+kLcBZdMVGUrteEMxlBzyzAn9VqrEmVd6pcSRIC7lYnzEFUBVJ7LgdPepdIS3sZGl1OKOWCeAuCTk5J6EfXrT3hna2tY32W0dsSI5CAVAJyfc+tRobe4MitkqlwswwvXIw30zwcUEszZ1Zg9zvlYucRusRAcjqM+oqe0kjt7l47mW5KyR48+IAuCeQBnpzgE1etoSXhWx80naymGFSR15P1x3pmjaNcXfntD5ZHmCOWJmy4HJ4HfgGheQ9LEttA8djMLm4ntpWKNDEU3JKc4bLeuOlXdFtNPsdVuZA1yIngzHKuN555Bz2NVbSKNNFeR9SbaszK1qCD8vBRl+vNSXV2rslxZqsUEqeSYJOdgAGDu7knJpt2EtTL1gh2vfs9vjzcEgciJR1qnaatc2wIUxCOSIoEK4DA1vaNCZ7p3g81F2ES+mfQ/WsrV7crcBUQbk6/7I9D70RWlypMr6bpyX8sAkuYkkB4iYEKR3wa7jU7VfD95rl3BocUXkeTZaZFJGXFw7c+Zg/eJHpXCxytfXkFnErI5cBc4OTXaarpES6deB7jUbu+0SeGKWU3BAGeWWJf4SBwDVPVEHM+K7RYvFKR29slsgSOSaNBlY5WQM6/ge1FJrlmug3l00dzLLC6CW2M338SLn5v8AaAPNFO5Jw5ZsfMMnpyO1P2qPL2uHEnVfQ+hq3qg/ehTJG8iO6MydDz2qG03RzCRDtkUEqRzg44oYiSW7SJ42toxt27Skg3bv/rVNb6m0LwBQFSOIxAIMEkg5JP41QgHm3B808NkkgZJPYfnU7QxC3Cbv9I3Zc5+UKegHv61IEywQS2cMkVx/pBLK0IXJjI6Ek9Qe1FnbZuB9meNpBMEWFjgvx7+/FQwyRRzuxyiFccckn1q7eXrvffbCpKTR4dmQDfxjt3460AI4txO1xHFut2fYI3Jwp6lT+NWZpLJ7c/YraRWMoc/3VUjHufvVUE0cjztKIj5jAmMD7p/pVoEtDI8qIkTgtGsTbdpH8Pt60irEo0qKKa3a4nRbZmIYxtuIHrz7Vbg1m6glhEJYpDvSEEFhzkEjNZUgMifNbyrLJwGfKr/9etGxsGEaSB3LplFIOQ2f60mzTluTxSH7PJ59uWZpPN3Dhx/9alnvTcCKK4UghuMgjPtU8AlW3lN0xZ87NuBuHpj296bne3kzOiyP8xJPQAYCg9OetSMrx26vbyO8zxuM+WhAwfr/AIU/fHNcQMSYlCjcwGdvHUe2auaqkcFnb+QhZyXVmQ7lYqRg/gDg1n3Igtra3VnFwxYO6YKhc/w57igLGjq0rSrcywlorPP7iFf4c4PB/u9T6c4qfSYiWRkxOXbC5OdpPG0/X+lZZljaaRDN5to3zOpJB6YAPrjoK6LQ44I5ppY4sxPGxVAcbcdCT6+1JjXmT28VuzK12sgBIGxUwcDg49K3oFihmaZ1PlgYhAbn2z61V06aAzRb1AjZf3hVeBn/APV2rQRPPlIRRAQN6E9CvbaTSsdMFbcugyCIxCPymKhmA53n3p9vJJK37+YxjBXcy5wo/wDr1QuLgmAYJLsTkZyR9fan2Z85TDbFTKAN25sDHpntRY6NLHQ2gki3wSTo4K8fKOmO1VbqCNLrKBlkEYJDdsDvS2l00VtIssaq6YAIYEHPoe9KbvzNOltpjGSjF/O6E56A+valfoJmTcSyrsNu4VCQzqvb2NXrbUIrqzkW6iSGYvuErfMzDoFH+zWc7jyfMliJnAzLG5xuHtjpxTbRoCkpVJJlPyxRq3zBj/PrTS1JdNPcidks9dFtGY/s0pDbmUAOR0A9K6PxpbaZDpdmwjQu0248gY+XhR7E9a43WohbRyusaqitwz/eGPT8awNX1efVnjnu8KsShCsWdo9Dg9Pc0ra6mNSF2mi7qGq3zJNBPI9w0apEHkHzoAeAPUDmuk8L3OlXWharAt3HauXErTXOd+VHCRgdyc8n1rl73VLjU4zK6qJ4tqrIo5wBgfy71SmuLizSO4mCiVujZ7YxyBVLTYza6Gzcw2jxLeWk3kyx/KyTtnJz/KnaVE93ItvbZSJZN2QwCksOQp7ZHamwazb3ItzNBG5tYdrtPjBboCoA5FdBoSRNqccVnbJ9jmkXJCElDjJjJ/rRZLUV2ty/bi100CbS3iFzFjKTEq2T1YDpj8av32rXsEitqFusrS7WEspwYR/DjHWq+oSaZa3LWUguGumcs2xAdozjBz6YrnYdStftMp1C5YWm5o9kq5P/AAEDjNDVmap6XOht76HUIJ5Lu4jZ4l+R+Awbd93rkjnJrpfCmrpd5USvLCDma3LbQwHUKe2a4HVo9PsNQhhtW+1ae0aSM+4Ha7HqpHt1B6YqxeBZLstZecltHIofYeW9W+nTiqCLUlZHpd5LaQXT7bOVbNP3tu8p6eoGO+fX0rXiuFFpHLdeY00kmZCxyuewGOelY0epQP4dezvpbc2RiJRAoDFgOQMc5zg5qpp969xawIkodiVfYPUDrikp3Jim73OnluxBP5MMjKGUuQoA2j/69StbrqCedczSRAfOP5ZHr9Kw1vZvOknxEkwbbKpHDoDwRnuOtaxcQlQkks28BkGNqsuc/hTTLcX0GaxcR/ZxDE7C4P8Aqyuc/WubWWVrqOR5JDIg2jZnLZ/rWvfXqyajLczJ/qvlwWwTn+VYrvI7yzKnlpj5A3fJxSaNIe6jM1zyFuIbeX5UdWjcMD8hPeufv7yGfRGlvVmZVgEAEn3ndW42+xArotdilcSscIix7ME/xDkc1xc1xIujRNcxqxgmdIXTnDZyS/1PQUupnV0Rzx07zb6yhmuyIbqPzYhA27ax/wCWR/2vWknitdHufLE7PCRkkN8oycEOB6daqFZI4fsqoMN+8kyPmRupZfzrN1e5kuIFbc5jhbJkIG4kccnvxyKpOxzBqeoSJNO8Fw1wN+BPtwFA4Gfr61s6HciMqnmLMscZRN7ZG7qX+grBvpJb2whu1MUDTTMs0ikANgAfc9Dj86fZSgS3Pl26kgExOjbQp74z1HtTJ33HCziiuJmuTHKGZx5MB+QY+64b05rfm0y4TRYzCkToULl2HCt9fX9KyNPdb6VRewxwxRxiNCoxgE5LH++c1o30wh08zRyiQzOyJGnCoRwDj0PpS3Kt1MmWW42GFZJIwgV9shAUk+lWdLs/tTpdajM0kJ3b9pLFTjjdVSczGM2qQx7Vw7SIxfnPGfT6Vq3cXlQM1ncuHndN8TYVTxg4/EEVNg5upLp04g1CbyreaOCT92UjGGBxwAO/rVXVGcxt5Sy280SnhRllOMlTjoeOfrVjSt01/PegtHbRuzJCrFyoHTaRz171kPcO9/JNLMQ+7zEaJsZznOe/eqv0E0VGlS5EEyRzG143uBwr+h9P84rc0uwM0czzTQWiOjshlJ2vt42r64yKwtPzFGyiZhDdLsdCAA2DkZHse9b011clLa3vbdUEeTCsLA/JjkAj1zyKEyZIyCZYkb/SGzDGRln2CUAZIBH6etZ2n311YSvc2pKSPlQ/op649x61uatBZpLullNyJYEfYg2tAN+BGc9Wxg1QMiQX9tcXck76ZLlSDtEicHjHTGcfrVJE3KJESzxujvtkUiVsABGPp68c/jWrb2rtZxXMZSSGCTu/X8PSsWMBmCIQsafOMHqavz3DpekQ7IIZNoVAN2ePXvR6lI1SZ7a/MTOiRXCi4HltuGccZx6elYs13NcNKqeSqv8AO+Dy/vVzVogbKB45HFynyMhOOOoP0rnrmaaSHyMLsDZztxj8f6U7diWzd0+aW5iENqmZYgxEsa/MufU/17V6Hbpqv9nyx3Xh61urq8jja4ka6VDPIn3GIB5OO4615r4eM+m3atlZLe4Qq4Dbd6A8qfrXS6tBYanqE+q22v2NtazYzHcsyyW4wBtUDqARxim9BIyvGFjq8t1JqmuWZi3lVYxsrIrAYCYBO3A7GitvUXsbvT/EF5De7hfpBDBA4IaUx43TN6E4+tFFhHCSWQudGsZXieOONmhd0QcnqPck+prNkhiihZ4pSs27YIu7e+aLNbtk2wlzHEPMIHQe9T3kMNgEuLS8EkshP7or86Lj7zHpz0piIUhuDMyKCkuQFJPf1z9KhMJWJy6tkPsyDnPrmtCd4xfpLbnNuoXEUhwzZ6jH1pkkyi1t7ZEBKSSSyMxxnd0/QVIynJGi4dMHp8pPOfpVsXhYCFo98MfzBB2z1pUs8qzyjymK70Xdy3PHFSIm3EIfcVP8IHH40mVFXEjhV5SscbFfvbAO9WrSdrdpSpcq3IwMeXIOhweOOasxFVCiK3wxO4Atnj1zVyZlmWaRpEaXy9uwp/rD6D0+tRc0sQ2Nrc3io9xK8jNlVDncUXPQDvW7LC9pF5Vrt3N8oAH3T61kwTi08uVIJDtUbwx79Me1aJeQzwgBVdFwqk4CcZJNDGZ9xeSu4NvEFkOY3LjLMT1Jz1pyW6RzStC7SRTOfKYpw5HUD0Iouo7fbLJM+Mx+Ypz98E+3vWY7sYTHZSfNJhirMV2t3AJPXHfvSDZ6GhukYzHzY96fIWPygR559s9qffRxRzQ26PNJayjzYnaMKH7DHfAPFZ+m3kljGyNCJIZAQwkGQ351pWEFzB5M0tv5q7uAcEMvQ8igRf0fQ7aa1HnlRsViSP4TuA3ue+c4AH1rRgtJWhS2COqSTAAk8NzjrVW2e6t5Z7drdFgEpm2BgwTPQbh1qzaXn2i6RikiRQsNpAzg89B1/Gk2XHzNbVoBbbURUDL0MX97p/Sk0K5uLSWa6uI1udm6EbgSsRPQg+3OKpyNdXTxSMvkwq4ALPyzds46AVSuZTaXcsUbmWR8rtjclVPqcdfpUXOiNram6nk2sbmOVgrLli3Ueop2nJGCQWuFlKtsKJncSOM+1YiSXBjUyrFIsihyu7LYHp/hXc+FJV1DRDNbDdNBMAhHfOMEkflUzfLqXOorEsenfabcXfzRWhVSkLj5pHx8232BrNvQtswQxE+Zj5zwQOxA9q6O+u7exaANJIoZwNofiRh1Cn+GuakkFxdvIxNuZCWUZ+7zkVUJOWoUpSm9RRdi4MbOIzsGMgfeHvUCSQ210jiKORVy6GPOVHpVyO2SNTHIhErYdX6ZBPOfam6shjKug8qUNnYi9VxzWjTN3Zow9fuJNZuWufJEcKr+7DEDp3IH5Vg380IhIto1MsnDL3b1BHatuaBktVYuMyLuEZXkg+hrmr8ReY4ijZTnCnHzfjSuzFpdCrZpqE9ybWxUvvG3ygcbv8a17C38sRzS2wukjP79JT0I7D27VjeUxijdSWkU7QFypP0NaIkurhJQVdSkYBWY8Ljv/wDWppnO4c2xduXtr3zEs4VtkMxZoM7tqnsG6kZ7V1PhjTtQe3iE1+8FtG3m7EJxj39O1claQ/6LGyYihK8OG5Y9/p9K9L8J3Mp8PC1CKI5uj4DP7gepqb3M2nHRlS9mtIr+WeGHzJ5VUFR0TH3jx3I61vReFLKazutReOJGmkxKciRouM5Ve2RgiuL8TajcaTbBdMBjVTtDnhlPcmsDwz4pv9OvXkXdcRSfLLDuIRiPfoDWftL6Fqm2kdtc6dYLaIIXUzpKAYkTl0wTnA71BaXiqBcuXSJVOQoGQTwTt78ACoVmF1bvMYRaxun2kFH3Nx1APbjPFZ2k+TcvPewMYpW/dxI4ySp7getax0Q4JrY1oI1vr6FNIeS7RR5khI2gAdSD6D1rrdNs5LHU7YKn7woSoUYIGM5Pr1rK8OW1xY3L3ktqtpMkbLI1xkfac9kBHB9MV0mm3Fva20V9FLMy+YAZTkkMOMc8dP5VXmapsdcoJbqUtiSN1wvd9w659q0rWZDYFZJv3wA2jHzBewzVKRnuDE2wFpSX8xeGcZIzjsKbcxpas2+583YoVtq8p2H1NBVr7ixO3nzrsDYclyR6jgfpWXdSrFYzQSTHEQxGyjqWOdtXLi68pzNAMIE2kMep965TUJo1QxS4WIYDEtj5vYfWgppIn8QTzXtqqJIsUBwkgXk7uwHfr3rkoopo7q6iJmhtjGbiUbd0eQOCR2J9avWkz2W27vHJhE2CDkFUBxn8R0rP1nxQJbD7FBKsQKvGzyDBAySAx7nBFFkzklPocjeXEE8iz3a3EilsRsCAwOcc+vpinWd2oSVPLE1oZRGRLjhj29+e9V5Ps0OiB7aUNcHiTLcqp9RjocdqWG6nuIxDqLxuxZYIrdFWJcbcq2cVS3Mm9BkcDyakBaRtP5iFzEI8GLHUL7j196vWUW9rkMzxQBNx81gCfQD0J9R1qK2ubdbK8EzZQuJFKkLs7EZ6gZ6jvUE6SSRSXUUqhUASSKZwPNXr8q45ANDRN7GrepZGezi84XVvtD4j+XIByVJ9j3rMW5BkufIkEUckojbIHyZbIAJ9B1IqPSnnjmlgt1WN3BXdONu0ddoHbrxTdMsEllmln3MYwVjUcZPfcKlblm1q0f8AZ1m8FvIoNzHvY54dFJyUPf61T0YnUQxUMsdlGHk3N/CDkfTmoIbTUGjja3gd7WLKbnG6OIHqW7ipgI4dCulhl3ySSpH5Y+8QMnAPQgHr+FNrW5PkaFnfus9xN5gitIoPLQLGFZtxB/HnPPpWLcWm69YxTIfmYE5+UAep/lV7c1y1ukEEn7wiI+axIYgf+O89Ktz5uJrOOA2y2yxqmxFC4cE/e9T70ijN0m0OJj58H2ZeRJLgYz0461nXV81tcjbIpIIVmUcDnrmtaaOzh0qWfaRcwttcK+75CTk4PfpWI7reWphb5XLb/lfbuI7keuKaQmyzaXMoZ7oDz1TMsjDDFBnB3Z4BPUCoNaEFybeRLaSx0+VcKu/fnJGWz2yeaZc20lvpyj7SBp7/ADOynCzSLztx3I6VCLxpbZkBU8YwBkkZyMGrMtyxELrT9OSTyI2tZJHiRsg5K43Y79MUj3D3VxHNIk0FtAcb40BK/SqthaG6EuZ/KMZOyJu/GSAfWpZLRrLUFUXMTKp5ZclQPoepFFiua2hHfXMl44YCR5ASHjZckL+HtyfSp5JyNJiS0jWKAOHzLyZJgMHB9MHpWhps11cXt/BpjNA+pRGE4VT5idSuT90sQOBXPSi5a2W3VhIIlJ2jkx88j9KFoSy3p12uG+1qJS37tR90ISfvA16beXF1ZTeINPi0qwQ6fHDPbK9qH3wkgEgj72euR0ryW3dWVbdlXzGbn5soe3Fdtc3uk+HdQS3m1HXXv7AeQZ4WVQoxkquedvPFO4jP8aGS68VtDNL9mSSCOZY9oUQ7owQmB6dKKwfEtxZve/arK5u7gTHe73RBkzjnJH6UUDKVtd7YYIrKNzN84lCjJkU4IBHfGKm1lSEsCto8aSxY3u2fMfPJBH8u1QRb7JIX0+Us7KJJDwGT6egqG7lkJKSzny1O5Ig24An6cCi5JBzJIrFFRQ2PlHT8a0QPLtiq7W8xiArLuI+hp9ndy2sEX2KRx5uUuI5Y1I3e3GcYqW1Je2Mbxl5EbepB27Rjk0mXFEMMrR2jr9iDfwmZiSVHp7Vf02zhaFnQ7ZAdwLH/AMdA71aTfAkbRsBCygzoCGB64Ofx6Uy1yx2lW8lDg8Y+lQ2aJFvy1mBCoyqpO8jpjsAKq3DpkoEZTty3HXHSrZkRY2VCCn94sADWTdhorxlkkWM5wNrbgePap3GaUJnXQpInEfzsJ/M6uT0xn29KMiawnd7lVn+UKu0lpDnkZ7cVTuWjhgEJKkyKN20/qKW53fPLdOHd1GQOMqB3x3piuQ2lzHHLcG5V32oTFGqjO73PYDrVK3uDbPFM8aysSdwJ5Yf3T6fWrN6sUc0cFpMsqbRvlQE9ecc8nHSrGnxpJOHkWRVwyiRDgqcHBPqM9qGw30Fs4BeOYoWdYtuAvUKfTNbUNv8AYkCPG0aqO5xgd6bo1zbxXCBolhRwQxQ/KXwcMR1znFVHuXv5fLuHDbnChezn0zUt9iki1BcW5uAtvbMiySiQAvuJGOFI9Ca3nVopyshiG8KxI/hOOlYkMcNpdhrgJ5KEAmJ8knsa6M2gTT1ldldmPmM2O3pS1ZaaW5lyrFIZtkrEIoYtjhj6VnWbRxXsJbJ2yEs/cnHX8K1NSgW2sLCaICSKfzCoU8Sc8/lVbe3lW52JF8hRcqBkdznrmpSLi7oNUjXyibRldXb91k4YfWmaDr2qaNcLJpkzRRsQjROAUJ6nj+tN0sxX2pRW05WOMEjezYU/n61v/wBnIJyLNGljt325hHAY9/TFO19yudbMiv8AU7m6MeoX12ZJjLlI0XaF+i9K6exELxC7Eu50XgsuefQD0rir2ZV1C1E8ZkCtu2MPlHrnFb9jeEQb4yw8xcBRjC+//wBaiKtojSKbaOi1TUJLtlvZUjCjaigLt4HTApukuLiSa8lmCSR5ARjy1Ujan5I5ySoj3kg57ZqO2EiyRCZRtdeCB2/z3q13NeVWsh2oRCSB5QGigHyrIPmU+ox1FczqSo86xSriFU/5ZHILY6/jXQLIyfaNrc44Q8gj3rLJmvLxIoFj3HGd3QUmTbl1MpXgtVtU8tnVRuZT0J6fhTo7bFwqtIiIwPlK5OTnsTXUnwddz2uoaqsXnWsSqW8r7vXBOPUVmXUVrbO7iXf5cilGI4YehpvRGKab0IdH0qC40C52Rt5vmeY+JB+5wccDuO9bvhe/bTr7y/OiMIctGJMquSOcen0rJurEkpc6QPLunYs6h8YA5P4dqZe6lq0sQe6sW8h3+ZopeM9iOKw1+yhKPMdT4y0u0u7SJ4Yj9qkOevytXDXel3tvHDZzxugRiQmcLKfX6iuk8P6tHPbM13FNmNioUtjB7GutuNOutRs4Z4ZInijP7tZAC0nHzHHoOmalO8tRJOBx0tuIrK2haUyZOzYxwU9ce1bGj+H7n7W1s1jI7KyqYQdsu4jIKj06fhVq50W8VfO82JCB904Cqvt6fSuk8DaraWE09zJuZ45DskkDEhccHJrdNbsHJ8t0bz+G9RexjEsUhGAyeZJvkiPfI6DPoK5WG6jsLyO2KAKhJcOvG7J6g961dV8WnUPMe1fy4S2fPiYsz/4fSq9vare6VeTRzOLsHe7Sr9/jgmq54y2FFuKvIjm1h7CxuDblMSgKXYgEDrtTuOtJHdy3Nn51xAkLPhwD2CjAx/j61ztnsuJo/LTYgbaN56v3HP8AOrt1G5Dx+cu0EgA80jrUFcSW484LGjFCTjcPu59c1X0aKI6rI87Wl0/2bI8yPeitvwV9mIFJE8cdrc2wj3vNEfKGcAN0J+tZunLPaW3mSxbI2iwVK/xDjJ9OckUJmdbVWOU8f6qs13dov7t1yGTspUcKvr9a5/Sr2S80ODTJvLjtvthuZ5dvzjICjn9cUniqZZ2EUlyjJHMzeUVwMkYznvWXpdre3UxisJIkLjcfMcKqhO5Y9KuO9zgkuxs309te3RtdO01nlSYH92pSSRDwFI+6fXNM1W3jga5gvNNSG9hjxuSQySA5HEgyRgDuKyRlJ3kuHaSV3whic4z3OahW4ggvZTHKYSvCRx/MJWz/ABe1UyLNmtaraXFwkjomIFDHI2jIHfrk59Khg/06F5nnaNxNvVTkkoeCoI6cmo1kuYEN/KSsUysruny7w3UY7fWpdLRJZbeSyYxEuZX3HIhGcADPUk0rlWsaMumXENiJikk0MjkJK4wHwADnvxV8YlaKeOaK2uGOxUQ9QQAGP1GeaW+kju76WLMtwkvyRtLJsKnv04qv+8hQQ3Ox4I2WDeqjcuDkj3z7VDuWkMvr4xGWHEUyB8swBB44IyOCOM81Q8O2SSzfaFU/uyW2nhTz0x0zW3OEvryHdD5NqqgtHEu0Ko6MfU1LB5cEFzbRgtMrs6gcdcEZHehXCxLptjOWkihXMhXzDHH1AByfYCqyyRSXwntopIkDb3YPuXd69Kha9s4rtoVDR7h87eYeDj+H2J9aabtp4PIj3Ln5ZGQZCqOuT+I5poGyhqMS3wiYpJCcnLN0YD/HrWHeWkX2aS5M0TAMqpEH3HnOW+gx+tdJO+3TnM6PgzfI237uOnHqa56W2t5I5LqFmRhIQYHGOndfaqRDRBaQyXskTNxCBtUOc9Bk4H86sTeeNMmvEsreCxkKhAuAV5yMZ5yepqK32GaSaQSi2jXJXIBbJx+FXy9g9mm+6Z5Au8W6x7U3Dtz6jPNUoszemxUuoY1uBtUWzQp5jSO2fMJHA2+uTUsF7bXj20YTILKDHtGQ3cg9SDVS7jEUh8tBtcb1Zf8AlmGHQVq366VbM9zaNJbTLtaNGcFkJUYyAPUH8DT8g2ZXePy/MCIImtmzNIj7l4PBA696zrkJHDJJaXUSlFzgcM27gqBU02xbG5mjVGaZlywJ+TByR+JqnbW0U8iySs1uinDy4zyenFFgbuRaDDI2ppFHbSXLOcCOJdzN64969M8WDXo7ll0zwxZ3Ompsjt5ZrIyyFdoxuOc569a4Tw75dvM97PrcujzwtiKSKMuSfUY6V0MUNrOxQ+Ob5nf5iTFLn8Tmi+gI5zXkmk+0f2lYrY3/AMg8qOPyo0UDrt96Ks+I4LSDUR9k1GbVlaNd0kobOcd888dKKQjl4XUsyyMV3/Kzg9vTHpSzxeRIsayjyx86tjGR2NQQlftKlozKgOSmcbh9ameTlldQVKjAPb0H4UCNKe5aW4Se5yzOo3umBk+uK0LaVN4leItEowB6k1z5KiGN1J3nlg3StGPzQ5fcXUYCgjAGRSNVoaYQpbxGABHBzIOgx1x7/WpY5pVXyoIyzPjbu6ZrMu3kJWNW+QgHGcjJqT+0XtsPDOoliICEDk9jUtFGmJba0iuHlcm8hwVIUMCxP5YH0ql9otFsYZo3X7VJuafKcRLnjb6k8n2qnLa3F5OJHfzUaLztyckD39/atSyhsrex+xyT20V3dOqyTy5JiXbu6DjB4BPXNOxPMYk2pB1EIUeUGyCB83uc1HFIUkYxbmQAjPfFa+j2FrGy+ZueTmRgrDCIDjPPfvj2pl5PbLeXP2bdGkieUoYfeB6vx09RQ0CkViHg+zXEKKXmbcjBtwGDgjb2NbkMUEuIX328+0GPPMZPof8APFYljbeZdKsDsFxl88fP0/Ct6GHylyQCecAjgHuSahuxUVcaLJ5GjjWM7gScg/eH+FaGg2bPebs7Bn/WEdD6j/PNRw2zSJAFkLu+dih/m2/0Fb8eltb6cjo8ck6gsRnoPcVDZoitew4STyY9ylOWx056nNJFqczaeLDePJik3mNF/eHj+E+lL/ah00Ot5EZ3x/q1OC24ZAHfPNY8E86Q3SXNivlyg4G/Dq2cj8AO1NaA9TS0sJPbXNpcutp8u9GfluucegyajdhJG4uVZ9qnDKQBgelVtKfF7PNb24M8MBlAdgwcfxcHvgitLUmVtMgl82PIBV1VMgNnIyfp0ptCi7MyIIowJtySM/lhI3Xna3GCf1rb8LaythJNDLMxSQ7SjDaQe3HesnS1llnmuIcRiJcnIJUfX8M1pX2lxNOrlPIcgZdhlW/unHWhLqacyejEnRXuXkjVwxJKr6A1es4x5BiuVZXwWjbGdrehx61VaIWwTzNwkzhnB+Vl9atrcxwg/ZSXP8RAzj3oSszoUro6O2kjkiISYIVQKFYd+4NWmszDY7rgo20ZVS/btXHNdRS3Iit2UyEZyDg8CuhvL92sY45CjbVBCLnIPTr3HtTUlewO7ehX1pHhSFpHVd68IP4EPYnvWLYyAX4bIMG5Y2PXIzzV6/OwKJAkvIw6knjHNYriePzSjrsd/JZFYByCM8D045NTJXZcvhsev3+qT6b4fEIw9lu8xVBClSO/415jq9xFeSXFw0WZJWEqbDgKP7uKz59UuljEc7LLGp2lMkn2q7aW0b2QmmkaO6aQkfLx04A/xoimlZGKpqI7T7O43NeXdyQR+7jizjKmt/TrcXEhjkk8sKeVzwPfHc1lSrK8SC7bMu3KoDxgev8AQ1ctYJbjMyyYhGAJVGAP/wBXNOOhoo9RzwXVtJciyMMsDncwkU5U9OKl07UL+yjaOS1jlgOfKKuVEfqPXGeauRr9nUoJ0likBZGPLccc+ldf4D0vS9St7iW/hYuh+6T8v0zUypQbuOc1BXaOfstSupNKlLW9tG0jbVYsXH5HkfWuY1y51OOCOMtK1uZNy7SSGx24roL2SEX9wkcYVfMbaiHgc9qckcjzRRvId4bGOmM+n4UnHSyHC0dUZlhqNxeviN1lu7hgQuAuR6EDoa0r6a+sZktdSSVJQQWhBIJTqOfeo30ubTtRLRq1vMoHlyQgFt3PrUM120c97cfaZZ2TBJnOWx3I+lKMeXclpN3J4Z4IZpXVBCkhyYnbdt+lak1xatbIY3YLgM5xyD7eorHsVinth5w3sz+ZjPUCr0cJiDtbMvkyNkDOdoJ6VVy2lYrXssfnRvZSFriNsqGGAQf5YqpqhCWl66GQsxI2jPzdMk/Q1tGzjaKRgCjqD82MAEetJe2AkjdreN5d6byI+ijHc+/pQjCb1PHrq0srmKeaWWSPsFj5y+elRWOkQTNdXLt+725NuGKGXucf57GtHUrcG4/dn5XYlowpHzZxiqc0Uf8AaSCEsio4DeSvOcdME8nNXFnPONynbX81vDe2tnC4WfawiK5CYyfkJ5B5/GoNFsLZblhOzSs1sZDHGp3KSCNp+nU+1XrNrh5JVUiBWI3yIOv1961f7Mkis7txcKybVBkRt5cNnC59KttGfKzl3gMkkZLOU+66A4CHtj2rW0+1jE32OZFF0mWjAIO849emKzdQt30uQy53I2QncA+mPapbi8jk1CeeeI+VNFl4YTs3HGM8dOcEio3Keh0UcqWOnoJII5ZgAXKyg8jr9fpVdgXtFnt1BRyCxxtjbHYD+9isqA3Labut0DRb0ALpkgjOdo7r2qaWVo5Y/MgWBimVijJ2dOTgng8559KdhI7DS7K3u7pYrd2dNocujfKSfXPOB0x61Ugt1u9QvZkZYpYpTEsQJLMEGCRnvnNZOr6vBp9tHDZwKl4qASXIJVpQRwSOx6fjzUmnX8U1taRyCPz5CD1GGHfPvTQ2UvEeov5MVuJJNiFmECYABJPDEc/maraZcWq6fszL9raREjTcfuc5Vh0OTg/rUWoQLE7EN5V+XEgXA2lOufZunFUZ43tpoyAjq6b48tzyecgdDQyb3OqvzJFpREqTKYCQW3fuzKTnnuTjsK5eOYmRZbyLAkVtrN8oUk9SBW0zSy2kaZLyhCUjTJKkfxD171m6feW8upXM2oTyMrgs8wUMd4B24XpzwPbrTTJZnSRx7LjMfzqBhs/eGeCM1LqkFlDJAts089qqKsjOdrNIRk8dlBrRt5Gvp7R3jhSG2jEbY43gH5uT/Fz1qldWgupri5FzEFD7IoGk/eFQcD8h3pklODzrxYrW1RvMjycohPmDrzSNGZY4HZxgcZZsD8R1rRsr5LLWUmh3CCIFEWQZLcYIOOvU4rO1K0mRY2PywN/q8PnH19DTFswjlSGSeBN1zAy7WONo45BqOJJL+OZZJI0MCBljPG/noPwqxFBAUtmSYkOro8R424759xUKqIolaDYzru3sTknPGPwFNIRd0jS7nVnmXRohdCFkmdZHVQPY5IyM1uweEPEEe64bT4iZMsEEycEf8C6VgeG7WCbVEjvSfJEbFvL/AN3j9cV3cNt4c0GPWl+w3l4+niOC4drjlg+AXUdsGgaONubC6tUu7a9VLe8iAdjuDZB5xxRUni2C0sNRkttOtwtsYo5Idzkkoyghsn1z07UUDsjkPPJiSNSFJByacv8ApNxmRvkzlse1V0RAVy+Mnkegq/p0DTyLFAC8zkqq5xkUiUShYPl80MY3BCpFy2R0p1vdbbiMlCU2hAjNzntz2qoyeVchJJSkkY+br1/u5qS3vPJZy8ETyHhXblk+nr+NFirk7Tv5bIwCrkkseufSqYAwCAGIH3ehI70/zo5kk8zKk9Nq5/8A1UW7efeMzjLbGPT7uB1wKQN3LtrK9rJF9gbyi6iRlOSNwyP0rLn3o7YIdSc7vf2rQESQ20NxBNIkjD5gVxj1weh+lQTBR50boMMoMeH4U+ue9AWEsCpaQLHLM7L8qqcZPufSrK3UpmIuISoHOwrgk+metR6ZYM4LiR4mVdyugzgjpWrdRT3MrXD3AllblmJ5yB3pNlRgWLWWW2SSMQoJL0K4Vfm2Dtz61pRMIUdYnEk0nyp3CAVW0uAFgryFEyBkA/M57E9gKtzRKl8qJua4GRJCFKlMHgD69azlqao19M0x45GLkKdq7GU4+fH3sH24qXV7xLS1hlSZPOdSrAcHAGMEH3rNe6mkKz22I5YCAIjyTnv+FYGsXhnu3admkL/eAOCT+PQUmrgnYs6rqqS6pBdeXLDDEcqSdzMf4iD3/wAKuWUz3EbXN6vmbDkx9AfbNc+CJY4wqkMrAA5wB7f/AF6vyN5e5GwBEQZQrAkqw4bHcgjBFVyibsCz/dZRIpRjKjMQAB/dIPUf4Vq6bdKlq5liKROdzXPQKSD8oB6/0rCdEuN0wk2xAYVVAbH1/pVm7Zby2sz5qHYhRkCENyev/wBeq2J3NCOQWrxeUjBEOWYylt498cGtk308txDIjkyRp8gdgwHp1rn5WuLhYBbOXkKENGBtOFHr0OahtArXgiu33osb42jDZxkH8DUs0sjo3d5IyzIXmDGNlB6E/Xsaz5Z/s8kJWRtr/wCsG3kDoRjv61ZsIppljLSybW/1gByc+/tT761Zbm4MZTfFk5/lgUm7GsNRsTx2lzNM0MsUMiYhBHPP8R/+tWj9pidNyZD8HA/h4qhO908RM4ExCIok/urnoB0qFvNgvJgvAJx8/JwalM1joXrq4wh8whs8/Ie5rPtHuJrifCBSznrzgYwMfhVCeaZj5LruAO0EcZx71YivxFHGyAtcLxhSeOehpoqUtDQsohGXjZfM8ss5bHPPWrlqHS7lWIow8oHr0Geo9KzIL8PObhZmWRgN+RwAf5/jWzYyo0suJhJHbpugPl8vk8qD+vtTXYHNbg5mUxCdS208Fuij6VYtNSnt4LqCPZ5LEMQev4GqlzdyyJGzbipYEjuo9DUkUcSMzHEmQWwOee1S1qaR5XqaCy+eysoMWxADn1P9cVox38lp5n2C6khBAVlXJyfxrMRZUjjEoJVWywHOSe+e9WJWaebaEBcHBIG0e3HrTBrm3EeedZlZkLhyMgHk/jXUaFbi9vhcv+6jT7gLfMfQ+44rEigVhtEgB6ZYYqG2jlj/AHlvK6mIkbs/dz2qeuhM1zLlPR/E8dvq0RniKoUjAJB5JA/nmvPTajeSxzKUypP8ZB6Uha88mXddSncMsob86vQ7WgjRZizMu6AH73uKq99yIL2ejZJKrG1jEEhjdf4hjkfWqs17csfKi2RT8csv3ue1P8preWTdKiowyYzwoz3/AB9RWfFdWUFxKLueQnhkPl8n1TH0pLUU5K1x19r0lm0VnLFNLLGczRykKCT06deKry38iXwSKV0WRvMdI/uhyOB/u1WvTaIWnibfDIDv3Lkx++fasrQDkXMxOG37EI5CrnjP40K6M3Z7GhqsRhdvMWQFjmYFBhOeq/j0NYaQrNqF00UsaIVLDc+0qce/fviuk1O/mmnjnvJzK7Hy5MgD7vTHtWfrqxrFPOYopoCUKPkAt7n6d6q6M2UbW3lhtgYvLPPUrwecHPpUMcsAZiWP2oHbEc4DtnnI71XF1ZWUERuLnYPKLNGFOHP8P+TWDe3F7Z2sMxhMV5MfmnZssEPTA6L9e9Va5nKVjZvnj1N7hJba6jniJaLAG0t3znkD6VkKk1rqCNbxRs5UsN5wroRypz171sWF/wCUzRkLDcyJsCgE7Xx6nqT+lZ9zZyoQXHlzMNyMGxkj09DSu0x6SRLbalam4kbm3hjbCRb+gPI56HpUsoeOzMt9H5zBmKFfmCbjnqO/FVdJW6R3aPBWRMPhQcHHBx0/GgbvK8qRRLMGxs6KpPGTj04ovclaGZrVx9quwwVw5KswY5yx+8c9hjHFOtZwLm5mhcKkCnYWO3a3qPX2rWm01ryK5kWWILB99y20SEDOB9RWEiQQQLLMC6NIQApxxjkn6HgCqRLZYnuXuLNnDcRsHaZ8s7t0AOev4VZs57Z7UiRXaBJFQSMACSfvf/WqDw7fC0u2ltVBK8qs4ypPQLjsferdwtu9ssTq5liTMqEAIshY8nHUY6UxI0rOcwWcsVnGZANzsx6onTPt17dayb8jUo5hEkjSxJiMqgCiMcHIA699xqe5to44YF3IHZezZBHX9KXSv3bSiPzAhjaNn+7nJ4JHpSuXYZbxzS2/2ODcTKVRLeIZ3v6Y65NK1ikFxKssImlUGNo2PEbexHp0+tXpFijmSWGWQuVAa6HDAdCE/u/XrUN60WlwXFpaXYuoi/3kbAkGOGx1qrohxZhXFu0csSSbgn3sDrjPUUSv9ouViSdmgViRn72fpVgotxEZUly+0hQR27kVmDKuACARyMUCe5c068azuBIhUCLJJcD5h3GDT5VGoaqXi2QtNJ5uFUIoBGcYqbUBpc2iRvbWbx3URy8kkhd5z3Yr0VV6e9ZkfmebFKYgH2E4zyKq5O5flt5YLYz7CqvgMVyM57AV1F1eXukeJLOLX5tNdr2zSG8Ei5QD+HzsdWHHIrnL24u5WFxcTyXEscaB9qkomD8obsK6nVLfT9ZvjqF/puvWt1NtaSCK13o7gclSfug+9FwRzvixb2bVrhdTWJLpSq7Yf9WEAGzZ/s7cYopNdvZb7Xbiae0ezTYkccEgIaNFUBc59qKQzkBK00UduSvB+VscnPakkdgoBRBg43Yx0qMho3RkIDYDAqeh9PrQCzZDk7gc9M9etBBKUbMbN827k/X0qwsC/aI1LKUfHzA9PX8qrGV3EacsidMcHBPrVkXAe786OBFG7HknkEd6BhO0YZ1t4gASAc8nj0PpT4iFlV0GHThxjjFF/GFdmMKwyBz8qtwPbHX0qOOSHenml02LmQjkuc9vwpDRdLIlmIMnn5pY3GGRuwHr9ffmpvstrPb2yfa3EmzJR48At2APf0qnNBKL6SC186dGYOjFf3jqRxxV+OJy6PblsMdu11zgjt9aCkWNLjhVZd8kqSR8ARdM+hrT0+PLLIyodz7AqofkqjZR+UxWbMSsWQkDkN0H5/1rXtprFNNtmCCO7jUecCxxJyeR2GAPxzUNmq0Fu2l3O8l1wAA2EAAPQAj+tY891cfbVzuQL8jSKecDr83epr+78zcsKsZS27Gf4Bzg+vNZUMq3BgjklkCElHUr0Gcll9TSWoPQ0p7qMW8qRI4Kt8ixf3OmSc9aw3kkmmV2Zwqn7znJrfjjs4tOkEShHh6zE7jPz90Y6Z9T0qlLILlBcKFQBSqxqmcr0/P3qrCuVhM1u6MI1R4zhdwyD6E0xyTBNdSlQXkA9Ce547A+tUyXdf3p65IH8qvri33w7I5PMQMxB3ZXGeP60WB3LksJsJJWvomhmkVXijkG3HQq3owIq/HqCnThIYGTzZmAklXC/NjcoI7dDjtWGbprtBHdzkLHGEA7HHTjt74p8ktu9jbxrFK6plnUyYQtnggfTrQ9RbGhcpJDE3l3W1F5YZJB54xQl2kkRihebYwAJYLktjnB64qjPcCa3UJsiTfyuCT+B9K1dMin8sPIT5WQwVMc4qWXub+lQma0fzJZI5FwNiDBKe5PStSCHbCJJ3Ds4O7AwOOgqPRUNtaktudy33HXjr1LfrzV7z0aOPzFjc7v9WmWJ9TWe5vCyMTVpY0jJUFAeF9KivZlYLdvbMsT8hg3XAwRTdYkHmqpjkZImztdex74qrFExiPlzLLCTgornIB9jSG5pMdp7YtpUcRuxJx5nIO4Yx+uc+oqsLERP5atIsx4CHrnHrVm61S30+Frb7NGJFGS8w3sO23ip4rmNtLeXUtnmtjy02H94noD2/GrUb7ke05TFujDb5FvM67wMKwG7Pof1q/4Z1v7LqQxCssRBBEjfIT7HtWN9skS4/dxBI2JiJbDEA9QD2471JapMI2hQRhMcrt7e/qRxzTtYlS5nqdbNcJd3jxEiMM4IYH5S+OntxTtIuh9oVZzlY9yoR0euThuZ7hkjmlfy0+Ykcnjp9f8K2NHvPOuP3KmQq27aDjbjjtUM2TsdNNeu7QI0oQom0Y6gZ4Aq7ZKRPKyvJJKRkfxfXpWQ8UauECgy5yA2Rnd0x9OlbkSeVZKMhWTjCfKQf8AClqaKRaEztA2/a0asVOOG/GidJXR8tGsbAZKn7x9/cVTiuWigkDSAsc7mP8AP3rOuNQ8iY7dsSSjOzJ+Y8DqenrSJcjSsLgbJ0lLGTkFQM8djntUF7MLJBOjOsu392R/D7Z71lTXaRbmVoJyBneUIJJ6YHeqF2bh5Fia7SLdF5+9+h/2f6AVSRLmW/7fiuAYrmEXEigncWIAPpgfzrMvHVUE7uluVYMqbidzZx8p9PWqdnAk8kl0JViGf42G1e5JHf6Vq6XbsZJnvAZVlIEaqBtGBkHHaqM27mhLcC5tDMQqSKoUoT1Pf5e+ahtEmR4VigPmFHk28bnz0GPpzVf7TP8AaljVleOZMONoMhUHoD2YY4NWkkku53kZhI8IG1XOGPPBBHtQ0Cl0JVt45o4jL+6UEtn7wfI6EHpXK6hcpFqUgnDCN+MFcr7fhXW2t5HEYwmxWGWIClgf85rNu4XuFM7whpmb51PTHpSQPXU4HUL03U7KeI0JYdzuPqfStuGe01GC0NxcfZpbNDyV3CUA8ofQ+hqKS1ij1R1ZsIR8p2/fHsPWszUI5NO/cR2yud27zSxyAf4WXpkfnWkZWOecG9i9fXiS6mktrvEdxLlCVGSPQdga6aSGNGi+0ThpDGQg28J6jjv/ADrl9JsJ40E+8FwSyxDkA46gVtvLcxaayEK6MwkAxjeR3z14pNjimgF3NDEhtI8RtlpGYAlR/CPTk1Ve7gNoss427VzhF6P3/OoRcxxpPbzxSeZNt8pwdo29SCnIPPTvUkdxY2ywrdW0hgYMp3PtCE8Ej6HnFNIGyvqmoXcNq620qG2nUCRVO4P6DHqPaoNIt7oTi7aNPK2fOGAZSp/2T14zT01T7FrCBhFKiIYi2AQU7sgPQkVLp9zYm5tp7d5vtjTcSSMAgUngMO/HWqVjNlOxjjS7YLaSqoztR2OcgcHPtV6N0hCzs5XJ37QoYNn69DUlpEJtU8yJTNsbYpQnLyZ+99KZq8AgjaQTIbgkgIGz0P6Umy0tDTDyXd8Lu5ii8oLhRNyuCOAQMVY0e0L+aZ4SkYZjuKkEkjp9BVHSJvPtDaldsoUMA3I9z9fSuvtlla1MspdpVyx3H5RwMAUr3KWhzN7bvayeU3mCFzldvWszUNKdTHeQyQSK+eF6N65B6Guv1pnkgjIH71Bngcn1rmXbMD+QMyK26RTxgfT096IiZTlZ7kPCYlg+bapKhcKBwDisq+sJIXKTuse45A3A7vfPQCrN1eXMMqtIhQuMr3+U+lUpJhcoqonlrGeMnOfWrTIsTG3lWyuJZFaKZ2RQzfKCM9Rntx+NUFvCqyb2LyMSWOOpPpWrdBtSljt2vRKq7Va4l6RqB0+gqgLSAW77pmNyJAsUSrw4/vZqr3IuWAJJLOZbWaZLdgvmoxwZCDnHvg9BXeXxj06UQXvjjWI5wi71EORCSBw3zdRmvNN15aztExbZE4crngN616LFYSauV1PU/C873lxtchb5IUusDhtjfNzjt1pAinruhpHdXMv9tzajcWojN19pjw3ltwjq2TuXpRVTVNdDQaot5ZG21O8dIJVOQIIY8bYlU+45NFIdzzqAI0mJGwuDkjsakiUFQ7SlAx2k96fbsJGQTNiPO3AAB/OomQM7YYbFODzzimQS3RlgUQlcZwxYfxjtj2pI3IJZ16cDjpmljja5mVIFHC/KpbAPrjPepJ7jzYoRtAKIEOB973PvQNEk9554JeGMOVC7h1GO9Phlt5t8cw2yYH7w8qoA+6B7nvVAEE46CtaXy5LGBIRGHxuZ9uHB6FT/ADFDKRDC08WJoJyoxgYb5x9P8a0o5zHaLJI7Mzv5hw5yP/r96hFu8UIEiriRRJHGBn269QajtoVdoUclQTh/b6VFzRItuwDQgOJNwEn7snhj1BJ74rQjeXy5nt4FELE4H3gB7k8mqEgUy+VAAQMNnpjHb8qmjuyblAhUouSVI4X/ABqSrFO4aSKJGh4IH3+cgn1qhHM0ZUBdsqyCTf1OfpWhNJK9xJIVJUHGcYBP9KjWLfI21lUggL659zTQNFm6kju9TjJeWZXA3kAIQe4wOMChctb7EcqiEhZMH5uariOW2nUrLItwQSz5/p9K37awZoxGhGF6gNkdOtDYJHP+UMqXHzNlven4AYOiBV2/Meu7nt6Vb8rybwCQ7ivAHrTnETR4ZjE3cnp9PpSuFjBnwJCIz8p4ye4q48ChCchZl6AHr/kUqQQyXJQudpUsSVxj86I4v3imJGlUdOMbh64qmxLVmxpLW1mqO+yWeaJ42jY58vOMH6mrEc8VvGkQSRG3BGQDAZaz7VXmZfOZhHn5AgAKEe/erGoefPciOYksD95j1FQ2WjX1C7H2MRyyGLcvLKcsMdD15zwKuaR9ottKnuIbYiAxrHvQ5+Ynueev61z8s1vdJEqqwVl2Ek85FT6YFtDPueYQqN0bxMA2/wDhLA8daLob8ibWbieNA05dc5CF2yzc4x+HTFY9ley208rRz+XGRnIHf0qbWkn81RNJvlDZyOPvcke3NZ91bNERH84HGPc+tCsg3QTvNeXau0iiQ8ljwc+4q0bhg0EkUhaYj94rZAx6e+aYtu9xOGkbM0xwzt0IGMHNW4LBDMyhvNTpGzjaGHqKLgo3KQmJkk+yRSZJJEY+Yrx1zW3Zyxrp0dvDAJi6hMkbdh65B7c/nSWdmI51GZA7ZC+UcP0PIPpVzYkLRjHnkZMqoMFmx8oHYDpRzByWKX2WVbZmlkjhl8wR+Xj5m4+8B2A71qWNudMbzVQpLHFudT3xzmmxRm6gkSOWQNg+bxuZV75Peo9PikubhozmTy8LGM9fUD/Ckx3OiTUpLieORlLuqqoBAI29gD+NXo7y0eynWViJS7KgB+YEHjP+NYeoSvYQIkEiP8ykLxuB681Tu9UjlV4UUNJJkjeOnPPNTuXex0EQd54EnwPN4BJx071h+JS8ZWaMlyqlBvOcZ6mqtzqN3C5S4dXlZQC20Ex9hg9s4/WotdvZ4rVGkgEKuMsYuMn6elO1hc5Xnu5rZ4pwXln27WbdjC9Bg+1VtVuFuFVItqOqj/Wn5+ByFHSl0hbjULhYpSBGSqllUEDPTPNN1RLUXE0aNNayxNhkl5I7fnVJNEOSGEr57SWwZrdX3L5g5Gcdav6fcXDyKrYkByvynGMnk1l2N3Gt0gcqEA8o5Bwp7HHeuls4tzyPCYSVUAkrhQfp60NCjK+peuFgtot7TxxzIpbc/G4jt0rPtbtIrkTyyIDLJsXD4UMRySe2Kjvb/wC0KySLuAOCpOWA9q5qVrYPNKxfacmNUwCD6n1ApJXLk7HY2LLugCuzQqjFz1xkkZGfwqxd6r5MLBpJFuBhVhK5GB1z25rl4tYaSa2+ynaiqA4PzE4+vHPpV/Wbm6cxx2sriJ2C5kO07j0GP6inYiU7Ip6pNFd3LLESJI+RgAYVs/1qOy026eIzXMjtvPAdSS+O/NZ+mvexhi4JZmOVf+Jh6Hv16Vvm5BkWRLi5kRosASHaVccFR6jOKLCUrlmPybW082aJ43idVLZOOR6+nWqN1It9IIYZGlUHcrj+EjqPTmnWcs01z9muHeQSHeYQ/wCVYVzHKl5LHFbyLmRo2iUlQCOc7unAoUbhKVtGLchLeVXnkKtu5OfnHcEDsRVK8uLJ5pDbxPHGucM0hZ5jnqfQ04edePHDjzNz/LtHcDoT3IFOSB7eGWdXG0sUbI46VSdiOXmG3VgosYmeaKSdvnaOIZMSDplu2fQZp0emSs0KOjIDyqMfmwR1HtSWlyos4LdFTYHEj5H3m6DJ9B2FdBaCW2d0nAllKsTKcMcEY4PoKGxWLMDLFZkxs4kBCKQNuRj/AOtWVNb+Y8US4BmODv8Al2gHgn3NdJZxGXRnW8jVFhVXiYDGAOAcd85qtZLai/tGuo5SdxEmWG1jjAxnp1yaRdyfSrc2M2xD5c3cKM7h6j2rq7aMu/2SQCMr80uSDnBz+tYt7PLAsEkUaqVDwB4vmBY8MTj27+9Qx30tvG6pNiUJsGUyFXvz/KltoPfU2Z5ollluiA8MTY5HB3AjH1rgtctjaXZlQNsdduSex6VrpcMbfyo2cZfdIueHPY1Xv9QRYmDxAsyBQH5B96blcLWMG+t0kmKwSiQxLjJOM8cgfSsiIhbhQ0UjKG+ZVNW2I3srK6DBZSh700yxFwsksm4DO+MYIPofU1cTOSH3kxiTyvLWC3HICjOfr71CzqrLNZkbhwsZ6gdyahubySSXAIKpwCw6+/1pbmFY4YzECJGGWOe1MmxC11m6EsnzKCCyjvjtXa6/p58TakdUs9bsBZSkMvn3HlvaDaPkKnnjHGK4a3068u2drG2nudo+byoy+PritSy0XUhCDPo9+ygkkC2fJ/SmBa8V6nb6hrlw9o5uIESKHzyMGYooBf8AE0VJ48/c+KXW3iEA+y2xMe3GD5Qzx60UhHF7WKk44/nUkQjClnOXA6GmqgMZKSdGACHqc05CYLlSFUlSDhuRTIHFkEbP1lJxgdAMdfrTFbKnGSBzxSyhWk+TkdT2570AsrMqkqG7HrigCxbxoWDbhgHOD2+o71PDzwwIk3cfSnRFYnCxqrAqDyOtWVVSu7gvnOewPpUSZtGJaiVpCq7cheA3TNWHiFy3lxRIgAKs/ZjUMJZkKEOVDbj6n6VpaeFEbKQwfna2OOetQalK3SKKDZIvLnlvp0qRVWKXeUIVDj5O49a07OzyA80G7zCQqsPlIHUj8aqXRisY8D95Gx4QnvQwMjC+awhbfEHJ2Mf506ztmEiqcg5JfjGOelTCIxqZokYKTkoBwoPbNW7WYQqX3Mu8bSR0deuD+NO4kRT2shuQdrDYQru/8LdK2dNt5bSGG4B3bshlJz/k00SNfQpD8+1Puhhhee59Tmrtg8duJIiRymSZPuhs9qhspIwtTjSa4MkT5ZurFdoGKzZmlmixIH2j0Arpru1E7SlQoV1JTaMgf561QgsFUMtxKDuOVGad7IGjDiWS5lWKSMyFR95jg4HvV2xAjklkZBt2kRhiWx71q3OnBLdZoo9hxt3N2+gptvYy+SMY8s84U8n0FJsEh8U0ZS3lS2ESnsnPzfSq188kg3fKsh+7kf5xWxbRxMrtK43IRxjgZPaob9Y2m2xEsB12jI98mpuWkYV3dTy3HnfKjqBkBQAe3H+NWrG4P2lVWCEIGDGHkIcfSrn2Fp4/NSPyQAGVSeo7/nVuawt1hjw+wjkBl5PsCPQ1VxcqKy6fKssdzHGnlHKjzmyGJPOD6elNudMlaTfKgfywQCvTAGTiknkaNEjyJs5Kxt1qa9FxdxMGlKRouEgz1HcbqLisZdpua6i8pd0Yyvlc7myPWt+AXMti9sSoVv8AVtjAU/zpdHtkSye7aNdynCAN0B/meD+dW7eU/aUmaN28zhgRgKM8f/XqWyrIzprW4thuldSwbaH6EH0/GrFtZPGZrwS4RsZHcfSrFzayTTMLxQXGcmJsqB1z9Ky8zuqsh226LkMVzz9OwoK2L8KqlvK1rN5RY78qeSp/vVkjUDbOUXJD52nBBB/vY9atFh5iRX6gArgywnbgdgR0wKzpwqX7FSsixFvLkzw49qoi6LvlhxNPOS2QDkfr9KqyX0UEhSNEdGRV3Bct1z+fatS7vYngiCR4lCBSjDk/41h31x5cTTwlYJlHLRsDgZwBz6UWBvQlEsL3U8V3crGHHm8EYI9PbjtVnXIYXtTtuI1gSNZMeZlmVjxgdtvf61xE6SO0sjMcZPrzj/69XLUiO3Xbte4cHO7+BcdfyrZGDbb0HwukcWFWRwx3DPyZPQfWkjunDu7rukZTGGcfcY9Dnuamt725jtG8plVmAUMy5KqBjAqvFbzTWqSj5Is/L3LNS0KSZsaPYLdzB4FIeOMB8HJd/UmtiQrFbIqs6+aSpTOcOO+OuMVi27GxVWdyjHjMZxg1btJJEkF7GckSrk45B29MVLZVrEuppCUklE3zADKeh/2a5vbJFJmSItlGC57ZHH4ZrtNaQTRSZZCOOVXB/CqBtPPtmcHIQfLk4J/+tmpixyVzkbbzIztAZhnHXkn0rehgU2BvxfrbXcUgSOA5MmCOCp6ADH61Ve2IP79CrISRs6ZqKNncRhwnopxnFXcnkNSGOVYZJmDTq6ksrPjPfcPQg9qfcToLK0LzyNLEDNGzYOzPX8Cce9LbMzQhroROGBGxSVz7n1x6VmapE4ynDyyDgAdB7Uuomivp2sTJqKT7kSQuG3uMqDn7xHcVq63eahqn2hjIk1rK5/e7gpY8Evt7A44FctDaXE4AQEJklRn866TRlnSLyoeFBDEnnnpx71TdiFFvUs2avv8AItVMeYyrNj5nzyeT9KjvkBtwjuocMXweRj0+ua1bdDNcPh2aRuNy+vf8cVTvrIIjLKWV93yEcBiOvHeouaLQy7a1JRNw3EtuOAAFPX9auRzIXMJJ82Q5wfurnsar290YXCGQYK/MD0GDVhfs8wMlyZWlbLRuR8ox2xjk1SQrmpYagIYri3upmCW+0w5XPmkNyM+g9ag1GQ3BEik+W0mN5HyM3dc+1Yzs4gieQuwCnyiT9057j0PWte2SXUF0+LYsNrbqSkYJzI2eXYepoaQXZqaak8VpOGlkNnk/Ih5I7/hUSvHMwDu6qPuyYya0r27jto2tkCh8YL9cZ6/lWV5aLI0toRJGCd275cj6H1rN3ZqrWM3Up0jieJZ1fB3LKowHA747Htio9SSOWzgeKUGR03PnhU9j71m3k32i9KIOS3yr0rbMZudL2b4fN3bgAOcDjmtFG5lJ2OWk+XG2Q9e1V3G9cZIGctW7cWVvAsELvh3Uuzg5Y5PSse9g8m8aEDeinPXOfxqkrCI7YoFJAJJPT/69Xt4a3ETKAzNkP3x6UmI5HZ0iYKo3MF6AVE8hEuY8Y/hz2ouK4+HUr3TBINOuri1DcP5TlS3pmrUfiHXwvmrrd9tXBI881Z0C1s2t9Y1PWYGvIbKNGWAMVDMzbQWI52irR0/Tdd0me70OBrW/tQZLjTw5dWj/AOekZPOB3HamS0Y/iDU73UHRrmcTuAPnxl8dsmitbxzEsGttFZwRW0CWkDARj7xaMEn86KCTh1kQFv3eMjC8/dNPgYKzsfvAYT2aoKn89nILBchdmMdv8aZmSeRPc3S+b/rZmO3cQAW75PanRK8reUEJYcMQMn86qs2X+c7sepq1HGYvmhkwP7ueTQNFpIHXacHBO3cfX0q/BBuJ3ZVF5O3uarW8YGzzGOMZx71sW0apbruByzHjPQe9ZNnTEsRMnyvIjYAwB2+o96bFMjSsmWyCOPb1+tNE726eYATnjGO1GmwlrpDMuUfheO3rUso33uUjklVA7BsbA/DKMfyrnnSV3+YbwM7T6DNdDNNDDC6PGXdSNsnfHesCd3tSz5DqzZKj09KVxkMs7RqSGOA29h6npz9KekymOHycttJO0Hk8ZqhOzPnCk54A+tOhZ3k2Oh2A5IHYCqEzoNJuj5IlcqSx2naPb0NXRDPJcIyR7whAJb+HJz8317VmWI3OS+6NoyPLx0Uf1rWt5zNKVAdRgFgBjcfrUMqJbV9k2xuF65TtT7iwSRtx54zuHBHvUSQoLvcjMHI6E9Owq8kTR2oVrp48552Age2aWpdjFu5ligMAYM8v3s8/L3+lIkcr28ciYG1doXGcfX3q9LZRm4neKTEe0ZZzuc1OIwkKpCp3cDg80XBaGCtpPJOjEsxHLduOvT61srGXBDQggfO5Py4+g+tU7yS5hLcx47kqckf40tlm6kKtcTQqw24ByD7e1SVc2JBG1puVAwePDqV7f4DtWJL8iLskHkq+dg5IPqK3ZvIso5Q8w2qMZB/mO9ZK2puJgqKdnUqvBJ9cUXEY8SBp5JZMGEH5VHDSY71cnk3r5aLjjZuLcsT2/KtK4isGnKGYB1QnIUn5u30qG1sXKlim5SxKjdyMU7hYruIYpoELiYBfuo3Cke9bkEVuls2JlIxljnuRms1o4545kRFDEgEhAQfXmq8itbRFmVoo1w0cmzr9RRfQFuT6lc+Ra+VDE2+VCoYEBs+mPSs37fHceV9oVoYIlC7YeC+O596POa5uSZQjIw3FuoH+FVGxO20RRhI8hCCRuNUmS9yylxF5lxG5Z1OSuD0bHc1A4DapbqhjdMfdQbgme3ueKryagIrY2+yLYcKx2YYEd8+tT6MYY0YRRZmkZf3hPA9fxquhHUW/nZEKKzC4jk3dc/u+m0++ax9YiW2uJI3jwTjO1wwIPPUcVv3BkO37OybrdXEhCg4z3I79eKwJZp7Rm+xfMhQxO+wEFWHv/OnHUUiFWtzp7oqyl9+zYTxjr8vvnOc8VBcI8cozbpAgwpx83Pse9WdMv5LIMHgURnAkMqdCPfr7478ZrT1RzqclvFskZYwZPMkG15Nx6sB06dPStNjJK7MONzEoDPuxkbAvf61oQW00RijMm9JVEgKN92mzxJBcHyirpk8qM4NSwTTrC7KyxDGMsOoPGKjc1tYbdOiFo8ks4GQeASeM1q6W7FhJJGA/mJsCHKs3TP0rDYAz+W4IKkbA3UY61vWs7CBEi3s3LFQnf+lS2Nali4hkluBHDJK6lgxDHgHvj0q1jZPJb7N22L+Lrz1z6/8A16IN1tGiyopDg4BGGX2z61kvJcWt4XM5IboQf0pIZLfFLgwJ5ITA8sMg5znofesglo7p5B8scfynt1rSvbgystwB9mdeWMnCn/7KqcscUlq91blg7tjyWYsU57Y6/WrsQ2Lp12k0zWxO1Sc5VcnA9Kj1u4Ekgi2/MgKhwNp6dKgaJ7YRyTcFjuiwcbjnH86viKS5ut8iDER2ZPTPehoEUIbPcRKqhVXGOO/pW2YTDZRyiRXGNypGMtER/eFWrKyiMsjSyEpxsVRlseoFVLhjb3AM7FcsRtA5dfcep6VLGaNgUtp2uDn5l+Ze6tjP51T8USfPHKvVowQc/nimXzXCNcHaXMb5bB3fMR0J9hVGaWOS1KXLNvC4jCgYAHUmhJgZEO9vNDRxk9iy/N+BqaG4v4rRYfn+zOxwhPG4DrSWkkbMcEGZuhc7VB/rViUXbyXU1yzuobMsijgcYqybENnFNdS4kXjAbrwSDXUJcCzthcH9/JL8sibsH0AHpVLTCtvZfLGGnPzIjDhl7EfjTbyIxQRxuoDt8xIHepY0uhoNLb2GkM8m2S8mG9dpyeezf4VBbFJLAoyhGYfPKx4z6VQkkDxqsajgZZiO/tVJrhlchAwQcbTzSTKaKuoxYmDAN5w+c9gPQU1ftFuUdJA3mIGYjtntVq9idp0lCld2OGPU+v8A9ap54c25RFIZOSccVbZPLcpbrZN0kzyFwQQgH3vYmpxNaS28x+z7ZWI8oKfljXuKrMmCCQWBPzVbuNklvAUQoVGCcdaObQfKUXbLt5QYKRgjPWo7aJZJT5oOAM8VYB2sffimXCAxgocN3pJg46Fnw/Jq8M1xceH4Z55V/dyxrD5qsh7OvQio7LRfFFlfLdWml6pBcxtvWRIGGD+XT2qPQ9SudH1SK5sd7yg7WiGSJVPVCB1zWg1j4kubx5Le11a2tXYsgkeQhF7DPetDGxDrl1qN1rE0+uReTftEgeIxeWcBcKdvbIorNvGmF47SStNKPlZnOScduaKBXRg0tJRTMheM8dPer1pIqjbMMx44IHINUasW2XOzPy+hoehSNTTn+dSwyAf1roI1VYlRWDAEHH/16yNMRNrGQgKFxye9a1o4Eojj2mM9SwxWDOmOxPcIZo1CKFj6Nk5NXLFQsqRxj7uSPpTQ/mExRxc9eD0qxD+7jWberS4OeOKkor3rmVjGDtUMeaieyYx+ZGmQflyfWr7RsiB2ACscjHvVZpGaYFCAgGMYzzQMpeQPuwwk+WvzyHgA1VWNU8wzCTcRgKoxgVvIyzYd4sP1PP3jTZFWQo0qNtHOSRnFFwSM61iu5LcMvGD8m7q3t71vWk7wQO+wfL8pAODj+lOgRY4bd4wrqp79simJG17ceWQANw5J4IpDRZ+3xOhnRcSqABGf15qoLy4dw8KYi3Z2SMGUD1HeoLqzIcxnBRSdmP4qr+U0bAsf3afffbgj0ApMdi5Oz+c7TSM85blQoCqfYfSrtqnkwkW8pdgpcrnk+vSsOMxorSCU+cvAU5wc9yaksmzciGIsZHBzITjIyKAbNO1WNnkWVwzjozdj9KY8SWb7ZJMxzEkEDlT61qNYwiD95kSM2WYnB+lUbvbCU8iIEHjDAtj6UiiLMl2iCCIM+4glzgnHtUebie4uGgi2qx28tx+FaEEoVl+fyQRljjr/APWp9xc20QQxENMVwI1Oc59aAuUJYQJNimKeVF+bKnK+mCP5VXfLny4cLKhA3gkbGPYeuetOe2ZnlZozFcM3OxsIq4/nUltZpCBErtwMr3/4FSegyxa25jSRGbGzqQSSTUGozRQwyxSREuy4Ql+/rj0qX7OIkaaZ/mb5c7j1/wDr0x7aMxrM6y7j90ryB9aY7HLW8T85Bzkkx59e/wBKs3okUfuvLLKMfLx+RrXvV8qAEBlBO3ft5Ptms+UM6LHCV64BJ5oTJaMkiS7kigzHEmfmc8Z9c+taKpJZxeVGW8knghBhvQ4NRxxBJxGSAwGcg+/etJ1MMyJdREqV/hPJq7kJIy5BHILq5/5ZxlVYscHJ6DH1HXtWP9oa4kmjXcplXHzPtUY55PermpPtvxvQMvC7Qcbh71UjtXZixjbbz34FXEiQ20W71BAkkplIUsokbpjrya3rNXkIJbzTj5g/VsDHX2rKuAkW1Z33Miqm0KVwOv8Ak1cS4JNvLEhgiPyNjnGT3pyYok8kSxIywxK3Z1xyPcVVmZrlWwpVUUNlucEfStK6QDcdnJJCuDwfpVPeehypPHHU+ufWsrmjjbYm0yC3b97IPNkPPXAA6AVrWz2o8wyKoSNtqgN1PrXNJKkUsglRigAVTuwRn29Ku2t5G8iuEjQLwq9P1q+oi/ql2ks0UMbbdrL8zHjPr9ax5bh8vLFJmNFIB9z1H51NO0cxk3ybCTkovJP49qz2cJOUfBtyQpCjBA6gA00kJlbUHneGNJyVb+72z6kVNa381t5MRKxyqoUyRgEMuSRkdCaJrZ7+R/JBZiSeWGQvYHNWILMbobWYMrgcuV+6D3x3p3sRy3K9qTc3J2LmRmwuVyoz1NdXOTZRxxQgFlG4kHk8dfes/TbSUJGWjbY3CycLwOvHqauzmRJgUJJCDexOQi5xn8qlu+hUY2JTNCtjOWXzJpR95mKsnfPFc3Pc3l+Ts3SPExd8gDp0HFS6vKsLMYvMZZGwNx7+tUIZJbiZo4SxO/dkNgntnimtNQl5GrBfSXP71UR3jZWbfwme3HTsfrUU00ktoyh/nOT5aRgFmLZ59qaLWRpNvG0khlQ9gOuKkjYmBkA2sgyr989KOZDUTJjBivpcqCuT93gZq7IwKANEIy4xweGHpVlIlR4omVfMxlyTnPuatiz85QzAArwAOwpOQ1EZZQSTW7MJWRxgAE5Bx0qa6knP2eGVVLBNpx2OeavCzBVRFksMcinpZhY0d2XJyCCeTUczL5UYt1EzqUjwMHB29ahNtkswUoox1OcfWtqO3/fBAp253c+lWprKN5JABi34Lj+I/SmuxLizMurXzo4VyS6rksBxUjWxFsdnKjkmtqJCLaVlVVTHHsPSs/BEUikf7uKbKtoc/Mm6Qse554pke7BCjIHrV50yX/ipgtirLzknsKVwUSsI1KkmPJ9ap3C7VJFbpQLgEfWqNzaMxOR8vWiLFJMd4NZkOqR2dzFaatNCq2c8rBQPmy6qx4ViOhq3a6X42juxI13dwAc+c18oUe5JbBFV9L0uwNrqGoarFJPbWcan7PG20yMzYAJ7L61FeaNY6xpsl74dSaKW3/4+tOkcyMif89EP8S+o6itkzCUbDfFXlal4rm/s545i6osksQwksoUB2HsTmivRtI8H2mn6v5kMQRDBC4TOcEoCTz6mis/aq9ilQbV2eA4op5XFMNbnJYO1SQnBGBk1HViyUNKM0PYqOrN6wgZQnRt2Gb1+lbUe3aC/HXbWfZJiFcdeMc1p20YcGTOGx0rnZ1RRbtHMp2Rg7erH0NSyoyI0arjfycrzimWilXwpwrdVH861IOC4lBKkc1JRTBdLcmRuRxx/F6YptuiSRBjEyyu3GDjgevvVswq6lwQEztVT3PrT4AqAq5BKHcMdjQVYVrdY13YGxv4T/SoruDzk3bQqL93A4/GpJNrBSHwg6jHeomfzJOGPlgYGOAfWgLAiH7V5eF24y5U5Gfart7IUUwWUO3eAqliMiqtorZcRjKYK7j1GamkAQEEruBxkUrjSIYEKAyNudV+Qdhkdyarzwif9zblXuGOSMcH6Gp7NcozM7FNxCq3T6/WkmC+bGCvJ6EcfjSKsZ80IxOhR23DGAOadpbPbyRlFDbhgLIOuOxzV/L20sm5XkX+IkdvwqtaI8t7vWNjDyV3Hn8qBNXL9tcXEK7rnO5uQFUEY9h1FNuCPMQyyZkY4ClsFQepqwYlMZ2sm5enykVUuoWiDEZkdgAZMZ20FFe58tmdwT+6IXlsk+3vVOCCae+Kom1+oCdVGen1q+0bLC0krFpTxuwMitLRoHijdsZLYG/PJY96QEqWrnaULyOehbBxTDBHG0m7lurZGM1fMfAUMSy9QOxqMKkjjj5AO/Bz/AFpX7jK0lo8jBnA8vsnp71I7xwqkedx7KOuP8auSyAQeXGuCOhPJNUoc/vPNibeUPzgDgk8D60CKEsYd5fORcZxyc7PQVn6l5NvEUhh2lgBnHJzW4Yy1p5YUqc53OOv1rMktUndVnZiVGODjJ9c0xmWsDM+WjCJHxuxyPx71FdSSXYkMZfeCOUOFYf0ro4LFWtXDSFlzuKE/eIrNu7Jo4VWPhJPkcE8Z6/nVIykkctMkhH2ic5wxBXOT9aorqUseIY5CFaTcUx98dua0tRha1aZMYz1B61iraSPJuZSYsYO3t7VqmRJOxsajHJc307ZSLbt/dBsgsemT0xWtoMD7RGyZRxguw4x6/WqemWBaERbpFR23MmOoFdAssj2aIqMETKg4AyB3qW7iirErW4FgA8SHc+FIbB/CsaRIRON37pXB+cjO3FbVqYJYgjMYzghfk3D/APXWLeqInjiQkMpPJ5xUGm5myxNMfJUJydzSA9vxqufKWRkEiFSNxbJA47VeuYClmdwdXUHp61zEjPuALPuxmtYq5E9DRub0ShViVBGg2gLk729eeau2cDQxqZVm8o/eHYPjpnpmsyzXG2Q7vNB5P+FaiSyRW0tvJGZUkO5AzH5D6jnqfWhuwkWdsDSwMPvD5iFGdv1q00O+5UBP3jENuJ6LSaZE0VskL5G8gAY6j6962YYlBhV5EZlOBx0qGy0upRlyWjhUNhBtBH8RPTNRXfm2sbiaXZGwAk28liOwFaFzbPNewOSA4VnYDqPSmS2jTTRFz053Y5x2qblnKS28moTZIeOFeMZzW1p2lGKzMqDahxn1PNbml26qGglCod2enWrdyFXeqINnQqPX1p8wrGJNbp5Wwxheigg8g1WvLZTbx7Y12ocbj3Na84ZpY0+4rsNwxycVLc2KB2255PO7tSuVYxbfScFmwNwO4H/PatG2gbyUDQ8E7i2elWk2CNjnEg4K44xU1qsibVcDJHNIdiKwjRVkZWJOSMehqOeIIxcYbfxuPY1dkVBMhx8oBY4rLc8kO2QTnFAWLIG0/O2M85qOHLN+9PGOKkZFEUYLcZyR3pAgDEZ47UDsV4yx8wcbDnrUMxZgEQ4XpyOtSyo5GyIjJPSrGA4wQPkGPxqgKcdssUJbAJzSSW+z5uMnmrM67QGQZJHIpyJ5qrnPFJjSM58BTxn1pFKbT3rUlsCRhR1rLntLq3lwFJBppMmVkUINSutMvXlthGyyr5UkMqb0lXP3WWuj8B6NNDqCakrGKdSdgUdAeox6e1T+DvD66hfPcX0XnRxFVSEnAkkY4UH26k/SvUtLQmaS3KWUkUYO1UiCh8dQpHI/GlKdtCIx6sIQ1zOLiWNFkIVSEGBwMDiitL7MsEoEX3MB1J6lTzRUFnxvMpU4qA1cuepqmetdqPOluL2q5YozOMcHtVE9B9a2dE6SH3olsEdzctk+THPA7VqRKJFAU1nWP3TWnZfwf71YSOlF23AIzuIZOCPUVeBbkRkmMnPzdaqQ/wCuP+9Vl/8Aj4X8f6VJY7KsjMDyeAgqMxL5Tbsh+SQKP+XlPrVif+P6mgoZCjGJklzg/pTkHyjO1F6e9RRn5x9f6U2//wCPhfoKTAsq+0KYx1O0L3OO9Q3cTB93y8ZIxUsn+phPfNUlJ8iQ98ijoC3JkWOOE8MxwAowcN75oDoJAPlDj+90U+1VnZst8x6etTaeMxyE8kA8mkWWEWfOzdmE/fY8FqngQGZwo+VRgj0pbTlYs/3RVi15tpc9waRIkpXKmLlQOUHQmlO/o8cY3dAD2picIuOOe31q13X60iih5KNcB33MB0XGFH+fWrVoAApY4wTsGf1qZ/vn6/0qon+tT/dNAGgUKuNzAFgenemMI2VUJOCBkdyKhXk8+9D/AOsj/GhjF1FgrjyFZlPAB/h981FbwPGEM0jsx+bGeh+lK7EbcE/ePf3qzP8AwHvigCuwUu0krSMAf4jgVFtiKK0KDbjd+NJd8x8/3aWHqw7b/wClMCEMIZ1ZHL7+NpwdpqnczNPOttG4VjullDfxe3tU5AF9cYH/ACzNUouZAx5bZjPemiWZWrWkly6kpz3w2efSqlrY7dwdiu1tyg87j9K6zUlG5uB9xKxCigKQoHPp71RD2L1g3lRySNn5wASedtSWcnlFm3Ax/wB3PzD2xVtlUQzYAHyelZcX/HtMe+0/zpXHa5JcT+WkzpH5ZDBhk/0rFQk3Tsejtnn2/lU90SY+T/y0pLofM34fzoF1Ib2YSSuIwWUDJUkZzWYdIeZxO33GPTPStC1UYuTgdavdLUY9T/Kqi7A7FLSrGNjMTGCFGAT61px6eojDv8xzUmlD5V/65ircf+uA7YP86G7gitKYjbEiNsLJ8pz29qt2Xlr/AAbJHGcYzgZ6mq0//H3EO3mdK04P+Qhd/wC6KRRRZs3S+WHDDIkb+9U0BBllZZG2gKOR90d6E/1UB75NT2Q+Vv8AfFStwQscQgkJjJkxglvXPWpZcSupt1JbOWGMAZqC+4uZAOBkcVb/AOXhfrQMimVXlBkBLbTkLxj3oV8k5Vl+vORT5f8AXN9KVP8Aj3f8KBjEBaRtwHA4JpLp+CRnIHUdqkg++/0qpL98/Q0ANmkBYKNwBGTmoVTzMA8BDkH1qaf7h+opsX/HtJ9RQMsOhwNw5x1pjwqFAGd/Wpo/9Yv0pz/6xv8AdpoXUq28W2TcRkYp6xbN+0EsxqxB2+lWLf8A1ppspBZaWWAL85rQXTET+EVqWg/dD6Uh6moKZTS1QYyBVbUIYo0LcZq8erVjar/D/vCqu7Csjc8GosAdZiUWYq6uBnY6nKkj06g121rCsUjTGOzh35zIku8DPdV9TXHaN/qh9RXTaf2+tZw13Jki5d3Eb7mRCoUBU9lAwKKqX/3m+lFWSf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A boggy plaque with pustules is present on the scalp.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42938=[""].join("\n");
var outline_f41_59_42938=null;
var title_f41_59_42939="Headache syndromes PI";
var content_f41_59_42939=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F76857&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F76857&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of common headache syndromes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Symptom",
"       </td>",
"       <td class=\"subtitle1\">",
"        Migraine headache",
"       </td>",
"       <td class=\"subtitle1\">",
"        Tension headache",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cluster headache",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Location",
"       </td>",
"       <td>",
"        Unilateral (one sided) in 60 to 70 percent; occurs on both sides of the forehead or all over the head in 30 percent of cases",
"       </td>",
"       <td>",
"        Bilateral (involves both sides of the head)",
"       </td>",
"       <td>",
"        Always unilateral, usually begins around the eye or temple",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Characteristics",
"       </td>",
"       <td>",
"        Gradual in onset, builds up over time; pulsating; moderate or severe intensity; aggravated by routine physical activity",
"       </td>",
"       <td>",
"        Pressure or tightness which waxes and wanes",
"       </td>",
"       <td>",
"        Pain begins quickly, reaches a crescendo within minutes; pain is deep, continuous, excruciating, and explosive in quality",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Activity",
"       </td>",
"       <td>",
"        Prefers to rest in a dark, quiet room",
"       </td>",
"       <td>",
"        May remain active or may need to rest",
"       </td>",
"       <td>",
"        Remains active",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Duration",
"       </td>",
"       <td>",
"        4 to 72 hours",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        30 minutes to 3 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Associated symptoms",
"       </td>",
"       <td>",
"        Nausea, vomiting, photophobia (bothered by light), phonophobia (bothered by sound); may have aura (usually visual, but can involve other senses or cause speech or motor problems)",
"       </td>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Tearing and redness of the eye on the same side as the headache; stuffy, runny nose; pallor; sweating; eye drooping; rarely neurologic deficits; sensitivity to alcohol",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42939=[""].join("\n");
var outline_f41_59_42939=null;
var title_f41_59_42940="Brands Ig for SQ IM use";
var content_f41_59_42940=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F59390&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F59390&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Immune globulin products available in the United States or Canada for subcutaneous and intramuscular use",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Trade name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Licensed route(s) of administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Manufacturer (processed by)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Available vial sizes (mL)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose adjustment factor*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Concentration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Stabilizer concentration",
"       </td>",
"       <td class=\"subtitle1\">",
"        IgA Content (average)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hizentra",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        Subcutaneous",
"       </td>",
"       <td>",
"        CSL Behring",
"       </td>",
"       <td>",
"        5, 10, 20",
"       </td>",
"       <td>",
"        1.53",
"       </td>",
"       <td>",
"        20 percent",
"       </td>",
"       <td>",
"        L-proline 0.25M",
"       </td>",
"       <td>",
"        &le;50 mcg/mL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gammagard",
"        <sup>",
"         &reg;",
"        </sup>",
"        Liquid",
"       </td>",
"       <td>",
"        Subcutaneous and intravenous",
"       </td>",
"       <td>",
"        Baxter",
"       </td>",
"       <td>",
"        <p>",
"         10, 25, 50,",
"        </p>",
"        <p>",
"         100, 200, 300",
"        </p>",
"       </td>",
"       <td>",
"        1.37",
"       </td>",
"       <td>",
"        10 percent",
"       </td>",
"       <td>",
"        Glycine 0.25M",
"       </td>",
"       <td>",
"        37 mcg/mL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gamunex",
"        <sup>",
"         &reg;",
"        </sup>",
"        -C",
"       </td>",
"       <td>",
"        Subcutaneous and intravenous",
"       </td>",
"       <td>",
"        Grifols",
"       </td>",
"       <td>",
"        <p>",
"         10, 25, 50,",
"        </p>",
"        <p>",
"         100, 200",
"        </p>",
"       </td>",
"       <td>",
"        1.37",
"       </td>",
"       <td>",
"        10 percent",
"       </td>",
"       <td>",
"        Glycine 0.16 to 0.24M",
"       </td>",
"       <td>",
"        46 mcg/mL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        GamaSTAN",
"        <sup>",
"         &reg;",
"        </sup>",
"        S/D",
"       </td>",
"       <td>",
"        Intramuscular",
"       </td>",
"       <td>",
"        Grifols",
"       </td>",
"       <td>",
"        2, 10",
"       </td>",
"       <td>",
"        Not applicable",
"       </td>",
"       <td>",
"        15 to 18 percent",
"       </td>",
"       <td>",
"        Glycine 0.21 to 0.32M",
"       </td>",
"       <td>",
"        Not specified",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gammaked&trade;",
"       </td>",
"       <td>",
"        Subcutaneous and intravenous",
"       </td>",
"       <td>",
"        Grifols",
"       </td>",
"       <td>",
"        10, 25, 50, 100, 200",
"       </td>",
"       <td>",
"        1.37",
"       </td>",
"       <td>",
"        10 percent",
"       </td>",
"       <td>",
"        Glycine 0.16 to 0.24M",
"       </td>",
"       <td>",
"        46 mcg/mL",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     M: mol/L",
"     <br>",
"      * To calculate the initial weekly dose for subcutaneous administration, multiply the previous&nbsp;intravenous immunoglobulin&nbsp;dose in grams by the dose adjustment factor shown; then divide this by the number of weeks between doses (eg,&nbsp;three or four).",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: US licensed product information&nbsp;(available online at",
"     <a href=\"file://dailymed.nlm.nih.gov/dailymed/about.cfm\" target=\"_blank\">",
"      file://dailymed.nlm.nih.gov/dailymed/about.cfm",
"     </a>",
"     , accessed on&nbsp;April 26, 2012) and Health Canada licensed product monograph (available online at",
"     <a href=\"file://webprod3.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp\">",
"      file://webprod3.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp",
"     </a>",
"     accessed on April 26, 2012). All preparations are in liquid form.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42940=[""].join("\n");
var outline_f41_59_42940=null;
var title_f41_59_42941="Antifungal susceptibility testing indications";
var content_f41_59_42941=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F52140&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F52140&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for antifungal susceptibility testing",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Clinical setting",
"       </td>",
"       <td class=\"subtitle1\">",
"        Recommendation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"7\">",
"        Routine",
"       </td>",
"       <td>",
"        &bull; Species level identification of all",
"        <em>",
"         Candida",
"        </em>",
"        isolates from deep sites (eg, blood, normally sterile fluids, tissues, abscesses).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Species level identification of",
"        <em>",
"         Aspergillus",
"        </em>",
"        , genus level for all other molds.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Species level (if possible) identification of non-candidal yeast isolates from deep sites (eg, blood, normally sterile fluids, tissues, abscesses).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Selection of therapy is generally based on published consensus guidelines and review of survey data on the organism-drug combination in question.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Routine susceptibility testing of fluconazole, voriconazole,&nbsp;and&nbsp;an echinocandin&nbsp;against",
"        <em>",
"         C. glabrata",
"        </em>",
"        and fluconazole against non-candidal yeast isolates from deep sites (eg, blood, normally sterile fluids, tissues, abscesses).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Susceptibility testing of fluconazole, voriconazole, an echinocandin, and flucytosine against other species of",
"        <em>",
"         Candida",
"        </em>",
"        may be helpful in special circumstances, but not routinely, since susceptibility is usually predictable.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Susceptibility of",
"        <em>",
"         Candida",
"        </em>",
"        spp other than",
"        <em>",
"         C. glabrata",
"        </em>",
"        to echinocandins may be assumed unless initial response is suboptimal. Susceptibility testing of isolates to an echinocandin should be considered if there is a prior history of exposure to this class of agents.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Mucosal&nbsp;candidiasis",
"       </td>",
"       <td>",
"        &bull; Susceptibility testing may be useful for patients unresponsive to therapy.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        Invasive disease with clinical failure of initial therapy",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &bull; Consider susceptibility testing.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         Candida",
"        </em>",
"        spp: amphotericin B, flucytosine, fluconazole, voriconazole, echinocandins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         C. neoformans",
"        </em>",
"        : fluconazole, amphotericin B, flucytosine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         Aspergillus",
"        </em>",
"        species: amphotericin B, posaconazole, itraconazole, voriconazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Consultation with an experienced microbiologist recommended",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"12\">",
"        Infection with species with high rates of intrinsic or acquired resistance",
"       </td>",
"       <td class=\"sublist1_start\">",
"        &bull; Susceptibility testing not necessary when intrinsic resistance is known.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         A. terreus",
"        </em>",
"        : amphotericin B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         C. krusei",
"        </em>",
"        : fluconazole, flucytosine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         Cryptococcus",
"        </em>",
"        and",
"        <em>",
"         Trichosporon",
"        </em>",
"        : echinocandins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         Rhodotorula",
"        </em>",
"        : azoles, echinocandins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         Mucorales",
"        </em>",
"        : voriconazole, echinocandins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        &bull; For species with significant rates of acquired resistance, monitor closely for signs of failure and perform susceptibility testing as needed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         C. glabrata",
"        </em>",
"        : fluconazole, voriconazole, amphotericin B, echinocandins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         C. krusei",
"        </em>",
"        : amphotericin B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         C. lusitaniae",
"        </em>",
"        : amphotericin B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         C. rugosa",
"        </em>",
"        : amphotericin B, fluconazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        -",
"        <em>",
"         Candida",
"        </em>",
"        spp: flucytosine, when used for endocarditis",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Unusual organisms",
"       </td>",
"       <td>",
"        &bull; Susceptibility testing may be helpful when treating patients infected with unusual organisms for which susceptibility patterns have not been well established or are unpredictable.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Mold infections",
"       </td>",
"       <td>",
"        &bull; Species level identification of",
"        <em>",
"         Aspergillus",
"        </em>",
"        , genus level for all other molds.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Routine susceptibility testing not recommended.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Susceptibility of",
"        <em>",
"         Aspergillus",
"        </em>",
"        species to itraconazole, voriconazole, and posaconazole may help to determine cross-resistance.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &bull; Clinical interpretive criteria have not been established for any agents.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Pfaller MA. Antifungal susceptibility testing methods. Curr Drug Targets 2005; 6:929.",
"       </li>",
"       <li>",
"        Rex JH, Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis 2002; 35:982.",
"       </li>",
"       <li>",
"        Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:503.",
"       </li>",
"       <li>",
"        Pfaller MA, Wu WL. Antifungal susceptibility testing: new technology and clinical applications. Infect Dis Clin N Am 2001; 15:1227.",
"       </li>",
"       <li>",
"        Spellberg BJ, Filler SG, Edwards JE Jr. Current treatment strategies for disseminated candidiasis. Clin Infect Dis 2006; 42:244.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42941=[""].join("\n");
var outline_f41_59_42941=null;
var title_f41_59_42942="Middle phalanx fracture with impaction lateral xray";
var content_f41_59_42942=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F55860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F55860&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Middle phalanx fracture with impaction: Lateral view",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 247px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This lateral radiograph shows significant volar impaction and dorsal subluxation of the middle phalanx.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Strickland JW, Graham TJ. Master Techniques in Orthopeadic Surgery: The Hand, 2nd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2005. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42942=[""].join("\n");
var outline_f41_59_42942=null;
var title_f41_59_42943="Croup lateral neck";
var content_f41_59_42943=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F64727&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F64727&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Croup lateral neck radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 368px; height: 389px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lateral neck radiograph showing subglottic narrowing and distended hypopharynx consistent with acute laryngotracheitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joe Black, Diagnostic Imaging, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f41_59_42943=[""].join("\n");
var outline_f41_59_42943=null;
